id	sid	tid	token	lemma	pos
bjos-8668998	1	1	1	1	NUM
bjos-8668998	1	2	volume	volume	NOUN
bjos-8668998	1	3	22	22	NUM
bjos-8668998	1	4	2023	2023	NUM
bjos-8668998	1	5	e238998	e238998	NUM
bjos-8668998	1	6	original	original	ADJ
bjos-8668998	1	7	article	article	NOUN
bjos-8668998	1	8	braz	braz	PROPN
bjos-8668998	1	9	j	j	PROPN
bjos-8668998	1	10	oral	oral	PROPN
bjos-8668998	1	11	sci	sci	PROPN
bjos-8668998	1	12	.	.	PUNCT
bjos-8668998	2	1	2023;22	2023;22	NUM
bjos-8668998	2	2	:	:	PUNCT
bjos-8668998	2	3	e238998http://dx.doi.org/10.20396	e238998http://dx.doi.org/10.20396	X
bjos-8668998	2	4	/	/	SYM
bjos-8668998	2	5	bjos.v22i00.8668998	bjos.v22i00.8668998	NOUN
bjos-8668998	2	6	1	1	NUM
bjos-8668998	2	7	department	department	NOUN
bjos-8668998	2	8	of	of	ADP
bjos-8668998	2	9	stomatology	stomatology	NOUN
bjos-8668998	2	10	,	,	PUNCT
bjos-8668998	2	11	school	school	NOUN
bjos-8668998	2	12	of	of	ADP
bjos-8668998	2	13	dentistry	dentistry	NOUN
bjos-8668998	2	14	,	,	PUNCT
bjos-8668998	2	15	federal	federal	ADJ
bjos-8668998	2	16	university	university	PROPN
bjos-8668998	2	17	of	of	ADP
bjos-8668998	2	18	paraná	paraná	PROPN
bjos-8668998	2	19	,	,	PUNCT
bjos-8668998	2	20	curitiba	curitiba	PROPN
bjos-8668998	2	21	,	,	PUNCT
bjos-8668998	2	22	paraná	paraná	PROPN
bjos-8668998	2	23	,	,	PUNCT
bjos-8668998	2	24	brazil	brazil	PROPN
bjos-8668998	2	25	.	.	PUNCT
bjos-8668998	3	1	2	2	NUM
bjos-8668998	3	2	bone	bone	NOUN
bjos-8668998	3	3	marrow	marrow	NOUN
bjos-8668998	3	4	transplantation	transplantation	NOUN
bjos-8668998	3	5	program	program	NOUN
bjos-8668998	3	6	,	,	PUNCT
bjos-8668998	3	7	clinical	clinical	ADJ
bjos-8668998	3	8	hospital	hospital	NOUN
bjos-8668998	3	9	complex	complex	NOUN
bjos-8668998	3	10	,	,	PUNCT
bjos-8668998	3	11	federal	federal	ADJ
bjos-8668998	3	12	university	university	PROPN
bjos-8668998	3	13	of	of	ADP
bjos-8668998	3	14	paraná	paraná	PROPN
bjos-8668998	3	15	,	,	PUNCT
bjos-8668998	3	16	curitiba	curitiba	PROPN
bjos-8668998	3	17	,	,	PUNCT
bjos-8668998	3	18	paraná	paraná	PROPN
bjos-8668998	3	19	,	,	PUNCT
bjos-8668998	3	20	brazil	brazil	PROPN
bjos-8668998	3	21	.	.	PUNCT
bjos-8668998	4	1	corresponding	correspond	VERB
bjos-8668998	4	2	author	author	NOUN
bjos-8668998	4	3	:	:	PUNCT
bjos-8668998	4	4	juliana	juliana	PROPN
bjos-8668998	4	5	lucena	lucena	PROPN
bjos-8668998	4	6	schussel	schussel	PROPN
bjos-8668998	4	7	dds	dds	PROPN
bjos-8668998	4	8	,	,	PUNCT
bjos-8668998	4	9	phd	phd	PROPN
bjos-8668998	4	10	department	department	PROPN
bjos-8668998	4	11	of	of	ADP
bjos-8668998	4	12	stomatology	stomatology	NOUN
bjos-8668998	4	13	,	,	PUNCT
bjos-8668998	4	14	federal	federal	ADJ
bjos-8668998	4	15	university	university	PROPN
bjos-8668998	4	16	of	of	ADP
bjos-8668998	4	17	paraná	paraná	PROPN
bjos-8668998	4	18	,	,	PUNCT
bjos-8668998	4	19	av	av	PROPN
bjos-8668998	4	20	.	.	PROPN
bjos-8668998	4	21	lothário	lothário	PROPN
bjos-8668998	4	22	meissner	meissner	PROPN
bjos-8668998	4	23	632	632	NUM
bjos-8668998	4	24	jardim	jardim	PROPN
bjos-8668998	4	25	botânico	botânico	PROPN
bjos-8668998	4	26	curitiba	curitiba	PROPN
bjos-8668998	4	27	paraná	paraná	PROPN
bjos-8668998	4	28	brazil	brazil	PROPN
bjos-8668998	4	29	cep	cep	VERB
bjos-8668998	4	30	:	:	PUNCT
bjos-8668998	4	31	80210	80210	NUM
bjos-8668998	4	32	-	-	SYM
bjos-8668998	4	33	170	170	NUM
bjos-8668998	4	34	telephone	telephone	NOUN
bjos-8668998	4	35	:	:	PUNCT
bjos-8668998	4	36	+55	+55	PROPN
bjos-8668998	4	37	41	41	NUM
bjos-8668998	4	38	3360	3360	NUM
bjos-8668998	4	39	-	-	SYM
bjos-8668998	4	40	4024	4024	NUM
bjos-8668998	4	41	fax	fax	NOUN
bjos-8668998	4	42	:	:	PUNCT
bjos-8668998	4	43	+55	+55	PROPN
bjos-8668998	4	44	41	41	NUM
bjos-8668998	4	45	33604053	33604053	NUM
bjos-8668998	4	46	e	e	NOUN
bjos-8668998	4	47	-	-	NOUN
bjos-8668998	4	48	mail	mail	NOUN
bjos-8668998	4	49	:	:	PUNCT
bjos-8668998	4	50	juliana.schussel24@gmail.com	juliana.schussel24@gmail.com	X
bjos-8668998	4	51	editor	editor	NOUN
bjos-8668998	4	52	:	:	PUNCT
bjos-8668998	4	53	dr	dr	PROPN
bjos-8668998	4	54	.	.	PROPN
bjos-8668998	4	55	altair	altair	PROPN
bjos-8668998	4	56	a.	a.	PROPN
bjos-8668998	4	57	del	del	PROPN
bjos-8668998	4	58	bel	bel	PROPN
bjos-8668998	4	59	cury	cury	PROPN
bjos-8668998	4	60	received	receive	VERB
bjos-8668998	4	61	:	:	PUNCT
bjos-8668998	4	62	august	august	PROPN
bjos-8668998	4	63	8	8	NUM
bjos-8668998	4	64	,	,	PUNCT
bjos-8668998	4	65	2022	2022	NUM
bjos-8668998	4	66	accepted	accept	VERB
bjos-8668998	4	67	:	:	PUNCT
bjos-8668998	4	68	november	november	PROPN
bjos-8668998	4	69	11	11	NUM
bjos-8668998	4	70	,	,	PUNCT
bjos-8668998	4	71	2022	2022	NUM
bjos-8668998	4	72	can	can	AUX
bjos-8668998	4	73	nlr	nlr	PROPN
bjos-8668998	4	74	be	be	AUX
bjos-8668998	4	75	a	a	DET
bjos-8668998	4	76	biomarker	biomarker	NOUN
bjos-8668998	4	77	for	for	ADP
bjos-8668998	4	78	mucositis	mucositis	NOUN
bjos-8668998	4	79	and	and	CCONJ
bjos-8668998	4	80	gvhd	gvhd	NOUN
bjos-8668998	4	81	in	in	ADP
bjos-8668998	4	82	patients	patient	NOUN
bjos-8668998	4	83	undergoing	undergo	VERB
bjos-8668998	4	84	allogeneic	allogeneic	ADJ
bjos-8668998	4	85	hsct	hsct	PROPN
bjos-8668998	4	86	?	?	PUNCT
bjos-8668998	5	1	isabella	isabella	PROPN
bjos-8668998	5	2	christina	christina	PROPN
bjos-8668998	5	3	costa	costa	PROPN
bjos-8668998	5	4	quadras1	quadras1	PROPN
bjos-8668998	5	5	,	,	PUNCT
bjos-8668998	5	6	fernanda	fernanda	PROPN
bjos-8668998	5	7	aparecida	aparecida	PROPN
bjos-8668998	5	8	stresser1	stresser1	PROPN
bjos-8668998	5	9	,	,	PUNCT
bjos-8668998	5	10	stephanie	stephanie	PROPN
bjos-8668998	5	11	von	von	PROPN
bjos-8668998	5	12	stein	stein	PROPN
bjos-8668998	5	13	cubas	cubas	PROPN
bjos-8668998	5	14	warnavin1	warnavin1	PROPN
bjos-8668998	5	15	,	,	PUNCT
bjos-8668998	5	16	vaneuza	vaneuza	NOUN
bjos-8668998	5	17	araújo	araújo	PROPN
bjos-8668998	5	18	moreira	moreira	PROPN
bjos-8668998	5	19	funke2	funke2	PROPN
bjos-8668998	5	20	,	,	PUNCT
bjos-8668998	5	21	rafael	rafael	PROPN
bjos-8668998	5	22	zancan	zancan	PROPN
bjos-8668998	5	23	mobile1	mobile1	PROPN
bjos-8668998	5	24	,	,	PUNCT
bjos-8668998	5	25	juliana	juliana	PROPN
bjos-8668998	5	26	lucena	lucena	PROPN
bjos-8668998	5	27	schussel1	schussel1	PROPN
bjos-8668998	5	28	,	,	PUNCT
bjos-8668998	5	29	*	*	PUNCT
bjos-8668998	5	30	allogeneic	allogeneic	ADJ
bjos-8668998	5	31	hematopoietic	hematopoietic	ADJ
bjos-8668998	5	32	stem	stem	NOUN
bjos-8668998	5	33	cell	cell	NOUN
bjos-8668998	5	34	transplantation	transplantation	NOUN
bjos-8668998	5	35	(	(	PUNCT
bjos-8668998	5	36	hsct	hsct	PROPN
bjos-8668998	5	37	)	)	PUNCT
bjos-8668998	5	38	is	be	AUX
bjos-8668998	5	39	a	a	DET
bjos-8668998	5	40	treatment	treatment	NOUN
bjos-8668998	5	41	for	for	ADP
bjos-8668998	5	42	many	many	ADJ
bjos-8668998	5	43	diseases	disease	NOUN
bjos-8668998	5	44	;	;	PUNCT
bjos-8668998	5	45	however	however	ADV
bjos-8668998	5	46	,	,	PUNCT
bjos-8668998	5	47	it	it	PRON
bjos-8668998	5	48	can	can	AUX
bjos-8668998	5	49	induce	induce	VERB
bjos-8668998	5	50	complications	complication	NOUN
bjos-8668998	5	51	such	such	ADJ
bjos-8668998	5	52	as	as	ADP
bjos-8668998	5	53	oral	oral	ADJ
bjos-8668998	5	54	mucositis	mucositis	NOUN
bjos-8668998	5	55	(	(	PUNCT
bjos-8668998	5	56	om	om	PROPN
bjos-8668998	5	57	)	)	PUNCT
bjos-8668998	5	58	and	and	CCONJ
bjos-8668998	5	59	graft	graft	NOUN
bjos-8668998	5	60	-	-	PUNCT
bjos-8668998	5	61	versushost	versushost	ADJ
bjos-8668998	5	62	disease	disease	NOUN
bjos-8668998	5	63	(	(	PUNCT
bjos-8668998	5	64	gvhd	gvhd	PROPN
bjos-8668998	5	65	)	)	PUNCT
bjos-8668998	5	66	.	.	PUNCT
bjos-8668998	6	1	the	the	DET
bjos-8668998	6	2	neutrophil	neutrophil	ADJ
bjos-8668998	6	3	-	-	PUNCT
bjos-8668998	6	4	lymphocyte	lymphocyte	ADJ
bjos-8668998	6	5	ratio	ratio	NOUN
bjos-8668998	6	6	(	(	PUNCT
bjos-8668998	6	7	nlr	nlr	PROPN
bjos-8668998	6	8	)	)	PUNCT
bjos-8668998	6	9	is	be	AUX
bjos-8668998	6	10	a	a	DET
bjos-8668998	6	11	peripheral	peripheral	ADJ
bjos-8668998	6	12	biomarker	biomarker	NOUN
bjos-8668998	6	13	of	of	ADP
bjos-8668998	6	14	systemic	systemic	ADJ
bjos-8668998	6	15	inflammation	inflammation	NOUN
bjos-8668998	6	16	and	and	CCONJ
bjos-8668998	6	17	an	an	DET
bjos-8668998	6	18	independent	independent	ADJ
bjos-8668998	6	19	prognostic	prognostic	ADJ
bjos-8668998	6	20	factor	factor	NOUN
bjos-8668998	6	21	for	for	ADP
bjos-8668998	6	22	several	several	ADJ
bjos-8668998	6	23	inflammatory	inflammatory	ADJ
bjos-8668998	6	24	diseases	disease	NOUN
bjos-8668998	6	25	.	.	PUNCT
bjos-8668998	7	1	aim	aim	NOUN
bjos-8668998	7	2	:	:	PUNCT
bjos-8668998	8	1	this	this	DET
bjos-8668998	8	2	study	study	NOUN
bjos-8668998	8	3	aimed	aim	VERB
bjos-8668998	8	4	to	to	PART
bjos-8668998	8	5	evaluate	evaluate	VERB
bjos-8668998	8	6	the	the	DET
bjos-8668998	8	7	association	association	NOUN
bjos-8668998	8	8	of	of	ADP
bjos-8668998	8	9	nlr	nlr	PROPN
bjos-8668998	8	10	with	with	ADP
bjos-8668998	8	11	om	om	PROPN
bjos-8668998	8	12	and	and	CCONJ
bjos-8668998	8	13	gvhd	gvhd	PROPN
bjos-8668998	8	14	in	in	ADP
bjos-8668998	8	15	patients	patient	NOUN
bjos-8668998	8	16	undergoing	undergo	VERB
bjos-8668998	8	17	allogeneic	allogeneic	ADJ
bjos-8668998	8	18	hsct	hsct	PROPN
bjos-8668998	8	19	.	.	PUNCT
bjos-8668998	9	1	methods	method	NOUN
bjos-8668998	9	2	:	:	PUNCT
bjos-8668998	9	3	patients	patient	NOUN
bjos-8668998	9	4	who	who	PRON
bjos-8668998	9	5	underwent	undergo	VERB
bjos-8668998	9	6	allogeneic	allogeneic	ADJ
bjos-8668998	9	7	hsct	hsct	NOUN
bjos-8668998	9	8	at	at	ADP
bjos-8668998	9	9	the	the	DET
bjos-8668998	9	10	bone	bone	NOUN
bjos-8668998	9	11	marrow	marrow	NOUN
bjos-8668998	9	12	transplant	transplant	NOUN
bjos-8668998	9	13	service	service	NOUN
bjos-8668998	9	14	of	of	ADP
bjos-8668998	9	15	the	the	DET
bjos-8668998	9	16	hospital	hospital	NOUN
bjos-8668998	9	17	de	de	X
bjos-8668998	9	18	clínicas	clínicas	X
bjos-8668998	9	19	complex	complex	NOUN
bjos-8668998	9	20	of	of	ADP
bjos-8668998	9	21	the	the	DET
bjos-8668998	9	22	federal	federal	ADJ
bjos-8668998	9	23	university	university	PROPN
bjos-8668998	9	24	of	of	ADP
bjos-8668998	9	25	paraná	paraná	PROPN
bjos-8668998	9	26	were	be	AUX
bjos-8668998	9	27	included	include	VERB
bjos-8668998	9	28	in	in	ADP
bjos-8668998	9	29	the	the	DET
bjos-8668998	9	30	study	study	NOUN
bjos-8668998	9	31	.	.	PUNCT
bjos-8668998	10	1	socio	socio	NOUN
bjos-8668998	10	2	-	-	ADJ
bjos-8668998	10	3	demographic	demographic	ADJ
bjos-8668998	10	4	data	datum	NOUN
bjos-8668998	10	5	and	and	CCONJ
bjos-8668998	10	6	blood	blood	NOUN
bjos-8668998	10	7	counts	count	NOUN
bjos-8668998	10	8	were	be	AUX
bjos-8668998	10	9	collected	collect	VERB
bjos-8668998	10	10	from	from	ADP
bjos-8668998	10	11	patients	patient	NOUN
bjos-8668998	10	12	’	'	PUNCT
bjos-8668998	10	13	medical	medical	ADJ
bjos-8668998	10	14	records	record	NOUN
bjos-8668998	10	15	.	.	PUNCT
bjos-8668998	11	1	the	the	DET
bjos-8668998	11	2	nlr	nlr	PROPN
bjos-8668998	11	3	was	be	AUX
bjos-8668998	11	4	calculated	calculate	VERB
bjos-8668998	11	5	and	and	CCONJ
bjos-8668998	11	6	associated	associate	VERB
bjos-8668998	11	7	with	with	ADP
bjos-8668998	11	8	om	om	PROPN
bjos-8668998	11	9	and	and	CCONJ
bjos-8668998	11	10	gvhd	gvhd	PROPN
bjos-8668998	11	11	.	.	PUNCT
bjos-8668998	12	1	results	result	NOUN
bjos-8668998	12	2	:	:	PUNCT
bjos-8668998	12	3	45	45	NUM
bjos-8668998	12	4	patients	patient	NOUN
bjos-8668998	12	5	were	be	AUX
bjos-8668998	12	6	included	include	VERB
bjos-8668998	12	7	in	in	ADP
bjos-8668998	12	8	the	the	DET
bjos-8668998	12	9	study	study	NOUN
bjos-8668998	12	10	.	.	PUNCT
bjos-8668998	13	1	although	although	SCONJ
bjos-8668998	13	2	nlr	nlr	PROPN
bjos-8668998	13	3	was	be	AUX
bjos-8668998	13	4	higher	high	ADJ
bjos-8668998	13	5	in	in	ADP
bjos-8668998	13	6	patients	patient	NOUN
bjos-8668998	13	7	with	with	ADP
bjos-8668998	13	8	om	om	PROPN
bjos-8668998	13	9	and	and	CCONJ
bjos-8668998	13	10	oral	oral	ADJ
bjos-8668998	13	11	gvhd	gvhd	NOUN
bjos-8668998	13	12	,	,	PUNCT
bjos-8668998	13	13	no	no	DET
bjos-8668998	13	14	statistical	statistical	ADJ
bjos-8668998	13	15	difference	difference	NOUN
bjos-8668998	13	16	was	be	AUX
bjos-8668998	13	17	observed	observe	VERB
bjos-8668998	13	18	,	,	PUNCT
bjos-8668998	13	19	and	and	CCONJ
bjos-8668998	13	20	no	no	DET
bjos-8668998	13	21	relationship	relationship	NOUN
bjos-8668998	13	22	between	between	ADP
bjos-8668998	13	23	om	om	PROPN
bjos-8668998	13	24	and	and	CCONJ
bjos-8668998	13	25	gvhd	gvhd	PROPN
bjos-8668998	13	26	with	with	ADP
bjos-8668998	13	27	nlr	nlr	PROPN
bjos-8668998	13	28	could	could	AUX
bjos-8668998	13	29	be	be	AUX
bjos-8668998	13	30	stated	state	VERB
bjos-8668998	13	31	.	.	PUNCT
bjos-8668998	14	1	conclusion	conclusion	NOUN
bjos-8668998	14	2	:	:	PUNCT
bjos-8668998	14	3	although	although	SCONJ
bjos-8668998	14	4	both	both	PRON
bjos-8668998	14	5	om	om	PROPN
bjos-8668998	14	6	and	and	CCONJ
bjos-8668998	14	7	gvhd	gvhd	PROPN
bjos-8668998	14	8	are	be	AUX
bjos-8668998	14	9	associated	associate	VERB
bjos-8668998	14	10	with	with	ADP
bjos-8668998	14	11	an	an	DET
bjos-8668998	14	12	inflammatory	inflammatory	ADJ
bjos-8668998	14	13	response	response	NOUN
bjos-8668998	14	14	as	as	ADV
bjos-8668998	14	15	well	well	ADV
bjos-8668998	14	16	as	as	ADP
bjos-8668998	14	17	the	the	DET
bjos-8668998	14	18	immune	immune	ADJ
bjos-8668998	14	19	system	system	NOUN
bjos-8668998	14	20	,	,	PUNCT
bjos-8668998	14	21	it	it	PRON
bjos-8668998	14	22	was	be	AUX
bjos-8668998	14	23	not	not	PART
bjos-8668998	14	24	associated	associate	VERB
bjos-8668998	14	25	with	with	ADP
bjos-8668998	14	26	nlr	nlr	PROPN
bjos-8668998	14	27	.	.	PUNCT
bjos-8668998	15	1	further	further	ADJ
bjos-8668998	15	2	investigation	investigation	NOUN
bjos-8668998	15	3	considering	consider	VERB
bjos-8668998	15	4	other	other	ADJ
bjos-8668998	15	5	variables	variable	NOUN
bjos-8668998	15	6	related	relate	VERB
bjos-8668998	15	7	to	to	ADP
bjos-8668998	15	8	hsct	hsct	PROPN
bjos-8668998	15	9	might	might	AUX
bjos-8668998	15	10	find	find	VERB
bjos-8668998	15	11	possible	possible	ADJ
bjos-8668998	15	12	associations	association	NOUN
bjos-8668998	15	13	,	,	PUNCT
bjos-8668998	15	14	as	as	SCONJ
bjos-8668998	15	15	it	it	PRON
bjos-8668998	15	16	could	could	AUX
bjos-8668998	15	17	favor	favor	VERB
bjos-8668998	15	18	patient	patient	ADJ
bjos-8668998	15	19	management	management	NOUN
bjos-8668998	15	20	and	and	CCONJ
bjos-8668998	15	21	prevention	prevention	NOUN
bjos-8668998	15	22	.	.	PUNCT
bjos-8668998	16	1	keywords	keyword	NOUN
bjos-8668998	16	2	:	:	PUNCT
bjos-8668998	16	3	neutrophils	neutrophil	NOUN
bjos-8668998	16	4	.	.	PUNCT
bjos-8668998	17	1	lymphocytes	lymphocyte	NOUN
bjos-8668998	17	2	.	.	PUNCT
bjos-8668998	18	1	hematopoietic	hematopoietic	ADJ
bjos-8668998	18	2	stem	stem	NOUN
bjos-8668998	18	3	cell	cell	NOUN
bjos-8668998	18	4	transplantation	transplantation	NOUN
bjos-8668998	18	5	.	.	PUNCT
bjos-8668998	19	1	mucositis	mucositis	NOUN
bjos-8668998	19	2	.	.	PUNCT
bjos-8668998	20	1	graft	graft	NOUN
bjos-8668998	20	2	vs	vs	ADP
bjos-8668998	20	3	host	host	NOUN
bjos-8668998	20	4	disease	disease	NOUN
bjos-8668998	20	5	.	.	PUNCT
bjos-8668998	21	1	https://orcid.org/0000-0003-0541-7254	https://orcid.org/0000-0003-0541-7254	PROPN
bjos-8668998	21	2	https://orcid.org/0000-0002-7995-3466	https://orcid.org/0000-0002-7995-3466	PROPN
bjos-8668998	21	3	https://orcid.org/0000-0001-9829-6230	https://orcid.org/0000-0001-9829-6230	VERB
bjos-8668998	21	4	https://orcid.org/0000-0002-2122-7277	https://orcid.org/0000-0002-2122-7277	PROPN
bjos-8668998	21	5	https://orcid.org/0000-0002-8603-2614	https://orcid.org/0000-0002-8603-2614	PROPN
bjos-8668998	21	6	https://orcid.org/0000-0001-5204-0782	https://orcid.org/0000-0001-5204-0782	NOUN
bjos-8668998	21	7	2	2	NUM
bjos-8668998	21	8	quadras	quadra	NOUN
bjos-8668998	21	9	et	et	PROPN
bjos-8668998	22	1	al	al	PROPN
bjos-8668998	22	2	.	.	PROPN
bjos-8668998	22	3	braz	braz	PROPN
bjos-8668998	22	4	j	j	PROPN
bjos-8668998	22	5	oral	oral	PROPN
bjos-8668998	22	6	sci	sci	PROPN
bjos-8668998	22	7	.	.	PUNCT
bjos-8668998	23	1	2023;22	2023;22	NUM
bjos-8668998	23	2	:	:	PUNCT
bjos-8668998	23	3	e238998	e238998	NOUN
bjos-8668998	23	4	abbreviations	abbreviation	NOUN
bjos-8668998	23	5	hsct	hsct	PROPN
bjos-8668998	23	6	,	,	PUNCT
bjos-8668998	23	7	hematopoietic	hematopoietic	ADJ
bjos-8668998	23	8	stem	stem	NOUN
bjos-8668998	23	9	cell	cell	NOUN
bjos-8668998	23	10	transplantation	transplantation	NOUN
bjos-8668998	23	11	;	;	PUNCT
bjos-8668998	23	12	om	om	PROPN
bjos-8668998	23	13	,	,	PUNCT
bjos-8668998	23	14	oral	oral	ADJ
bjos-8668998	23	15	mucositis	mucositis	NOUN
bjos-8668998	23	16	;	;	PUNCT
bjos-8668998	23	17	gvhd	gvhd	NOUN
bjos-8668998	23	18	,	,	PUNCT
bjos-8668998	23	19	graft	graft	NOUN
bjos-8668998	23	20	-	-	PUNCT
bjos-8668998	23	21	versus	versus	ADP
bjos-8668998	23	22	-	-	PUNCT
bjos-8668998	23	23	host	host	NOUN
bjos-8668998	23	24	disease	disease	NOUN
bjos-8668998	23	25	;	;	PUNCT
bjos-8668998	23	26	nlr	nlr	PROPN
bjos-8668998	23	27	,	,	PUNCT
bjos-8668998	23	28	neutrophil	neutrophil	ADJ
bjos-8668998	23	29	-	-	PUNCT
bjos-8668998	23	30	lymphocyte	lymphocyte	NOUN
bjos-8668998	23	31	ratio	ratio	NOUN
bjos-8668998	23	32	;	;	PUNCT
bjos-8668998	23	33	stmo	stmo	NOUN
bjos-8668998	23	34	-	-	PUNCT
bjos-8668998	23	35	chc	chc	PROPN
bjos-8668998	23	36	,	,	PUNCT
bjos-8668998	23	37	serviço	serviço	X
bjos-8668998	23	38	de	de	X
bjos-8668998	23	39	transplante	transplante	PROPN
bjos-8668998	23	40	de	de	PROPN
bjos-8668998	23	41	medula	medula	PROPN
bjos-8668998	23	42	óssea	óssea	NOUN
bjos-8668998	23	43	of	of	ADP
bjos-8668998	23	44	the	the	DET
bjos-8668998	23	45	complexo	complexo	PROPN
bjos-8668998	23	46	hospital	hospital	PROPN
bjos-8668998	23	47	de	de	X
bjos-8668998	23	48	clínicas	clínicas	PROPN
bjos-8668998	23	49	;	;	PUNCT
bjos-8668998	23	50	mascc	mascc	ADJ
bjos-8668998	23	51	/	/	SYM
bjos-8668998	23	52	isoo	isoo	ADJ
bjos-8668998	23	53	,	,	PUNCT
bjos-8668998	23	54	multinational	multinational	ADJ
bjos-8668998	23	55	association	association	NOUN
bjos-8668998	23	56	of	of	ADP
bjos-8668998	23	57	supportive	supportive	ADJ
bjos-8668998	23	58	care	care	NOUN
bjos-8668998	23	59	in	in	ADP
bjos-8668998	23	60	cancer	cancer	NOUN
bjos-8668998	23	61	and	and	CCONJ
bjos-8668998	23	62	international	international	ADJ
bjos-8668998	23	63	society	society	NOUN
bjos-8668998	23	64	of	of	ADP
bjos-8668998	23	65	oral	oral	ADJ
bjos-8668998	23	66	oncology	oncology	NOUN
bjos-8668998	23	67	;	;	PUNCT
bjos-8668998	23	68	spss	spss	ADJ
bjos-8668998	23	69	,	,	PUNCT
bjos-8668998	23	70	statistical	statistical	ADJ
bjos-8668998	23	71	package	package	NOUN
bjos-8668998	23	72	for	for	ADP
bjos-8668998	23	73	the	the	DET
bjos-8668998	23	74	social	social	ADJ
bjos-8668998	23	75	sciences	science	NOUN
bjos-8668998	23	76	.	.	PUNCT
bjos-8668998	24	1	introduction	introduction	NOUN
bjos-8668998	24	2	allogeneic	allogeneic	VERB
bjos-8668998	24	3	hematopoietic	hematopoietic	ADJ
bjos-8668998	24	4	stem	stem	NOUN
bjos-8668998	24	5	cell	cell	NOUN
bjos-8668998	24	6	transplantation	transplantation	NOUN
bjos-8668998	24	7	(	(	PUNCT
bjos-8668998	24	8	hsct	hsct	PROPN
bjos-8668998	24	9	)	)	PUNCT
bjos-8668998	24	10	is	be	AUX
bjos-8668998	24	11	considered	consider	VERB
bjos-8668998	24	12	a	a	DET
bjos-8668998	24	13	curative	curative	ADJ
bjos-8668998	24	14	treatment	treatment	NOUN
bjos-8668998	24	15	for	for	ADP
bjos-8668998	24	16	a	a	DET
bjos-8668998	24	17	variety	variety	NOUN
bjos-8668998	24	18	of	of	ADP
bjos-8668998	24	19	neoplastic	neoplastic	ADJ
bjos-8668998	24	20	and	and	CCONJ
bjos-8668998	24	21	non	non	ADJ
bjos-8668998	24	22	-	-	ADJ
bjos-8668998	24	23	neoplastic	neoplastic	ADJ
bjos-8668998	24	24	hematological	hematological	ADJ
bjos-8668998	24	25	diseases1,2	diseases1,2	PROPN
bjos-8668998	24	26	that	that	PRON
bjos-8668998	24	27	cause	cause	VERB
bjos-8668998	24	28	bone	bone	NOUN
bjos-8668998	24	29	marrow	marrow	NOUN
bjos-8668998	24	30	defects	defect	NOUN
bjos-8668998	24	31	,	,	PUNCT
bjos-8668998	24	32	such	such	ADJ
bjos-8668998	24	33	as	as	ADP
bjos-8668998	24	34	anemia	anemia	NOUN
bjos-8668998	24	35	,	,	PUNCT
bjos-8668998	24	36	leukemia	leukemia	NOUN
bjos-8668998	24	37	,	,	PUNCT
bjos-8668998	24	38	and	and	CCONJ
bjos-8668998	24	39	lymphoma1,3	lymphoma1,3	PROPN
bjos-8668998	24	40	.	.	PUNCT
bjos-8668998	25	1	hsct	hsct	PROPN
bjos-8668998	25	2	occurs	occur	VERB
bjos-8668998	25	3	by	by	ADP
bjos-8668998	25	4	replacing	replace	VERB
bjos-8668998	25	5	receptor	receptor	NOUN
bjos-8668998	25	6	cells	cell	NOUN
bjos-8668998	25	7	with	with	ADP
bjos-8668998	25	8	hematopoietic	hematopoietic	ADJ
bjos-8668998	25	9	progenitor	progenitor	NOUN
bjos-8668998	25	10	cells4	cells4	PROPN
bjos-8668998	25	11	.	.	PUNCT
bjos-8668998	26	1	oral	oral	ADJ
bjos-8668998	26	2	mucositis	mucositis	NOUN
bjos-8668998	26	3	(	(	PUNCT
bjos-8668998	26	4	om	om	PROPN
bjos-8668998	26	5	)	)	PUNCT
bjos-8668998	26	6	and	and	CCONJ
bjos-8668998	26	7	graft	graft	NOUN
bjos-8668998	26	8	-	-	PUNCT
bjos-8668998	26	9	versus	versus	ADP
bjos-8668998	26	10	-	-	PUNCT
bjos-8668998	26	11	host	host	NOUN
bjos-8668998	26	12	disease	disease	NOUN
bjos-8668998	26	13	(	(	PUNCT
bjos-8668998	26	14	gvhd	gvhd	PROPN
bjos-8668998	26	15	)	)	PUNCT
bjos-8668998	26	16	are	be	AUX
bjos-8668998	26	17	potential	potential	ADJ
bjos-8668998	26	18	consequences	consequence	NOUN
bjos-8668998	26	19	of	of	ADP
bjos-8668998	26	20	hsct	hsct	PROPN
bjos-8668998	26	21	.	.	PUNCT
bjos-8668998	27	1	om	om	PROPN
bjos-8668998	27	2	is	be	AUX
bjos-8668998	27	3	an	an	DET
bjos-8668998	27	4	inflammation	inflammation	NOUN
bjos-8668998	27	5	of	of	ADP
bjos-8668998	27	6	the	the	DET
bjos-8668998	27	7	mucosa	mucosa	NOUN
bjos-8668998	27	8	that	that	PRON
bjos-8668998	27	9	occurs	occur	VERB
bjos-8668998	27	10	in	in	ADP
bjos-8668998	27	11	approximately	approximately	ADV
bjos-8668998	27	12	75	75	NUM
bjos-8668998	27	13	%	%	NOUN
bjos-8668998	27	14	of	of	ADP
bjos-8668998	27	15	patients	patient	NOUN
bjos-8668998	27	16	who	who	PRON
bjos-8668998	27	17	receive	receive	VERB
bjos-8668998	27	18	ablative	ablative	ADJ
bjos-8668998	27	19	chemotherapy	chemotherapy	NOUN
bjos-8668998	27	20	or	or	CCONJ
bjos-8668998	27	21	total	total	ADJ
bjos-8668998	27	22	body	body	NOUN
bjos-8668998	27	23	irradiation	irradiation	NOUN
bjos-8668998	27	24	as	as	ADP
bjos-8668998	27	25	conditioning	conditioning	NOUN
bjos-8668998	27	26	for	for	ADP
bjos-8668998	27	27	hsct	hsct	NOUN
bjos-8668998	27	28	,	,	PUNCT
bjos-8668998	27	29	intensifying	intensify	VERB
bjos-8668998	27	30	in	in	ADP
bjos-8668998	27	31	the	the	DET
bjos-8668998	27	32	first	first	ADJ
bjos-8668998	27	33	two	two	NUM
bjos-8668998	27	34	weeks	week	NOUN
bjos-8668998	27	35	after	after	ADP
bjos-8668998	27	36	transplantation	transplantation	NOUN
bjos-8668998	27	37	,	,	PUNCT
bjos-8668998	27	38	which	which	PRON
bjos-8668998	27	39	may	may	AUX
bjos-8668998	27	40	reduce	reduce	VERB
bjos-8668998	27	41	their	their	PRON
bjos-8668998	27	42	ability	ability	NOUN
bjos-8668998	27	43	to	to	PART
bjos-8668998	27	44	ingest	ingest	VERB
bjos-8668998	27	45	food	food	NOUN
bjos-8668998	27	46	due	due	ADP
bjos-8668998	27	47	to	to	ADP
bjos-8668998	27	48	pain	pain	NOUN
bjos-8668998	27	49	and	and	CCONJ
bjos-8668998	27	50	discomfort5	discomfort5	NOUN
bjos-8668998	27	51	.	.	PUNCT
bjos-8668998	28	1	the	the	DET
bjos-8668998	28	2	pathophysiology	pathophysiology	NOUN
bjos-8668998	28	3	of	of	ADP
bjos-8668998	28	4	gvhd	gvhd	NOUN
bjos-8668998	28	5	is	be	AUX
bjos-8668998	28	6	not	not	PART
bjos-8668998	28	7	yet	yet	ADV
bjos-8668998	28	8	fully	fully	ADV
bjos-8668998	28	9	understood6	understood6	ADJ
bjos-8668998	28	10	,	,	PUNCT
bjos-8668998	28	11	however	however	ADV
bjos-8668998	28	12	it	it	PRON
bjos-8668998	28	13	is	be	AUX
bjos-8668998	28	14	known	know	VERB
bjos-8668998	28	15	to	to	PART
bjos-8668998	28	16	result	result	VERB
bjos-8668998	28	17	from	from	ADP
bjos-8668998	28	18	an	an	DET
bjos-8668998	28	19	immunological	immunological	ADJ
bjos-8668998	28	20	attack	attack	NOUN
bjos-8668998	28	21	by	by	ADP
bjos-8668998	28	22	donor	donor	NOUN
bjos-8668998	28	23	immunocompetent	immunocompetent	ADJ
bjos-8668998	28	24	t	t	PROPN
bjos-8668998	28	25	-	-	PUNCT
bjos-8668998	28	26	cells	cell	NOUN
bjos-8668998	28	27	in	in	ADP
bjos-8668998	28	28	the	the	DET
bjos-8668998	28	29	recipient	recipient	NOUN
bjos-8668998	28	30	patient	patient	NOUN
bjos-8668998	28	31	’s	’s	PART
bjos-8668998	28	32	tissues7	tissues7	NOUN
bjos-8668998	28	33	,	,	PUNCT
bjos-8668998	28	34	either	either	CCONJ
bjos-8668998	28	35	directly	directly	ADV
bjos-8668998	28	36	or	or	CCONJ
bjos-8668998	28	37	through	through	ADP
bjos-8668998	28	38	exaggerated	exaggerated	ADJ
bjos-8668998	28	39	inflammatory	inflammatory	ADJ
bjos-8668998	28	40	responses	response	NOUN
bjos-8668998	28	41	after	after	ADP
bjos-8668998	28	42	allogeneic	allogeneic	ADJ
bjos-8668998	28	43	hsct	hsct	NOUN
bjos-8668998	28	44	,	,	PUNCT
bjos-8668998	28	45	manifesting	manifest	VERB
bjos-8668998	28	46	in	in	ADP
bjos-8668998	28	47	30–50	30–50	NUM
bjos-8668998	28	48	%	%	NOUN
bjos-8668998	28	49	of	of	ADP
bjos-8668998	28	50	cases7	cases7	NOUN
bjos-8668998	28	51	-	-	PUNCT
bjos-8668998	28	52	9	9	NUM
bjos-8668998	28	53	.	.	X
bjos-8668998	28	54	gvhd	gvhd	PROPN
bjos-8668998	28	55	can	can	AUX
bjos-8668998	28	56	affect	affect	VERB
bjos-8668998	28	57	one	one	NUM
bjos-8668998	28	58	or	or	CCONJ
bjos-8668998	28	59	more	more	ADJ
bjos-8668998	28	60	sites	site	NOUN
bjos-8668998	28	61	in	in	ADP
bjos-8668998	28	62	the	the	DET
bjos-8668998	28	63	body	body	NOUN
bjos-8668998	28	64	and	and	CCONJ
bjos-8668998	28	65	is	be	AUX
bjos-8668998	28	66	considered	consider	VERB
bjos-8668998	28	67	one	one	NUM
bjos-8668998	28	68	of	of	ADP
bjos-8668998	28	69	the	the	DET
bjos-8668998	28	70	main	main	ADJ
bjos-8668998	28	71	causes	cause	NOUN
bjos-8668998	28	72	of	of	ADP
bjos-8668998	28	73	morbidity	morbidity	NOUN
bjos-8668998	28	74	and	and	CCONJ
bjos-8668998	28	75	mortality	mortality	NOUN
bjos-8668998	28	76	after	after	ADP
bjos-8668998	28	77	hsct	hsct	PROPN
bjos-8668998	28	78	.	.	PUNCT
bjos-8668998	29	1	the	the	DET
bjos-8668998	29	2	oral	oral	ADJ
bjos-8668998	29	3	cavity	cavity	NOUN
bjos-8668998	29	4	is	be	AUX
bjos-8668998	29	5	frequently	frequently	ADV
bjos-8668998	29	6	affected	affect	VERB
bjos-8668998	29	7	,	,	PUNCT
bjos-8668998	29	8	especially	especially	ADV
bjos-8668998	29	9	chronic	chronic	ADJ
bjos-8668998	29	10	variant	variant	NOUN
bjos-8668998	29	11	that	that	PRON
bjos-8668998	29	12	correspond	correspond	VERB
bjos-8668998	29	13	to	to	ADP
bjos-8668998	29	14	the	the	DET
bjos-8668998	29	15	manifestations	manifestation	NOUN
bjos-8668998	29	16	present	present	ADJ
bjos-8668998	29	17	after	after	ADP
bjos-8668998	29	18	the	the	DET
bjos-8668998	29	19	+100	+100	NUM
bjos-8668998	29	20	day	day	NOUN
bjos-8668998	29	21	after	after	ADP
bjos-8668998	29	22	hsct	hsct	NOUN
bjos-8668998	29	23	and	and	CCONJ
bjos-8668998	29	24	affect	affect	VERB
bjos-8668998	29	25	between	between	ADP
bjos-8668998	29	26	25	25	NUM
bjos-8668998	29	27	%	%	NOUN
bjos-8668998	29	28	and	and	CCONJ
bjos-8668998	29	29	83	83	NUM
bjos-8668998	29	30	%	%	NOUN
bjos-8668998	29	31	of	of	ADP
bjos-8668998	29	32	patients1,3,8,10	patients1,3,8,10	PROPN
bjos-8668998	29	33	.	.	PUNCT
bjos-8668998	30	1	the	the	DET
bjos-8668998	30	2	neutrophil	neutrophil	ADJ
bjos-8668998	30	3	-	-	PUNCT
bjos-8668998	30	4	lymphocyte	lymphocyte	ADJ
bjos-8668998	30	5	ratio	ratio	NOUN
bjos-8668998	30	6	(	(	PUNCT
bjos-8668998	30	7	nlr	nlr	PROPN
bjos-8668998	30	8	)	)	PUNCT
bjos-8668998	30	9	,	,	PUNCT
bjos-8668998	30	10	initially	initially	ADV
bjos-8668998	30	11	described	describe	VERB
bjos-8668998	30	12	by	by	ADP
bjos-8668998	30	13	zahorec	zahorec	PROPN
bjos-8668998	30	14	et	et	PROPN
bjos-8668998	30	15	al.11	al.11	PROPN
bjos-8668998	30	16	,	,	PUNCT
bjos-8668998	30	17	is	be	AUX
bjos-8668998	30	18	a	a	DET
bjos-8668998	30	19	peripheral	peripheral	ADJ
bjos-8668998	30	20	biomarker	biomarker	NOUN
bjos-8668998	30	21	of	of	ADP
bjos-8668998	30	22	systemic	systemic	ADJ
bjos-8668998	30	23	inflammation	inflammation	NOUN
bjos-8668998	30	24	and	and	CCONJ
bjos-8668998	30	25	an	an	DET
bjos-8668998	30	26	independent	independent	ADJ
bjos-8668998	30	27	prognostic	prognostic	ADJ
bjos-8668998	30	28	factor	factor	NOUN
bjos-8668998	30	29	in	in	ADP
bjos-8668998	30	30	several	several	ADJ
bjos-8668998	30	31	inflammatory	inflammatory	ADJ
bjos-8668998	30	32	,	,	PUNCT
bjos-8668998	30	33	cardiovascular	cardiovascular	ADJ
bjos-8668998	30	34	diseases	disease	NOUN
bjos-8668998	30	35	,	,	PUNCT
bjos-8668998	30	36	and	and	CCONJ
bjos-8668998	30	37	solid	solid	ADJ
bjos-8668998	30	38	hematological	hematological	ADJ
bjos-8668998	30	39	neoplasms12	neoplasms12	NOUN
bjos-8668998	30	40	-	-	PUNCT
bjos-8668998	30	41	15	15	NUM
bjos-8668998	30	42	.	.	PUNCT
bjos-8668998	31	1	nlr	nlr	PROPN
bjos-8668998	31	2	is	be	AUX
bjos-8668998	31	3	an	an	DET
bjos-8668998	31	4	indirect	indirect	ADJ
bjos-8668998	31	5	measure	measure	NOUN
bjos-8668998	31	6	of	of	ADP
bjos-8668998	31	7	the	the	DET
bjos-8668998	31	8	imbalance	imbalance	NOUN
bjos-8668998	31	9	between	between	ADP
bjos-8668998	31	10	the	the	DET
bjos-8668998	31	11	innate	innate	ADJ
bjos-8668998	31	12	immune	immune	NOUN
bjos-8668998	31	13	(	(	PUNCT
bjos-8668998	31	14	neutrophils	neutrophil	NOUN
bjos-8668998	31	15	)	)	PUNCT
bjos-8668998	31	16	and	and	CCONJ
bjos-8668998	31	17	adaptive	adaptive	ADJ
bjos-8668998	31	18	or	or	CCONJ
bjos-8668998	31	19	humorous	humorous	ADJ
bjos-8668998	31	20	(	(	PUNCT
bjos-8668998	31	21	lymphocytes	lymphocyte	NOUN
bjos-8668998	31	22	)	)	PUNCT
bjos-8668998	31	23	systems	system	NOUN
bjos-8668998	31	24	,	,	PUNCT
bjos-8668998	31	25	obtained	obtain	VERB
bjos-8668998	31	26	by	by	ADP
bjos-8668998	31	27	the	the	DET
bjos-8668998	31	28	absolute	absolute	ADJ
bjos-8668998	31	29	count	count	NOUN
bjos-8668998	31	30	of	of	ADP
bjos-8668998	31	31	neutrophils	neutrophil	NOUN
bjos-8668998	31	32	divided	divide	VERB
bjos-8668998	31	33	by	by	ADP
bjos-8668998	31	34	the	the	DET
bjos-8668998	31	35	absolute	absolute	ADJ
bjos-8668998	31	36	count	count	NOUN
bjos-8668998	31	37	of	of	ADP
bjos-8668998	31	38	lymphocytes	lymphocyte	NOUN
bjos-8668998	31	39	,	,	PUNCT
bjos-8668998	31	40	which	which	PRON
bjos-8668998	31	41	is	be	AUX
bjos-8668998	31	42	a	a	DET
bjos-8668998	31	43	biomarker	biomarker	NOUN
bjos-8668998	31	44	of	of	ADP
bjos-8668998	31	45	low	low	ADJ
bjos-8668998	31	46	cost	cost	NOUN
bjos-8668998	31	47	,	,	PUNCT
bjos-8668998	31	48	reliability	reliability	NOUN
bjos-8668998	31	49	,	,	PUNCT
bjos-8668998	31	50	and	and	CCONJ
bjos-8668998	31	51	simple	simple	ADJ
bjos-8668998	31	52	collection	collection	NOUN
bjos-8668998	31	53	through	through	ADP
bjos-8668998	31	54	a	a	DET
bjos-8668998	31	55	common	common	ADJ
bjos-8668998	31	56	peripheral	peripheral	ADJ
bjos-8668998	31	57	blood	blood	NOUN
bjos-8668998	31	58	count12,14,16,17	count12,14,16,17	NOUN
bjos-8668998	31	59	.	.	PUNCT
bjos-8668998	32	1	it	it	PRON
bjos-8668998	32	2	can	can	AUX
bjos-8668998	32	3	be	be	AUX
bjos-8668998	32	4	used	use	VERB
bjos-8668998	32	5	in	in	ADP
bjos-8668998	32	6	a	a	DET
bjos-8668998	32	7	series	series	NOUN
bjos-8668998	32	8	of	of	ADP
bjos-8668998	32	9	inflammatory	inflammatory	ADJ
bjos-8668998	32	10	diseases12,17	diseases12,17	NOUN
bjos-8668998	32	11	-	-	SYM
bjos-8668998	32	12	22	22	NUM
bjos-8668998	32	13	and	and	CCONJ
bjos-8668998	32	14	is	be	AUX
bjos-8668998	32	15	an	an	DET
bjos-8668998	32	16	important	important	ADJ
bjos-8668998	32	17	marker	marker	NOUN
bjos-8668998	32	18	of	of	ADP
bjos-8668998	32	19	poor	poor	ADJ
bjos-8668998	32	20	prognosis	prognosis	NOUN
bjos-8668998	32	21	,	,	PUNCT
bjos-8668998	32	22	overall	overall	ADJ
bjos-8668998	32	23	survival	survival	NOUN
bjos-8668998	32	24	,	,	PUNCT
bjos-8668998	32	25	and	and	CCONJ
bjos-8668998	32	26	disease	disease	NOUN
bjos-8668998	32	27	-	-	PUNCT
bjos-8668998	32	28	free	free	ADJ
bjos-8668998	32	29	survival19	survival19	NOUN
bjos-8668998	32	30	.	.	PUNCT
bjos-8668998	33	1	to	to	ADP
bjos-8668998	33	2	the	the	DET
bjos-8668998	33	3	best	good	ADJ
bjos-8668998	33	4	of	of	ADP
bjos-8668998	33	5	our	our	PRON
bjos-8668998	33	6	knowledge	knowledge	NOUN
bjos-8668998	33	7	,	,	PUNCT
bjos-8668998	33	8	there	there	PRON
bjos-8668998	33	9	is	be	VERB
bjos-8668998	33	10	little	little	ADJ
bjos-8668998	33	11	evidence	evidence	NOUN
bjos-8668998	33	12	of	of	ADP
bjos-8668998	33	13	the	the	DET
bjos-8668998	33	14	use	use	NOUN
bjos-8668998	33	15	of	of	ADP
bjos-8668998	33	16	nlr	nlr	PROPN
bjos-8668998	33	17	as	as	ADP
bjos-8668998	33	18	a	a	DET
bjos-8668998	33	19	biomarker	biomarker	NOUN
bjos-8668998	33	20	after	after	ADP
bjos-8668998	33	21	hsct23	hsct23	NOUN
bjos-8668998	33	22	,	,	PUNCT
bjos-8668998	33	23	and	and	CCONJ
bjos-8668998	33	24	perhaps	perhaps	ADV
bjos-8668998	33	25	no	no	DET
bjos-8668998	33	26	evidence	evidence	NOUN
bjos-8668998	33	27	of	of	ADP
bjos-8668998	33	28	its	its	PRON
bjos-8668998	33	29	application	application	NOUN
bjos-8668998	33	30	in	in	ADP
bjos-8668998	33	31	the	the	DET
bjos-8668998	33	32	assessment	assessment	NOUN
bjos-8668998	33	33	of	of	ADP
bjos-8668998	33	34	om	om	PROPN
bjos-8668998	33	35	and	and	CCONJ
bjos-8668998	33	36	gvhd	gvhd	PROPN
bjos-8668998	33	37	after	after	ADP
bjos-8668998	33	38	hsct	hsct	PROPN
bjos-8668998	33	39	.	.	PUNCT
bjos-8668998	34	1	om	om	PROPN
bjos-8668998	34	2	and	and	CCONJ
bjos-8668998	34	3	gvhd	gvhd	PROPN
bjos-8668998	34	4	are	be	AUX
bjos-8668998	34	5	exacerbated	exacerbate	VERB
bjos-8668998	34	6	inflammatory	inflammatory	ADJ
bjos-8668998	34	7	processes	process	NOUN
bjos-8668998	34	8	that	that	PRON
bjos-8668998	34	9	affect	affect	VERB
bjos-8668998	34	10	the	the	DET
bjos-8668998	34	11	prognosis	prognosis	NOUN
bjos-8668998	34	12	of	of	ADP
bjos-8668998	34	13	allogeneic	allogeneic	ADJ
bjos-8668998	34	14	hsct	hsct	NOUN
bjos-8668998	34	15	patients	patient	NOUN
bjos-8668998	34	16	.	.	PUNCT
bjos-8668998	35	1	therefore	therefore	ADV
bjos-8668998	35	2	,	,	PUNCT
bjos-8668998	35	3	it	it	PRON
bjos-8668998	35	4	is	be	AUX
bjos-8668998	35	5	essential	essential	ADJ
bjos-8668998	35	6	to	to	PART
bjos-8668998	35	7	consider	consider	VERB
bjos-8668998	35	8	markers	marker	NOUN
bjos-8668998	35	9	that	that	PRON
bjos-8668998	35	10	can	can	AUX
bjos-8668998	35	11	assist	assist	VERB
bjos-8668998	35	12	in	in	ADP
bjos-8668998	35	13	the	the	DET
bjos-8668998	35	14	prediction	prediction	NOUN
bjos-8668998	35	15	,	,	PUNCT
bjos-8668998	35	16	management	management	NOUN
bjos-8668998	35	17	,	,	PUNCT
bjos-8668998	35	18	and	and	CCONJ
bjos-8668998	35	19	treatment	treatment	NOUN
bjos-8668998	35	20	of	of	ADP
bjos-8668998	35	21	these	these	DET
bjos-8668998	35	22	conditions	condition	NOUN
bjos-8668998	35	23	.	.	PUNCT
bjos-8668998	36	1	3	3	NUM
bjos-8668998	36	2	quadras	quadras	NOUN
bjos-8668998	36	3	et	et	PROPN
bjos-8668998	36	4	al	al	PROPN
bjos-8668998	36	5	.	.	PROPN
bjos-8668998	37	1	braz	braz	PROPN
bjos-8668998	37	2	j	j	PROPN
bjos-8668998	37	3	oral	oral	PROPN
bjos-8668998	37	4	sci	sci	PROPN
bjos-8668998	37	5	.	.	PUNCT
bjos-8668998	38	1	2023;22	2023;22	NUM
bjos-8668998	38	2	:	:	PUNCT
bjos-8668998	38	3	e238998	e238998	NOUN
bjos-8668998	38	4	aim	aim	VERB
bjos-8668998	38	5	considering	consider	VERB
bjos-8668998	38	6	the	the	DET
bjos-8668998	38	7	applicability	applicability	NOUN
bjos-8668998	38	8	of	of	ADP
bjos-8668998	38	9	nlr	nlr	PROPN
bjos-8668998	38	10	to	to	ADP
bjos-8668998	38	11	a	a	DET
bjos-8668998	38	12	series	series	NOUN
bjos-8668998	38	13	of	of	ADP
bjos-8668998	38	14	inflammatory	inflammatory	ADJ
bjos-8668998	38	15	diseases	disease	NOUN
bjos-8668998	38	16	,	,	PUNCT
bjos-8668998	38	17	this	this	DET
bjos-8668998	38	18	study	study	NOUN
bjos-8668998	38	19	aimed	aim	VERB
bjos-8668998	38	20	to	to	PART
bjos-8668998	38	21	evaluate	evaluate	VERB
bjos-8668998	38	22	the	the	DET
bjos-8668998	38	23	association	association	NOUN
bjos-8668998	38	24	of	of	ADP
bjos-8668998	38	25	nlr	nlr	PROPN
bjos-8668998	38	26	with	with	ADP
bjos-8668998	38	27	om	om	PROPN
bjos-8668998	38	28	and	and	CCONJ
bjos-8668998	38	29	gvhd	gvhd	PROPN
bjos-8668998	38	30	in	in	ADP
bjos-8668998	38	31	patients	patient	NOUN
bjos-8668998	38	32	undergoing	undergo	VERB
bjos-8668998	38	33	allogeneic	allogeneic	ADJ
bjos-8668998	38	34	hsct	hsct	NOUN
bjos-8668998	38	35	.	.	PUNCT
bjos-8668998	39	1	materials	material	NOUN
bjos-8668998	39	2	and	and	CCONJ
bjos-8668998	39	3	methods	method	NOUN
bjos-8668998	39	4	this	this	DET
bjos-8668998	39	5	longitudinal	longitudinal	ADJ
bjos-8668998	39	6	observational	observational	ADJ
bjos-8668998	39	7	study	study	NOUN
bjos-8668998	39	8	included	include	VERB
bjos-8668998	39	9	a	a	DET
bjos-8668998	39	10	convenience	convenience	NOUN
bjos-8668998	39	11	sample	sample	NOUN
bjos-8668998	39	12	of	of	ADP
bjos-8668998	39	13	45	45	NUM
bjos-8668998	39	14	patients	patient	NOUN
bjos-8668998	39	15	,	,	PUNCT
bjos-8668998	39	16	older	old	ADJ
bjos-8668998	39	17	than	than	ADP
bjos-8668998	39	18	18	18	NUM
bjos-8668998	39	19	years	year	NOUN
bjos-8668998	39	20	,	,	PUNCT
bjos-8668998	39	21	admitted	admit	VERB
bjos-8668998	39	22	to	to	ADP
bjos-8668998	39	23	the	the	DET
bjos-8668998	39	24	serviço	serviço	PROPN
bjos-8668998	39	25	de	de	X
bjos-8668998	39	26	transplante	transplante	X
bjos-8668998	39	27	de	de	PROPN
bjos-8668998	39	28	medula	medula	PROPN
bjos-8668998	39	29	óssea	óssea	NOUN
bjos-8668998	39	30	of	of	ADP
bjos-8668998	39	31	the	the	DET
bjos-8668998	39	32	complexo	complexo	PROPN
bjos-8668998	39	33	hospital	hospital	PROPN
bjos-8668998	39	34	de	de	ADP
bjos-8668998	39	35	clínicas	clínicas	PROPN
bjos-8668998	39	36	of	of	ADP
bjos-8668998	39	37	the	the	DET
bjos-8668998	39	38	universidade	universidade	PROPN
bjos-8668998	39	39	federal	federal	PROPN
bjos-8668998	39	40	do	do	AUX
bjos-8668998	39	41	paraná	paraná	PROPN
bjos-8668998	39	42	,	,	PUNCT
bjos-8668998	39	43	and	and	CCONJ
bjos-8668998	39	44	who	who	PRON
bjos-8668998	39	45	underwent	undergo	VERB
bjos-8668998	39	46	allogeneic	allogeneic	ADJ
bjos-8668998	39	47	hsct	hsct	PROPN
bjos-8668998	39	48	.	.	PUNCT
bjos-8668998	40	1	this	this	DET
bjos-8668998	40	2	study	study	NOUN
bjos-8668998	40	3	was	be	AUX
bjos-8668998	40	4	approved	approve	VERB
bjos-8668998	40	5	by	by	ADP
bjos-8668998	40	6	the	the	DET
bjos-8668998	40	7	research	research	NOUN
bjos-8668998	40	8	ethics	ethic	NOUN
bjos-8668998	40	9	committee	committee	PROPN
bjos-8668998	40	10	of	of	ADP
bjos-8668998	40	11	the	the	DET
bjos-8668998	40	12	complexo	complexo	PROPN
bjos-8668998	40	13	hospital	hospital	PROPN
bjos-8668998	40	14	de	de	ADP
bjos-8668998	40	15	clínicas	clínicas	PROPN
bjos-8668998	40	16	of	of	ADP
bjos-8668998	40	17	the	the	DET
bjos-8668998	40	18	universidade	universidade	PROPN
bjos-8668998	40	19	federal	federal	PROPN
bjos-8668998	40	20	do	do	VERB
bjos-8668998	40	21	paraná	paraná	PROPN
bjos-8668998	40	22	(	(	PUNCT
bjos-8668998	40	23	number	number	NOUN
bjos-8668998	40	24	4.414.355	4.414.355	NUM
bjos-8668998	40	25	)	)	PUNCT
bjos-8668998	40	26	.	.	PUNCT
bjos-8668998	41	1	those	those	PRON
bjos-8668998	41	2	who	who	PRON
bjos-8668998	41	3	agreed	agree	VERB
bjos-8668998	41	4	to	to	PART
bjos-8668998	41	5	participate	participate	VERB
bjos-8668998	41	6	signed	sign	VERB
bjos-8668998	41	7	an	an	DET
bjos-8668998	41	8	informed	informed	ADJ
bjos-8668998	41	9	consent	consent	NOUN
bjos-8668998	41	10	form	form	NOUN
bjos-8668998	41	11	.	.	PUNCT
bjos-8668998	42	1	the	the	DET
bjos-8668998	42	2	inclusion	inclusion	NOUN
bjos-8668998	42	3	criteria	criterion	NOUN
bjos-8668998	42	4	consisted	consist	VERB
bjos-8668998	42	5	of	of	ADP
bjos-8668998	42	6	patients	patient	NOUN
bjos-8668998	42	7	older	old	ADJ
bjos-8668998	42	8	than	than	ADP
bjos-8668998	42	9	18	18	NUM
bjos-8668998	42	10	years	year	NOUN
bjos-8668998	42	11	who	who	PRON
bjos-8668998	42	12	underwent	undergo	VERB
bjos-8668998	42	13	hsct	hsct	NOUN
bjos-8668998	42	14	.	.	PUNCT
bjos-8668998	43	1	exclusion	exclusion	NOUN
bjos-8668998	43	2	criteria	criterion	NOUN
bjos-8668998	43	3	consisted	consist	VERB
bjos-8668998	43	4	of	of	ADP
bjos-8668998	43	5	patients	patient	NOUN
bjos-8668998	43	6	undergoing	undergo	VERB
bjos-8668998	43	7	autologous	autologous	ADJ
bjos-8668998	43	8	hsct	hsct	NOUN
bjos-8668998	43	9	,	,	PUNCT
bjos-8668998	43	10	and	and	CCONJ
bjos-8668998	43	11	those	those	PRON
bjos-8668998	43	12	with	with	ADP
bjos-8668998	43	13	fanconi	fanconi	PROPN
bjos-8668998	43	14	anemia	anemia	NOUN
bjos-8668998	43	15	as	as	ADP
bjos-8668998	43	16	an	an	DET
bjos-8668998	43	17	underlying	underlying	ADJ
bjos-8668998	43	18	disease	disease	NOUN
bjos-8668998	43	19	were	be	AUX
bjos-8668998	43	20	excluded	exclude	VERB
bjos-8668998	43	21	.	.	PUNCT
bjos-8668998	44	1	sociodemographic	sociodemographic	ADJ
bjos-8668998	44	2	data	datum	NOUN
bjos-8668998	44	3	and	and	CCONJ
bjos-8668998	44	4	blood	blood	NOUN
bjos-8668998	44	5	count	count	NOUN
bjos-8668998	44	6	results	result	NOUN
bjos-8668998	44	7	were	be	AUX
bjos-8668998	44	8	collected	collect	VERB
bjos-8668998	44	9	from	from	ADP
bjos-8668998	44	10	patients	patient	NOUN
bjos-8668998	44	11	’	'	PUNCT
bjos-8668998	44	12	medical	medical	ADJ
bjos-8668998	44	13	records	record	NOUN
bjos-8668998	44	14	.	.	PUNCT
bjos-8668998	45	1	nlr	nlr	PROPN
bjos-8668998	45	2	was	be	AUX
bjos-8668998	45	3	calculated	calculate	VERB
bjos-8668998	45	4	using	use	VERB
bjos-8668998	45	5	a	a	DET
bjos-8668998	45	6	spreadsheet	spreadsheet	NOUN
bjos-8668998	45	7	in	in	ADP
bjos-8668998	45	8	excel	excel	NOUN
bjos-8668998	45	9	for	for	ADP
bjos-8668998	45	10	windows	window	NOUN
bjos-8668998	45	11	software	software	NOUN
bjos-8668998	45	12	.	.	PUNCT
bjos-8668998	46	1	oral	oral	ADJ
bjos-8668998	46	2	mucositis	mucositis	NOUN
bjos-8668998	46	3	(	(	PUNCT
bjos-8668998	46	4	om	om	PROPN
bjos-8668998	46	5	)	)	PUNCT
bjos-8668998	46	6	and	and	CCONJ
bjos-8668998	46	7	graft	graft	NOUN
bjos-8668998	46	8	versus	versus	ADP
bjos-8668998	46	9	host	host	NOUN
bjos-8668998	46	10	disease	disease	NOUN
bjos-8668998	46	11	(	(	PUNCT
bjos-8668998	46	12	gvhd	gvhd	PROPN
bjos-8668998	46	13	)	)	PUNCT
bjos-8668998	46	14	were	be	AUX
bjos-8668998	46	15	assessed	assess	VERB
bjos-8668998	46	16	by	by	ADP
bjos-8668998	46	17	physical	physical	ADJ
bjos-8668998	46	18	examination	examination	NOUN
bjos-8668998	46	19	and	and	CCONJ
bjos-8668998	46	20	classified	classify	VERB
bjos-8668998	46	21	according	accord	VERB
bjos-8668998	46	22	to	to	ADP
bjos-8668998	46	23	the	the	DET
bjos-8668998	46	24	mascc	mascc	ADJ
bjos-8668998	46	25	/	/	SYM
bjos-8668998	46	26	isoo	isoo	ADJ
bjos-8668998	46	27	guidelines	guideline	NOUN
bjos-8668998	46	28	202024	202024	NUM
bjos-8668998	46	29	and	and	CCONJ
bjos-8668998	46	30	nih	nih	PROPN
bjos-8668998	46	31	2014	2014	NUM
bjos-8668998	46	32	classifications	classification	NOUN
bjos-8668998	46	33	,	,	PUNCT
bjos-8668998	46	34	respectively25	respectively25	NOUN
bjos-8668998	46	35	.	.	PUNCT
bjos-8668998	47	1	patients	patient	NOUN
bjos-8668998	47	2	were	be	AUX
bjos-8668998	47	3	evaluated	evaluate	VERB
bjos-8668998	47	4	pre	pre	ADJ
bjos-8668998	47	5	-	-	NOUN
bjos-8668998	47	6	hsct	hsct	NOUN
bjos-8668998	47	7	and	and	CCONJ
bjos-8668998	47	8	15	15	NUM
bjos-8668998	47	9	,	,	PUNCT
bjos-8668998	47	10	30	30	NUM
bjos-8668998	47	11	,	,	PUNCT
bjos-8668998	47	12	60	60	NUM
bjos-8668998	47	13	,	,	PUNCT
bjos-8668998	47	14	90	90	NUM
bjos-8668998	47	15	,	,	PUNCT
bjos-8668998	47	16	120	120	NUM
bjos-8668998	47	17	,	,	PUNCT
bjos-8668998	47	18	150	150	NUM
bjos-8668998	47	19	,	,	PUNCT
bjos-8668998	47	20	and	and	CCONJ
bjos-8668998	47	21	180	180	NUM
bjos-8668998	47	22	days	day	NOUN
bjos-8668998	47	23	after	after	ADP
bjos-8668998	47	24	hsct	hsct	PROPN
bjos-8668998	47	25	.	.	PUNCT
bjos-8668998	48	1	nlr	nlr	PROPN
bjos-8668998	48	2	data	data	PROPN
bjos-8668998	48	3	for	for	ADP
bjos-8668998	48	4	association	association	NOUN
bjos-8668998	48	5	with	with	ADP
bjos-8668998	48	6	om	om	PROPN
bjos-8668998	48	7	were	be	AUX
bjos-8668998	48	8	collected	collect	VERB
bjos-8668998	48	9	from	from	ADP
bjos-8668998	48	10	the	the	DET
bjos-8668998	48	11	blood	blood	NOUN
bjos-8668998	48	12	counts	count	NOUN
bjos-8668998	48	13	at	at	ADP
bjos-8668998	48	14	15	15	NUM
bjos-8668998	48	15	days	day	NOUN
bjos-8668998	48	16	post	post	NOUN
bjos-8668998	48	17	-	-	NOUN
bjos-8668998	48	18	hsct	hsct	NOUN
bjos-8668998	48	19	,	,	PUNCT
bjos-8668998	48	20	since	since	SCONJ
bjos-8668998	48	21	this	this	PRON
bjos-8668998	48	22	is	be	AUX
bjos-8668998	48	23	the	the	DET
bjos-8668998	48	24	time	time	NOUN
bjos-8668998	48	25	when	when	SCONJ
bjos-8668998	48	26	there	there	PRON
bjos-8668998	48	27	is	be	VERB
bjos-8668998	48	28	the	the	DET
bjos-8668998	48	29	most	most	ADV
bjos-8668998	48	30	severe	severe	ADJ
bjos-8668998	48	31	manifestation	manifestation	NOUN
bjos-8668998	48	32	.	.	PUNCT
bjos-8668998	49	1	for	for	ADP
bjos-8668998	49	2	gvhd	gvhd	PROPN
bjos-8668998	49	3	,	,	PUNCT
bjos-8668998	49	4	patients	patient	NOUN
bjos-8668998	49	5	were	be	AUX
bjos-8668998	49	6	followed	follow	VERB
bjos-8668998	49	7	up	up	ADP
bjos-8668998	49	8	monthly	monthly	ADV
bjos-8668998	49	9	for	for	ADP
bjos-8668998	49	10	180	180	NUM
bjos-8668998	49	11	days	day	NOUN
bjos-8668998	49	12	after	after	ADP
bjos-8668998	49	13	hsct	hsct	PROPN
bjos-8668998	49	14	.	.	PUNCT
bjos-8668998	50	1	nlr	nlr	PROPN
bjos-8668998	50	2	data	data	PROPN
bjos-8668998	50	3	for	for	ADP
bjos-8668998	50	4	association	association	NOUN
bjos-8668998	50	5	with	with	ADP
bjos-8668998	50	6	gvhd	gvhd	PROPN
bjos-8668998	50	7	were	be	AUX
bjos-8668998	50	8	collected	collect	VERB
bjos-8668998	50	9	from	from	ADP
bjos-8668998	50	10	blood	blood	NOUN
bjos-8668998	50	11	counts	count	NOUN
bjos-8668998	50	12	corresponding	correspond	VERB
bjos-8668998	50	13	to	to	ADP
bjos-8668998	50	14	the	the	DET
bjos-8668998	50	15	day	day	NOUN
bjos-8668998	50	16	of	of	ADP
bjos-8668998	50	17	gvhd	gvhd	NOUN
bjos-8668998	50	18	diagnosis	diagnosis	NOUN
bjos-8668998	50	19	,	,	PUNCT
bjos-8668998	50	20	whereas	whereas	SCONJ
bjos-8668998	50	21	nlr	nlr	PROPN
bjos-8668998	50	22	data	datum	NOUN
bjos-8668998	50	23	from	from	ADP
bjos-8668998	50	24	patients	patient	NOUN
bjos-8668998	50	25	who	who	PRON
bjos-8668998	50	26	did	do	AUX
bjos-8668998	50	27	not	not	PART
bjos-8668998	50	28	manifest	manifest	VERB
bjos-8668998	50	29	gvhd	gvhd	NOUN
bjos-8668998	50	30	were	be	AUX
bjos-8668998	50	31	collected	collect	VERB
bjos-8668998	50	32	from	from	ADP
bjos-8668998	50	33	the	the	DET
bjos-8668998	50	34	last	last	ADJ
bjos-8668998	50	35	follow	follow	NOUN
bjos-8668998	50	36	-	-	PUNCT
bjos-8668998	50	37	up	up	NOUN
bjos-8668998	50	38	visit	visit	NOUN
bjos-8668998	50	39	180	180	NUM
bjos-8668998	50	40	days	day	NOUN
bjos-8668998	50	41	after	after	ADP
bjos-8668998	50	42	hsct	hsct	PROPN
bjos-8668998	50	43	.	.	PUNCT
bjos-8668998	51	1	all	all	DET
bjos-8668998	51	2	patients	patient	NOUN
bjos-8668998	51	3	underwent	undergo	VERB
bjos-8668998	51	4	dental	dental	ADJ
bjos-8668998	51	5	consultation	consultation	NOUN
bjos-8668998	51	6	and	and	CCONJ
bjos-8668998	51	7	had	have	VERB
bjos-8668998	51	8	oral	oral	ADJ
bjos-8668998	51	9	cavity	cavity	NOUN
bjos-8668998	51	10	adequacy	adequacy	NOUN
bjos-8668998	51	11	before	before	ADP
bjos-8668998	51	12	the	the	DET
bjos-8668998	51	13	chemotherapy	chemotherapy	NOUN
bjos-8668998	51	14	regimen	regiman	NOUN
bjos-8668998	51	15	.	.	PUNCT
bjos-8668998	52	1	all	all	DET
bjos-8668998	52	2	patients	patient	NOUN
bjos-8668998	52	3	received	receive	VERB
bjos-8668998	52	4	photobiomodulation	photobiomodulation	NOUN
bjos-8668998	52	5	to	to	PART
bjos-8668998	52	6	prevent	prevent	VERB
bjos-8668998	52	7	om	om	PROPN
bjos-8668998	52	8	from	from	ADP
bjos-8668998	52	9	the	the	DET
bjos-8668998	52	10	first	first	ADJ
bjos-8668998	52	11	day	day	NOUN
bjos-8668998	52	12	of	of	ADP
bjos-8668998	52	13	the	the	DET
bjos-8668998	52	14	conditioning	conditioning	NOUN
bjos-8668998	52	15	regimen	regiman	NOUN
bjos-8668998	52	16	,	,	PUNCT
bjos-8668998	52	17	following	follow	VERB
bjos-8668998	52	18	the	the	DET
bjos-8668998	52	19	massc	massc	NOUN
bjos-8668998	52	20	/	/	SYM
bjos-8668998	52	21	isso	isso	PROPN
bjos-8668998	52	22	clinical	clinical	ADJ
bjos-8668998	52	23	practice	practice	NOUN
bjos-8668998	52	24	guidelines	guideline	NOUN
bjos-8668998	52	25	.	.	PUNCT
bjos-8668998	53	1	statistical	statistical	ADJ
bjos-8668998	53	2	analysis	analysis	NOUN
bjos-8668998	53	3	was	be	AUX
bjos-8668998	53	4	performed	perform	VERB
bjos-8668998	53	5	using	use	VERB
bjos-8668998	53	6	spss	spss	PROPN
bjos-8668998	53	7	version	version	NOUN
bjos-8668998	53	8	20.0	20.0	NUM
bjos-8668998	53	9	(	(	PUNCT
bjos-8668998	53	10	ibm	ibm	PROPN
bjos-8668998	53	11	,	,	PUNCT
bjos-8668998	53	12	armonk	armonk	PROPN
bjos-8668998	53	13	,	,	PUNCT
bjos-8668998	53	14	new	new	PROPN
bjos-8668998	53	15	,	,	PUNCT
bjos-8668998	53	16	usa	usa	PROPN
bjos-8668998	53	17	)	)	PUNCT
bjos-8668998	53	18	.	.	PUNCT
bjos-8668998	54	1	results	result	VERB
bjos-8668998	54	2	the	the	DET
bjos-8668998	54	3	45	45	NUM
bjos-8668998	54	4	patients	patient	NOUN
bjos-8668998	54	5	were	be	AUX
bjos-8668998	54	6	mostly	mostly	ADV
bjos-8668998	54	7	male	male	ADJ
bjos-8668998	54	8	(	(	PUNCT
bjos-8668998	54	9	61.7	61.7	NUM
bjos-8668998	54	10	%	%	NOUN
bjos-8668998	54	11	)	)	PUNCT
bjos-8668998	54	12	,	,	PUNCT
bjos-8668998	54	13	with	with	ADP
bjos-8668998	54	14	an	an	DET
bjos-8668998	54	15	average	average	ADJ
bjos-8668998	54	16	age	age	NOUN
bjos-8668998	54	17	of	of	ADP
bjos-8668998	54	18	37	37	NUM
bjos-8668998	54	19	years	year	NOUN
bjos-8668998	54	20	.	.	PUNCT
bjos-8668998	55	1	the	the	DET
bjos-8668998	55	2	most	most	ADV
bjos-8668998	55	3	frequent	frequent	ADJ
bjos-8668998	55	4	underlying	underlying	ADJ
bjos-8668998	55	5	disease	disease	NOUN
bjos-8668998	55	6	was	be	AUX
bjos-8668998	55	7	severe	severe	ADJ
bjos-8668998	55	8	aplastic	aplastic	ADJ
bjos-8668998	55	9	anemia	anemia	NOUN
bjos-8668998	55	10	(	(	PUNCT
bjos-8668998	55	11	31.9	31.9	NUM
bjos-8668998	55	12	%	%	NOUN
bjos-8668998	55	13	)	)	PUNCT
bjos-8668998	55	14	,	,	PUNCT
bjos-8668998	55	15	followed	follow	VERB
bjos-8668998	55	16	by	by	ADP
bjos-8668998	55	17	acute	acute	ADJ
bjos-8668998	55	18	myeloid	myeloid	NOUN
bjos-8668998	55	19	leukemia	leukemia	NOUN
bjos-8668998	55	20	(	(	PUNCT
bjos-8668998	55	21	29.8	29.8	NUM
bjos-8668998	55	22	%	%	NOUN
bjos-8668998	55	23	)	)	PUNCT
bjos-8668998	55	24	;	;	PUNCT
bjos-8668998	55	25	66	66	NUM
bjos-8668998	55	26	%	%	NOUN
bjos-8668998	55	27	of	of	ADP
bjos-8668998	55	28	donors	donor	NOUN
bjos-8668998	55	29	were	be	AUX
bjos-8668998	55	30	related	relate	VERB
bjos-8668998	55	31	,	,	PUNCT
bjos-8668998	55	32	and	and	CCONJ
bjos-8668998	55	33	55.3	55.3	NUM
bjos-8668998	55	34	%	%	NOUN
bjos-8668998	55	35	were	be	AUX
bjos-8668998	55	36	matched	match	VERB
bjos-8668998	55	37	.	.	PUNCT
bjos-8668998	56	1	men	man	NOUN
bjos-8668998	56	2	had	have	VERB
bjos-8668998	56	3	a	a	DET
bjos-8668998	56	4	higher	high	ADJ
bjos-8668998	56	5	frequency	frequency	NOUN
bjos-8668998	56	6	of	of	ADP
bjos-8668998	56	7	om	om	PROPN
bjos-8668998	56	8	than	than	ADP
bjos-8668998	56	9	women	woman	NOUN
bjos-8668998	56	10	.	.	PUNCT
bjos-8668998	57	1	the	the	DET
bjos-8668998	57	2	most	most	ADV
bjos-8668998	57	3	common	common	ADJ
bjos-8668998	57	4	underlying	underlying	ADJ
bjos-8668998	57	5	disease	disease	NOUN
bjos-8668998	57	6	is	be	AUX
bjos-8668998	57	7	severe	severe	ADJ
bjos-8668998	57	8	aplastic	aplastic	ADJ
bjos-8668998	57	9	anemia	anemia	NOUN
bjos-8668998	57	10	.	.	PUNCT
bjos-8668998	58	1	most	most	ADJ
bjos-8668998	58	2	allogeneic	allogeneic	ADJ
bjos-8668998	58	3	hsct	hsct	NOUN
bjos-8668998	58	4	cases	case	NOUN
bjos-8668998	58	5	were	be	AUX
bjos-8668998	58	6	related	relate	VERB
bjos-8668998	58	7	,	,	PUNCT
bjos-8668998	58	8	and	and	CCONJ
bjos-8668998	58	9	those	those	PRON
bjos-8668998	58	10	who	who	PRON
bjos-8668998	58	11	found	find	VERB
bjos-8668998	58	12	an	an	DET
bjos-8668998	58	13	unrelated	unrelated	ADJ
bjos-8668998	58	14	donor	donor	NOUN
bjos-8668998	58	15	with	with	ADP
bjos-8668998	58	16	a	a	DET
bjos-8668998	58	17	good	good	ADJ
bjos-8668998	58	18	match	match	NOUN
bjos-8668998	58	19	almost	almost	ADV
bjos-8668998	58	20	entirely	entirely	ADV
bjos-8668998	58	21	showed	show	VERB
bjos-8668998	58	22	om	om	PRON
bjos-8668998	58	23	.	.	PUNCT
bjos-8668998	59	1	most	most	ADJ
bjos-8668998	59	2	patients	patient	NOUN
bjos-8668998	59	3	manifested	manifest	VERB
bjos-8668998	59	4	om	om	PROPN
bjos-8668998	59	5	regardless	regardless	ADV
bjos-8668998	59	6	of	of	ADP
bjos-8668998	59	7	graft	graft	NOUN
bjos-8668998	59	8	compatibility	compatibility	NOUN
bjos-8668998	59	9	.	.	PUNCT
bjos-8668998	60	1	regarding	regard	VERB
bjos-8668998	60	2	the	the	DET
bjos-8668998	60	3	om	om	PROPN
bjos-8668998	60	4	grade	grade	NOUN
bjos-8668998	60	5	,	,	PUNCT
bjos-8668998	60	6	six	six	NUM
bjos-8668998	60	7	cases	case	NOUN
bjos-8668998	60	8	were	be	AUX
bjos-8668998	60	9	classified	classify	VERB
bjos-8668998	60	10	as	as	ADP
bjos-8668998	60	11	grade	grade	NOUN
bjos-8668998	60	12	0	0	NUM
bjos-8668998	60	13	;	;	PUNCT
bjos-8668998	60	14	three	three	NUM
bjos-8668998	60	15	as	as	ADP
bjos-8668998	60	16	grade	grade	NOUN
bjos-8668998	60	17	1	1	NUM
bjos-8668998	60	18	;	;	PUNCT
bjos-8668998	60	19	eight	eight	NUM
bjos-8668998	60	20	as	as	ADP
bjos-8668998	60	21	grade	grade	NOUN
bjos-8668998	60	22	2	2	NUM
bjos-8668998	60	23	,	,	PUNCT
bjos-8668998	60	24	and	and	CCONJ
bjos-8668998	60	25	14	14	NUM
bjos-8668998	60	26	as	as	ADP
bjos-8668998	60	27	grades	grade	NOUN
bjos-8668998	60	28	3	3	NUM
bjos-8668998	60	29	and	and	CCONJ
bjos-8668998	60	30	4	4	NUM
bjos-8668998	60	31	.	.	NOUN
bjos-8668998	60	32	4	4	NUM
bjos-8668998	60	33	quadras	quadras	NOUN
bjos-8668998	61	1	et	et	PROPN
bjos-8668998	61	2	al	al	PROPN
bjos-8668998	61	3	.	.	PROPN
bjos-8668998	61	4	braz	braz	PROPN
bjos-8668998	61	5	j	j	PROPN
bjos-8668998	61	6	oral	oral	PROPN
bjos-8668998	61	7	sci	sci	PROPN
bjos-8668998	61	8	.	.	PUNCT
bjos-8668998	62	1	2023;22	2023;22	NUM
bjos-8668998	62	2	:	:	PUNCT
bjos-8668998	62	3	e238998	e238998	VERB
bjos-8668998	62	4	there	there	PRON
bjos-8668998	62	5	was	be	VERB
bjos-8668998	62	6	no	no	DET
bjos-8668998	62	7	statistically	statistically	ADV
bjos-8668998	62	8	significant	significant	ADJ
bjos-8668998	62	9	difference	difference	NOUN
bjos-8668998	62	10	in	in	ADP
bjos-8668998	62	11	om	om	PROPN
bjos-8668998	62	12	associated	associate	VERB
bjos-8668998	62	13	with	with	ADP
bjos-8668998	62	14	sex	sex	NOUN
bjos-8668998	62	15	,	,	PUNCT
bjos-8668998	62	16	underlying	underlying	ADJ
bjos-8668998	62	17	disease	disease	NOUN
bjos-8668998	62	18	,	,	PUNCT
bjos-8668998	62	19	donor	donor	NOUN
bjos-8668998	62	20	relation	relation	NOUN
bjos-8668998	62	21	,	,	PUNCT
bjos-8668998	62	22	match	match	NOUN
bjos-8668998	62	23	,	,	PUNCT
bjos-8668998	62	24	age	age	NOUN
bjos-8668998	62	25	,	,	PUNCT
bjos-8668998	62	26	or	or	CCONJ
bjos-8668998	62	27	nlr	nlr	PROPN
bjos-8668998	62	28	.	.	PUNCT
bjos-8668998	63	1	the	the	DET
bjos-8668998	63	2	distribution	distribution	NOUN
bjos-8668998	63	3	of	of	ADP
bjos-8668998	63	4	the	the	DET
bjos-8668998	63	5	sample	sample	NOUN
bjos-8668998	63	6	according	accord	VERB
bjos-8668998	63	7	to	to	ADP
bjos-8668998	63	8	sex	sex	NOUN
bjos-8668998	63	9	,	,	PUNCT
bjos-8668998	63	10	underlying	underlying	ADJ
bjos-8668998	63	11	disease	disease	NOUN
bjos-8668998	63	12	,	,	PUNCT
bjos-8668998	63	13	donor	donor	NOUN
bjos-8668998	63	14	relation	relation	NOUN
bjos-8668998	63	15	,	,	PUNCT
bjos-8668998	63	16	and	and	CCONJ
bjos-8668998	63	17	match	match	VERB
bjos-8668998	63	18	associated	associate	VERB
bjos-8668998	63	19	with	with	ADP
bjos-8668998	63	20	the	the	DET
bjos-8668998	63	21	presence	presence	NOUN
bjos-8668998	63	22	or	or	CCONJ
bjos-8668998	63	23	absence	absence	NOUN
bjos-8668998	63	24	of	of	ADP
bjos-8668998	63	25	om	om	PROPN
bjos-8668998	63	26	is	be	AUX
bjos-8668998	63	27	described	describe	VERB
bjos-8668998	63	28	in	in	ADP
bjos-8668998	63	29	table	table	NOUN
bjos-8668998	63	30	1	1	NUM
bjos-8668998	63	31	below	below	ADV
bjos-8668998	63	32	.	.	PUNCT
bjos-8668998	64	1	table	table	NOUN
bjos-8668998	64	2	1	1	NUM
bjos-8668998	64	3	.	.	PUNCT
bjos-8668998	65	1	distribution	distribution	NOUN
bjos-8668998	65	2	of	of	ADP
bjos-8668998	65	3	clinical	clinical	ADJ
bjos-8668998	65	4	data	datum	NOUN
bjos-8668998	65	5	and	and	CCONJ
bjos-8668998	65	6	nlr	nlr	PROPN
bjos-8668998	65	7	associated	associate	VERB
bjos-8668998	65	8	with	with	ADP
bjos-8668998	65	9	oral	oral	ADJ
bjos-8668998	65	10	mucositis	mucositis	NOUN
bjos-8668998	65	11	.	.	PUNCT
bjos-8668998	66	1	variables	variable	NOUN
bjos-8668998	66	2	oral	oral	ADJ
bjos-8668998	66	3	mucositis	mucositis	NOUN
bjos-8668998	66	4	total	total	NOUN
bjos-8668998	66	5	p	p	NOUN
bjos-8668998	66	6	value	value	NOUN
bjos-8668998	67	1	yes	yes	INTJ
bjos-8668998	67	2	no	no	DET
bjos-8668998	67	3	sex	sex	NOUN
bjos-8668998	67	4	n(%	n(%	NOUN
bjos-8668998	67	5	)	)	PUNCT
bjos-8668998	67	6	0,658	0,658	NUM
bjos-8668998	68	1	*	*	PUNCT
bjos-8668998	68	2	female	female	ADJ
bjos-8668998	68	3	14(82,4	14(82,4	NUM
bjos-8668998	68	4	)	)	PUNCT
bjos-8668998	68	5	3(17,6	3(17,6	NUM
bjos-8668998	68	6	)	)	PUNCT
bjos-8668998	68	7	17(100	17(100	NOUN
bjos-8668998	68	8	)	)	PUNCT
bjos-8668998	68	9	male	male	NOUN
bjos-8668998	68	10	25(89,3	25(89,3	NUM
bjos-8668998	68	11	)	)	PUNCT
bjos-8668998	68	12	3(10,7	3(10,7	NUM
bjos-8668998	68	13	)	)	PUNCT
bjos-8668998	68	14	28(100	28(100	NOUN
bjos-8668998	68	15	)	)	PUNCT
bjos-8668998	68	16	total	total	NOUN
bjos-8668998	68	17	39(86,7	39(86,7	NUM
bjos-8668998	68	18	)	)	PUNCT
bjos-8668998	68	19	6(13,3	6(13,3	NOUN
bjos-8668998	68	20	)	)	PUNCT
bjos-8668998	68	21	45(100	45(100	NOUN
bjos-8668998	68	22	)	)	PUNCT
bjos-8668998	68	23	underlying	underlie	VERB
bjos-8668998	68	24	disease	disease	NOUN
bjos-8668998	68	25	n(%	n(%	NOUN
bjos-8668998	68	26	)	)	PUNCT
bjos-8668998	68	27	acute	acute	ADJ
bjos-8668998	68	28	lymphoid	lymphoid	NOUN
bjos-8668998	68	29	leukemia	leukemia	NOUN
bjos-8668998	68	30	8(100	8(100	NUM
bjos-8668998	68	31	)	)	PUNCT
bjos-8668998	68	32	0(0	0(0	NUM
bjos-8668998	68	33	)	)	PUNCT
bjos-8668998	68	34	8(100	8(100	X
bjos-8668998	68	35	)	)	PUNCT
bjos-8668998	68	36	acute	acute	ADJ
bjos-8668998	68	37	myeloid	myeloid	NOUN
bjos-8668998	68	38	leukemia	leukemia	PROPN
bjos-8668998	68	39	13(92,9	13(92,9	NUM
bjos-8668998	68	40	)	)	PUNCT
bjos-8668998	68	41	1(7,1	1(7,1	NUM
bjos-8668998	68	42	)	)	PUNCT
bjos-8668998	68	43	14(100	14(100	NOUN
bjos-8668998	68	44	)	)	PUNCT
bjos-8668998	68	45	non	non	ADJ
bjos-8668998	68	46	-	-	ADJ
bjos-8668998	68	47	hodgkin	hodgkin	ADJ
bjos-8668998	68	48	’s	’s	PART
bjos-8668998	68	49	lymphoma	lymphoma	NOUN
bjos-8668998	68	50	2(50	2(50	NUM
bjos-8668998	68	51	)	)	PUNCT
bjos-8668998	68	52	2(50	2(50	NUM
bjos-8668998	68	53	)	)	PUNCT
bjos-8668998	68	54	4(100	4(100	NUM
bjos-8668998	68	55	)	)	PUNCT
bjos-8668998	68	56	myelodysplastic	myelodysplastic	ADJ
bjos-8668998	68	57	syndrome	syndrome	NOUN
bjos-8668998	68	58	3(100	3(100	NUM
bjos-8668998	68	59	)	)	PUNCT
bjos-8668998	68	60	0(0	0(0	NUM
bjos-8668998	68	61	)	)	PUNCT
bjos-8668998	68	62	3(100	3(100	NUM
bjos-8668998	68	63	)	)	PUNCT
bjos-8668998	68	64	severe	severe	ADJ
bjos-8668998	68	65	aplastic	aplastic	ADJ
bjos-8668998	68	66	anemia	anemia	NOUN
bjos-8668998	68	67	11(78,6	11(78,6	NUM
bjos-8668998	68	68	)	)	PUNCT
bjos-8668998	68	69	3(21,4	3(21,4	ADV
bjos-8668998	68	70	)	)	PUNCT
bjos-8668998	68	71	14(100	14(100	NOUN
bjos-8668998	68	72	)	)	PUNCT
bjos-8668998	68	73	others	other	NOUN
bjos-8668998	68	74	2(100	2(100	NUM
bjos-8668998	68	75	)	)	PUNCT
bjos-8668998	68	76	0(0	0(0	NUM
bjos-8668998	68	77	)	)	PUNCT
bjos-8668998	68	78	2(100	2(100	NUM
bjos-8668998	68	79	)	)	PUNCT
bjos-8668998	68	80	total	total	NOUN
bjos-8668998	68	81	39(86,7	39(86,7	NUM
bjos-8668998	68	82	)	)	PUNCT
bjos-8668998	68	83	6(13,3	6(13,3	NOUN
bjos-8668998	68	84	)	)	PUNCT
bjos-8668998	68	85	45(100	45(100	NOUN
bjos-8668998	68	86	)	)	PUNCT
bjos-8668998	68	87	donor	donor	NOUN
bjos-8668998	68	88	relation	relation	NOUN
bjos-8668998	68	89	n(%	n(%	NOUN
bjos-8668998	68	90	)	)	PUNCT
bjos-8668998	68	91	related	relate	VERB
bjos-8668998	68	92	25(83,3	25(83,3	NUM
bjos-8668998	68	93	)	)	PUNCT
bjos-8668998	68	94	5(16,7	5(16,7	NUM
bjos-8668998	68	95	)	)	PUNCT
bjos-8668998	68	96	30(100	30(100	NOUN
bjos-8668998	68	97	)	)	PUNCT
bjos-8668998	68	98	unrelated	unrelated	ADJ
bjos-8668998	68	99	14(93,3	14(93,3	NUM
bjos-8668998	68	100	)	)	PUNCT
bjos-8668998	68	101	1(6,7	1(6,7	PROPN
bjos-8668998	68	102	)	)	PUNCT
bjos-8668998	68	103	15(100	15(100	NOUN
bjos-8668998	68	104	)	)	PUNCT
bjos-8668998	68	105	0,647	0,647	NUM
bjos-8668998	69	1	*	*	PUNCT
bjos-8668998	69	2	total	total	NOUN
bjos-8668998	69	3	39(86,7	39(86,7	NUM
bjos-8668998	69	4	)	)	PUNCT
bjos-8668998	69	5	6(13,3	6(13,3	NOUN
bjos-8668998	69	6	)	)	PUNCT
bjos-8668998	69	7	45(100	45(100	NOUN
bjos-8668998	69	8	)	)	PUNCT
bjos-8668998	69	9	matchn(%	matchn(%	NOUN
bjos-8668998	69	10	)	)	PUNCT
bjos-8668998	69	11	matched	match	VERB
bjos-8668998	69	12	22(88	22(88	NUM
bjos-8668998	69	13	)	)	PUNCT
bjos-8668998	69	14	3(12	3(12	NUM
bjos-8668998	69	15	)	)	PUNCT
bjos-8668998	69	16	25(100	25(100	NOUN
bjos-8668998	69	17	)	)	PUNCT
bjos-8668998	69	18	unmatched	unmatched	ADJ
bjos-8668998	69	19	17(85	17(85	PROPN
bjos-8668998	69	20	)	)	PUNCT
bjos-8668998	69	21	3(15	3(15	NUM
bjos-8668998	69	22	)	)	PUNCT
bjos-8668998	69	23	20(100	20(100	NOUN
bjos-8668998	69	24	)	)	PUNCT
bjos-8668998	69	25	1,000	1,000	NUM
bjos-8668998	69	26	*	*	PUNCT
bjos-8668998	69	27	total	total	ADJ
bjos-8668998	69	28	39(86,7	39(86,7	NUM
bjos-8668998	69	29	)	)	PUNCT
bjos-8668998	69	30	6(13,3	6(13,3	NOUN
bjos-8668998	69	31	)	)	PUNCT
bjos-8668998	69	32	45(100	45(100	NOUN
bjos-8668998	69	33	)	)	PUNCT
bjos-8668998	69	34	age	age	NOUN
bjos-8668998	69	35	–	–	PUNCT
bjos-8668998	69	36	median	median	NOUN
bjos-8668998	69	37	(	(	PUNCT
bjos-8668998	69	38	min	min	NOUN
bjos-8668998	69	39	-	-	PUNCT
bjos-8668998	69	40	max	max	NOUN
bjos-8668998	69	41	)	)	PUNCT
bjos-8668998	69	42	41(20	41(20	PROPN
bjos-8668998	69	43	-	-	NUM
bjos-8668998	69	44	62	62	NUM
bjos-8668998	69	45	)	)	PUNCT
bjos-8668998	69	46	24,50(19	24,50(19	NUM
bjos-8668998	69	47	-	-	SYM
bjos-8668998	69	48	60	60	NUM
bjos-8668998	69	49	)	)	PUNCT
bjos-8668998	69	50	0,300	0,300	NUM
bjos-8668998	69	51	*	*	PUNCT
bjos-8668998	69	52	*	*	PUNCT
bjos-8668998	69	53	nlr	nlr	PROPN
bjos-8668998	69	54	–	–	PUNCT
bjos-8668998	69	55	median	median	NOUN
bjos-8668998	69	56	(	(	PUNCT
bjos-8668998	69	57	min	min	NOUN
bjos-8668998	69	58	-	-	PUNCT
bjos-8668998	69	59	max	max	NOUN
bjos-8668998	69	60	)	)	PUNCT
bjos-8668998	70	1	1,13(0,00	1,13(0,00	NUM
bjos-8668998	70	2	-	-	PUNCT
bjos-8668998	70	3	22,45	22,45	NUM
bjos-8668998	70	4	)	)	PUNCT
bjos-8668998	70	5	0,44(0,0027,70	0,44(0,0027,70	NOUN
bjos-8668998	70	6	)	)	PUNCT
bjos-8668998	70	7	0,917	0,917	NUM
bjos-8668998	71	1	*	*	PUNCT
bjos-8668998	71	2	*	*	PUNCT
bjos-8668998	71	3	*	*	PUNCT
bjos-8668998	71	4	fisher	fisher	PROPN
bjos-8668998	71	5	’s	’s	PART
bjos-8668998	71	6	exact	exact	ADJ
bjos-8668998	71	7	test	test	NOUN
bjos-8668998	71	8	.	.	PUNCT
bjos-8668998	72	1	*	*	PUNCT
bjos-8668998	72	2	*	*	PUNCT
bjos-8668998	72	3	mann	mann	PROPN
bjos-8668998	72	4	whitney	whitney	PROPN
bjos-8668998	72	5	u	u	PROPN
bjos-8668998	72	6	test	test	NOUN
bjos-8668998	72	7	.	.	PUNCT
bjos-8668998	73	1	regarding	regard	VERB
bjos-8668998	73	2	oral	oral	ADJ
bjos-8668998	73	3	gvhd	gvhd	NOUN
bjos-8668998	73	4	,	,	PUNCT
bjos-8668998	73	5	the	the	DET
bjos-8668998	73	6	majority	majority	NOUN
bjos-8668998	73	7	of	of	ADP
bjos-8668998	73	8	the	the	DET
bjos-8668998	73	9	patients	patient	NOUN
bjos-8668998	73	10	were	be	AUX
bjos-8668998	73	11	men	man	NOUN
bjos-8668998	73	12	.	.	PUNCT
bjos-8668998	74	1	the	the	DET
bjos-8668998	74	2	most	most	ADV
bjos-8668998	74	3	frequent	frequent	ADJ
bjos-8668998	74	4	underlying	underlie	VERB
bjos-8668998	74	5	hematological	hematological	ADJ
bjos-8668998	74	6	disease	disease	NOUN
bjos-8668998	74	7	was	be	AUX
bjos-8668998	74	8	severe	severe	ADJ
bjos-8668998	74	9	aplastic	aplastic	ADJ
bjos-8668998	74	10	anemia	anemia	NOUN
bjos-8668998	74	11	,	,	PUNCT
bjos-8668998	74	12	followed	follow	VERB
bjos-8668998	74	13	by	by	ADP
bjos-8668998	74	14	acute	acute	ADJ
bjos-8668998	74	15	myeloid	myeloid	ADJ
bjos-8668998	74	16	leukemia	leukemia	NOUN
bjos-8668998	74	17	.	.	PUNCT
bjos-8668998	75	1	as	as	ADP
bjos-8668998	75	2	for	for	ADP
bjos-8668998	75	3	the	the	DET
bjos-8668998	75	4	donor	donor	NOUN
bjos-8668998	75	5	relationship	relationship	NOUN
bjos-8668998	75	6	for	for	ADP
bjos-8668998	75	7	allogeneic	allogeneic	ADJ
bjos-8668998	75	8	hsct	hsct	NOUN
bjos-8668998	75	9	,	,	PUNCT
bjos-8668998	75	10	most	most	ADJ
bjos-8668998	75	11	were	be	AUX
bjos-8668998	75	12	related	relate	VERB
bjos-8668998	75	13	and	and	CCONJ
bjos-8668998	75	14	matched	match	VERB
bjos-8668998	75	15	.	.	PUNCT
bjos-8668998	76	1	over	over	ADP
bjos-8668998	76	2	30	30	NUM
bjos-8668998	76	3	%	%	NOUN
bjos-8668998	76	4	(	(	PUNCT
bjos-8668998	76	5	10/31	10/31	NUM
bjos-8668998	76	6	)	)	PUNCT
bjos-8668998	76	7	of	of	ADP
bjos-8668998	76	8	patients	patient	NOUN
bjos-8668998	76	9	developed	develop	VERB
bjos-8668998	76	10	oral	oral	ADJ
bjos-8668998	76	11	manifestations	manifestation	NOUN
bjos-8668998	76	12	of	of	ADP
bjos-8668998	76	13	gvhd	gvhd	PROPN
bjos-8668998	76	14	.	.	PUNCT
bjos-8668998	77	1	regarding	regard	VERB
bjos-8668998	77	2	the	the	DET
bjos-8668998	77	3	nlr	nlr	PROPN
bjos-8668998	77	4	,	,	PUNCT
bjos-8668998	77	5	it	it	PRON
bjos-8668998	77	6	was	be	AUX
bjos-8668998	77	7	analyzed	analyze	VERB
bjos-8668998	77	8	that	that	SCONJ
bjos-8668998	77	9	the	the	DET
bjos-8668998	77	10	result	result	NOUN
bjos-8668998	77	11	obtained	obtain	VERB
bjos-8668998	77	12	was	be	AUX
bjos-8668998	77	13	greater	great	ADJ
bjos-8668998	77	14	in	in	ADP
bjos-8668998	77	15	patients	patient	NOUN
bjos-8668998	77	16	who	who	PRON
bjos-8668998	77	17	had	have	VERB
bjos-8668998	77	18	oral	oral	ADJ
bjos-8668998	77	19	gvhd	gvhd	NOUN
bjos-8668998	77	20	compared	compare	VERB
bjos-8668998	77	21	to	to	ADP
bjos-8668998	77	22	those	those	PRON
bjos-8668998	77	23	who	who	PRON
bjos-8668998	77	24	did	do	VERB
bjos-8668998	77	25	not	not	PART
bjos-8668998	77	26	.	.	PUNCT
bjos-8668998	78	1	5	5	NUM
bjos-8668998	78	2	quadras	quadra	NOUN
bjos-8668998	78	3	et	et	PROPN
bjos-8668998	78	4	al	al	PROPN
bjos-8668998	78	5	.	.	PROPN
bjos-8668998	79	1	braz	braz	PROPN
bjos-8668998	79	2	j	j	PROPN
bjos-8668998	79	3	oral	oral	PROPN
bjos-8668998	79	4	sci	sci	PROPN
bjos-8668998	79	5	.	.	PUNCT
bjos-8668998	80	1	2023;22	2023;22	NUM
bjos-8668998	80	2	:	:	PUNCT
bjos-8668998	80	3	e238998	e238998	VERB
bjos-8668998	80	4	for	for	ADP
bjos-8668998	80	5	non	non	ADJ
bjos-8668998	80	6	-	-	ADJ
bjos-8668998	80	7	oral	oral	ADJ
bjos-8668998	80	8	gvhd	gvhd	NOUN
bjos-8668998	80	9	,	,	PUNCT
bjos-8668998	80	10	similar	similar	ADJ
bjos-8668998	80	11	results	result	NOUN
bjos-8668998	80	12	were	be	AUX
bjos-8668998	80	13	found	find	VERB
bjos-8668998	80	14	;	;	PUNCT
bjos-8668998	80	15	a	a	DET
bjos-8668998	80	16	large	large	ADJ
bjos-8668998	80	17	part	part	NOUN
bjos-8668998	80	18	of	of	ADP
bjos-8668998	80	19	the	the	DET
bjos-8668998	80	20	sample	sample	NOUN
bjos-8668998	80	21	was	be	AUX
bjos-8668998	80	22	men	man	NOUN
bjos-8668998	80	23	,	,	PUNCT
bjos-8668998	80	24	mostly	mostly	ADV
bjos-8668998	80	25	diagnosed	diagnose	VERB
bjos-8668998	80	26	with	with	ADP
bjos-8668998	80	27	severe	severe	ADJ
bjos-8668998	80	28	aplastic	aplastic	ADJ
bjos-8668998	80	29	anemia	anemia	NOUN
bjos-8668998	80	30	,	,	PUNCT
bjos-8668998	80	31	with	with	ADP
bjos-8668998	80	32	a	a	DET
bjos-8668998	80	33	related	relate	VERB
bjos-8668998	80	34	and	and	CCONJ
bjos-8668998	80	35	matched	match	VERB
bjos-8668998	80	36	donor	donor	NOUN
bjos-8668998	80	37	in	in	ADP
bjos-8668998	80	38	most	most	ADJ
bjos-8668998	80	39	cases	case	NOUN
bjos-8668998	80	40	.	.	PUNCT
bjos-8668998	81	1	nlr	nlr	PROPN
bjos-8668998	81	2	was	be	AUX
bjos-8668998	81	3	considerably	considerably	ADV
bjos-8668998	81	4	higher	high	ADJ
bjos-8668998	81	5	in	in	ADP
bjos-8668998	81	6	individuals	individual	NOUN
bjos-8668998	81	7	who	who	PRON
bjos-8668998	81	8	developed	develop	VERB
bjos-8668998	81	9	non	non	ADJ
bjos-8668998	81	10	-	-	ADJ
bjos-8668998	81	11	oral	oral	ADJ
bjos-8668998	81	12	gvhd	gvhd	NOUN
bjos-8668998	81	13	than	than	ADP
bjos-8668998	81	14	in	in	ADP
bjos-8668998	81	15	those	those	PRON
bjos-8668998	81	16	who	who	PRON
bjos-8668998	81	17	did	do	VERB
bjos-8668998	81	18	not	not	PART
bjos-8668998	81	19	.	.	PUNCT
bjos-8668998	82	1	however	however	ADV
bjos-8668998	82	2	,	,	PUNCT
bjos-8668998	82	3	no	no	DET
bjos-8668998	82	4	statistically	statistically	ADV
bjos-8668998	82	5	significant	significant	ADJ
bjos-8668998	82	6	difference	difference	NOUN
bjos-8668998	82	7	was	be	AUX
bjos-8668998	82	8	observed	observe	VERB
bjos-8668998	82	9	for	for	ADP
bjos-8668998	82	10	oral	oral	ADJ
bjos-8668998	82	11	and	and	CCONJ
bjos-8668998	82	12	non	non	ADJ
bjos-8668998	82	13	-	-	ADJ
bjos-8668998	82	14	oral	oral	ADJ
bjos-8668998	82	15	gvhd	gvhd	NOUN
bjos-8668998	82	16	in	in	ADP
bjos-8668998	82	17	terms	term	NOUN
bjos-8668998	82	18	of	of	ADP
bjos-8668998	82	19	sex	sex	NOUN
bjos-8668998	82	20	,	,	PUNCT
bjos-8668998	82	21	underlying	underlying	ADJ
bjos-8668998	82	22	disease	disease	NOUN
bjos-8668998	82	23	,	,	PUNCT
bjos-8668998	82	24	donor	donor	NOUN
bjos-8668998	82	25	relation	relation	NOUN
bjos-8668998	82	26	,	,	PUNCT
bjos-8668998	82	27	match	match	NOUN
bjos-8668998	82	28	,	,	PUNCT
bjos-8668998	82	29	age	age	NOUN
bjos-8668998	82	30	,	,	PUNCT
bjos-8668998	82	31	and	and	CCONJ
bjos-8668998	82	32	nlr	nlr	PROPN
bjos-8668998	82	33	,	,	PUNCT
bjos-8668998	82	34	except	except	SCONJ
bjos-8668998	82	35	for	for	ADP
bjos-8668998	82	36	the	the	DET
bjos-8668998	82	37	donor	donor	NOUN
bjos-8668998	82	38	relation	relation	NOUN
bjos-8668998	82	39	in	in	ADP
bjos-8668998	82	40	non	non	ADJ
bjos-8668998	82	41	-	-	ADJ
bjos-8668998	82	42	oral	oral	ADJ
bjos-8668998	82	43	gvhd	gvhd	NOUN
bjos-8668998	82	44	,	,	PUNCT
bjos-8668998	82	45	as	as	SCONJ
bjos-8668998	82	46	shown	show	VERB
bjos-8668998	82	47	in	in	ADP
bjos-8668998	82	48	tables	table	NOUN
bjos-8668998	82	49	2	2	NUM
bjos-8668998	82	50	and	and	CCONJ
bjos-8668998	82	51	3	3	NUM
bjos-8668998	82	52	.	.	NOUN
bjos-8668998	82	53	table	table	NOUN
bjos-8668998	82	54	2	2	NUM
bjos-8668998	82	55	.	.	PUNCT
bjos-8668998	83	1	distribution	distribution	NOUN
bjos-8668998	83	2	of	of	ADP
bjos-8668998	83	3	clinical	clinical	ADJ
bjos-8668998	83	4	data	datum	NOUN
bjos-8668998	83	5	and	and	CCONJ
bjos-8668998	83	6	nlr	nlr	PROPN
bjos-8668998	83	7	associated	associate	VERB
bjos-8668998	83	8	with	with	ADP
bjos-8668998	83	9	oral	oral	ADJ
bjos-8668998	83	10	gvhd	gvhd	NOUN
bjos-8668998	83	11	.	.	PUNCT
bjos-8668998	84	1	variables	variable	NOUN
bjos-8668998	84	2	oral	oral	ADJ
bjos-8668998	84	3	gvhd	gvhd	PROPN
bjos-8668998	84	4	total	total	NOUN
bjos-8668998	84	5	p	p	NOUN
bjos-8668998	84	6	value	value	NOUN
bjos-8668998	85	1	yes	yes	INTJ
bjos-8668998	85	2	no	no	DET
bjos-8668998	85	3	sex	sex	NOUN
bjos-8668998	85	4	n(%	n(%	NOUN
bjos-8668998	85	5	)	)	PUNCT
bjos-8668998	86	1	0,262	0,262	NUM
bjos-8668998	86	2	*	*	PUNCT
bjos-8668998	86	3	female	female	ADJ
bjos-8668998	86	4	2(18,2	2(18,2	NUM
bjos-8668998	86	5	)	)	PUNCT
bjos-8668998	86	6	9(81,8	9(81,8	NOUN
bjos-8668998	86	7	)	)	PUNCT
bjos-8668998	86	8	11(100	11(100	NOUN
bjos-8668998	86	9	)	)	PUNCT
bjos-8668998	86	10	male	male	ADJ
bjos-8668998	86	11	8(40	8(40	NUM
bjos-8668998	86	12	)	)	PUNCT
bjos-8668998	86	13	12(60	12(60	NUM
bjos-8668998	86	14	)	)	PUNCT
bjos-8668998	86	15	20(100	20(100	NOUN
bjos-8668998	86	16	)	)	PUNCT
bjos-8668998	86	17	total	total	PROPN
bjos-8668998	86	18	10(32,3	10(32,3	NUM
bjos-8668998	86	19	)	)	PUNCT
bjos-8668998	86	20	21(67,7	21(67,7	NUM
bjos-8668998	86	21	)	)	PUNCT
bjos-8668998	86	22	31(100	31(100	NOUN
bjos-8668998	86	23	)	)	PUNCT
bjos-8668998	86	24	underlying	underlie	VERB
bjos-8668998	86	25	disease	disease	NOUN
bjos-8668998	86	26	n(%	n(%	NOUN
bjos-8668998	86	27	)	)	PUNCT
bjos-8668998	86	28	acute	acute	ADJ
bjos-8668998	86	29	lymphoid	lymphoid	NOUN
bjos-8668998	86	30	leukemia	leukemia	NOUN
bjos-8668998	86	31	1(33,3	1(33,3	NUM
bjos-8668998	86	32	)	)	PUNCT
bjos-8668998	86	33	2(66,7	2(66,7	NUM
bjos-8668998	86	34	)	)	PUNCT
bjos-8668998	86	35	3(100	3(100	NUM
bjos-8668998	86	36	)	)	PUNCT
bjos-8668998	86	37	acute	acute	ADJ
bjos-8668998	86	38	myeloid	myeloid	NOUN
bjos-8668998	86	39	leukemia	leukemia	PROPN
bjos-8668998	86	40	4(40	4(40	NUM
bjos-8668998	86	41	)	)	PUNCT
bjos-8668998	86	42	6(60	6(60	NUM
bjos-8668998	86	43	)	)	PUNCT
bjos-8668998	86	44	10(100	10(100	X
bjos-8668998	86	45	)	)	PUNCT
bjos-8668998	86	46	non	non	ADJ
bjos-8668998	86	47	-	-	ADJ
bjos-8668998	86	48	hodgkin	hodgkin	ADJ
bjos-8668998	86	49	’s	’s	PART
bjos-8668998	86	50	lymphoma	lymphoma	NOUN
bjos-8668998	86	51	2(66,7	2(66,7	NUM
bjos-8668998	86	52	)	)	PUNCT
bjos-8668998	86	53	1(33,3	1(33,3	NUM
bjos-8668998	86	54	)	)	PUNCT
bjos-8668998	86	55	3(100	3(100	NUM
bjos-8668998	86	56	)	)	PUNCT
bjos-8668998	86	57	myelodysplastic	myelodysplastic	ADJ
bjos-8668998	86	58	syndrome	syndrome	NOUN
bjos-8668998	86	59	1(50	1(50	NOUN
bjos-8668998	86	60	)	)	PUNCT
bjos-8668998	86	61	1(50	1(50	NOUN
bjos-8668998	86	62	)	)	PUNCT
bjos-8668998	86	63	2(100	2(100	NOUN
bjos-8668998	86	64	)	)	PUNCT
bjos-8668998	86	65	severe	severe	ADJ
bjos-8668998	86	66	aplastic	aplastic	ADJ
bjos-8668998	86	67	anemia	anemia	NOUN
bjos-8668998	86	68	2(16,7	2(16,7	NOUN
bjos-8668998	86	69	)	)	PUNCT
bjos-8668998	86	70	10(83,3	10(83,3	NUM
bjos-8668998	86	71	)	)	PUNCT
bjos-8668998	86	72	12(100	12(100	NOUN
bjos-8668998	86	73	)	)	PUNCT
bjos-8668998	86	74	others	other	NOUN
bjos-8668998	86	75	0(0	0(0	NUM
bjos-8668998	86	76	)	)	PUNCT
bjos-8668998	86	77	1(100	1(100	NUM
bjos-8668998	86	78	)	)	PUNCT
bjos-8668998	86	79	1(100	1(100	PROPN
bjos-8668998	86	80	)	)	PUNCT
bjos-8668998	86	81	total	total	ADJ
bjos-8668998	86	82	10(32,3	10(32,3	NUM
bjos-8668998	86	83	)	)	PUNCT
bjos-8668998	86	84	21(67,7	21(67,7	NUM
bjos-8668998	86	85	)	)	PUNCT
bjos-8668998	86	86	31(100	31(100	NOUN
bjos-8668998	86	87	)	)	PUNCT
bjos-8668998	86	88	donor	donor	NOUN
bjos-8668998	86	89	relation	relation	NOUN
bjos-8668998	86	90	n(%	n(%	NOUN
bjos-8668998	86	91	)	)	PUNCT
bjos-8668998	86	92	related	relate	VERB
bjos-8668998	86	93	9(37,5	9(37,5	NUM
bjos-8668998	86	94	)	)	PUNCT
bjos-8668998	86	95	15(62,5	15(62,5	NUM
bjos-8668998	86	96	)	)	PUNCT
bjos-8668998	86	97	24(100	24(100	NOUN
bjos-8668998	86	98	)	)	PUNCT
bjos-8668998	86	99	unrelated	unrelated	ADJ
bjos-8668998	86	100	1(14,3	1(14,3	NUM
bjos-8668998	86	101	)	)	PUNCT
bjos-8668998	86	102	6(85,7	6(85,7	NOUN
bjos-8668998	86	103	)	)	PUNCT
bjos-8668998	86	104	7(100	7(100	NUM
bjos-8668998	86	105	)	)	PUNCT
bjos-8668998	86	106	0,379	0,379	PROPN
bjos-8668998	86	107	*	*	SYM
bjos-8668998	86	108	total	total	PROPN
bjos-8668998	86	109	10(32,3	10(32,3	NUM
bjos-8668998	86	110	)	)	PUNCT
bjos-8668998	86	111	21(67,7	21(67,7	NUM
bjos-8668998	86	112	)	)	PUNCT
bjos-8668998	86	113	31(100	31(100	NOUN
bjos-8668998	86	114	)	)	PUNCT
bjos-8668998	86	115	matchn(%	matchn(%	NOUN
bjos-8668998	86	116	)	)	PUNCT
bjos-8668998	86	117	matched	match	VERB
bjos-8668998	86	118	7(36,8	7(36,8	NOUN
bjos-8668998	86	119	)	)	PUNCT
bjos-8668998	86	120	12(63,2	12(63,2	NUM
bjos-8668998	86	121	)	)	PUNCT
bjos-8668998	86	122	19(100	19(100	NOUN
bjos-8668998	86	123	)	)	PUNCT
bjos-8668998	86	124	unmatched	unmatche	VERB
bjos-8668998	86	125	3(25	3(25	NUM
bjos-8668998	86	126	)	)	PUNCT
bjos-8668998	86	127	9(75	9(75	NUM
bjos-8668998	86	128	)	)	PUNCT
bjos-8668998	86	129	12(100	12(100	NOUN
bjos-8668998	86	130	)	)	PUNCT
bjos-8668998	86	131	0,697	0,697	NUM
bjos-8668998	86	132	*	*	PUNCT
bjos-8668998	86	133	total	total	ADJ
bjos-8668998	86	134	10(32,3	10(32,3	NUM
bjos-8668998	86	135	)	)	PUNCT
bjos-8668998	86	136	21(67,7	21(67,7	NUM
bjos-8668998	86	137	)	)	PUNCT
bjos-8668998	86	138	31(100	31(100	NOUN
bjos-8668998	86	139	)	)	PUNCT
bjos-8668998	86	140	age	age	NOUN
bjos-8668998	86	141	–	–	PUNCT
bjos-8668998	86	142	median	median	NOUN
bjos-8668998	86	143	(	(	PUNCT
bjos-8668998	86	144	min	min	NOUN
bjos-8668998	86	145	-	-	PUNCT
bjos-8668998	86	146	max	max	NOUN
bjos-8668998	86	147	)	)	PUNCT
bjos-8668998	86	148	44,5(21	44,5(21	NUM
bjos-8668998	86	149	-	-	SYM
bjos-8668998	86	150	62	62	NUM
bjos-8668998	86	151	)	)	PUNCT
bjos-8668998	86	152	32(19	32(19	NUM
bjos-8668998	86	153	-	-	SYM
bjos-8668998	86	154	60	60	NUM
bjos-8668998	86	155	)	)	PUNCT
bjos-8668998	86	156	0,526	0,526	NOUN
bjos-8668998	87	1	*	*	PUNCT
bjos-8668998	87	2	*	*	PUNCT
bjos-8668998	87	3	nlr	nlr	PROPN
bjos-8668998	87	4	–	–	PUNCT
bjos-8668998	87	5	median	median	NOUN
bjos-8668998	87	6	(	(	PUNCT
bjos-8668998	87	7	min	min	NOUN
bjos-8668998	87	8	-	-	PUNCT
bjos-8668998	87	9	max	max	NOUN
bjos-8668998	87	10	)	)	PUNCT
bjos-8668998	87	11	2,63(0,43	2,63(0,43	PROPN
bjos-8668998	87	12	-	-	PUNCT
bjos-8668998	87	13	14,50	14,50	NUM
bjos-8668998	87	14	)	)	PUNCT
bjos-8668998	87	15	1,42(0,00	1,42(0,00	NUM
bjos-8668998	87	16	-	-	PUNCT
bjos-8668998	87	17	10,99	10,99	NUM
bjos-8668998	87	18	)	)	PUNCT
bjos-8668998	87	19	0,310	0,310	NOUN
bjos-8668998	88	1	*	*	PUNCT
bjos-8668998	88	2	*	*	PUNCT
bjos-8668998	88	3	*	*	PUNCT
bjos-8668998	88	4	fisher	fisher	PROPN
bjos-8668998	88	5	’s	’s	PART
bjos-8668998	88	6	exact	exact	ADJ
bjos-8668998	88	7	test	test	NOUN
bjos-8668998	88	8	.	.	PUNCT
bjos-8668998	89	1	*	*	PUNCT
bjos-8668998	90	1	*	*	PUNCT
bjos-8668998	90	2	mann	mann	PROPN
bjos-8668998	90	3	whitney	whitney	PROPN
bjos-8668998	90	4	u	u	PROPN
bjos-8668998	90	5	test	test	VERB
bjos-8668998	90	6	.	.	PUNCT
bjos-8668998	91	1	6	6	NUM
bjos-8668998	91	2	quadras	quadra	NOUN
bjos-8668998	91	3	et	et	PROPN
bjos-8668998	91	4	al	al	PROPN
bjos-8668998	91	5	.	.	PROPN
bjos-8668998	92	1	braz	braz	PROPN
bjos-8668998	92	2	j	j	PROPN
bjos-8668998	92	3	oral	oral	PROPN
bjos-8668998	92	4	sci	sci	PROPN
bjos-8668998	92	5	.	.	PUNCT
bjos-8668998	93	1	2023;22	2023;22	NUM
bjos-8668998	93	2	:	:	PUNCT
bjos-8668998	93	3	e238998	e238998	VERB
bjos-8668998	93	4	table	table	NOUN
bjos-8668998	93	5	3	3	NUM
bjos-8668998	93	6	.	.	PUNCT
bjos-8668998	94	1	distribution	distribution	NOUN
bjos-8668998	94	2	of	of	ADP
bjos-8668998	94	3	clinical	clinical	ADJ
bjos-8668998	94	4	data	datum	NOUN
bjos-8668998	94	5	and	and	CCONJ
bjos-8668998	94	6	nlr	nlr	PROPN
bjos-8668998	94	7	associated	associate	VERB
bjos-8668998	94	8	with	with	ADP
bjos-8668998	94	9	non	non	ADJ
bjos-8668998	94	10	-	-	ADJ
bjos-8668998	94	11	oral	oral	ADJ
bjos-8668998	94	12	gvhd	gvhd	NOUN
bjos-8668998	94	13	.	.	PUNCT
bjos-8668998	95	1	variables	variable	NOUN
bjos-8668998	95	2	non	non	ADJ
bjos-8668998	95	3	-	-	ADJ
bjos-8668998	95	4	oral	oral	ADJ
bjos-8668998	95	5	gvhd	gvhd	NOUN
bjos-8668998	95	6	total	total	NOUN
bjos-8668998	95	7	p	p	NOUN
bjos-8668998	95	8	value	value	NOUN
bjos-8668998	95	9	yes	yes	INTJ
bjos-8668998	95	10	não	não	NOUN
bjos-8668998	95	11	sex	sex	NOUN
bjos-8668998	95	12	n(%	n(%	NOUN
bjos-8668998	95	13	)	)	PUNCT
bjos-8668998	95	14	0,139	0,139	NUM
bjos-8668998	96	1	*	*	PUNCT
bjos-8668998	96	2	female	female	ADJ
bjos-8668998	96	3	2(18,2	2(18,2	NUM
bjos-8668998	96	4	)	)	PUNCT
bjos-8668998	96	5	9(81,8	9(81,8	NOUN
bjos-8668998	96	6	)	)	PUNCT
bjos-8668998	96	7	11(100	11(100	NOUN
bjos-8668998	96	8	)	)	PUNCT
bjos-8668998	96	9	male	male	NOUN
bjos-8668998	96	10	10(47,6	10(47,6	NUM
bjos-8668998	96	11	)	)	PUNCT
bjos-8668998	96	12	11(52,4	11(52,4	NUM
bjos-8668998	96	13	)	)	PUNCT
bjos-8668998	96	14	21(100	21(100	NOUN
bjos-8668998	96	15	)	)	PUNCT
bjos-8668998	96	16	total	total	NOUN
bjos-8668998	96	17	12(37,5	12(37,5	NUM
bjos-8668998	96	18	)	)	PUNCT
bjos-8668998	96	19	20(62,5	20(62,5	NUM
bjos-8668998	96	20	)	)	PUNCT
bjos-8668998	96	21	32(100	32(100	NOUN
bjos-8668998	96	22	)	)	PUNCT
bjos-8668998	96	23	underlying	underlie	VERB
bjos-8668998	96	24	disease	disease	NOUN
bjos-8668998	96	25	n(%	n(%	NOUN
bjos-8668998	96	26	)	)	PUNCT
bjos-8668998	96	27	acute	acute	ADJ
bjos-8668998	96	28	lymphoid	lymphoid	NOUN
bjos-8668998	96	29	leukemia	leukemia	NOUN
bjos-8668998	96	30	2(66,7	2(66,7	NUM
bjos-8668998	96	31	)	)	PUNCT
bjos-8668998	96	32	1(33,3	1(33,3	NUM
bjos-8668998	96	33	)	)	PUNCT
bjos-8668998	96	34	3(100	3(100	NUM
bjos-8668998	96	35	)	)	PUNCT
bjos-8668998	96	36	acute	acute	ADJ
bjos-8668998	96	37	myeloid	myeloid	NOUN
bjos-8668998	96	38	leukemia	leukemia	PROPN
bjos-8668998	96	39	5(50	5(50	NUM
bjos-8668998	96	40	)	)	PUNCT
bjos-8668998	96	41	5(50	5(50	NUM
bjos-8668998	96	42	)	)	PUNCT
bjos-8668998	96	43	10(100	10(100	NOUN
bjos-8668998	96	44	)	)	PUNCT
bjos-8668998	97	1	non	non	ADJ
bjos-8668998	97	2	-	-	ADJ
bjos-8668998	97	3	hodgkin	hodgkin	ADJ
bjos-8668998	97	4	’s	’s	PART
bjos-8668998	97	5	lymphoma	lymphoma	NOUN
bjos-8668998	97	6	3(75	3(75	NUM
bjos-8668998	97	7	)	)	PUNCT
bjos-8668998	97	8	1(25	1(25	NUM
bjos-8668998	97	9	)	)	PUNCT
bjos-8668998	97	10	4(100	4(100	NUM
bjos-8668998	97	11	)	)	PUNCT
bjos-8668998	97	12	myelodysplastic	myelodysplastic	ADJ
bjos-8668998	97	13	syndrome	syndrome	NOUN
bjos-8668998	97	14	0(0	0(0	PROPN
bjos-8668998	97	15	)	)	PUNCT
bjos-8668998	97	16	2(100	2(100	NOUN
bjos-8668998	97	17	)	)	PUNCT
bjos-8668998	97	18	2(100	2(100	PROPN
bjos-8668998	97	19	)	)	PUNCT
bjos-8668998	97	20	severe	severe	ADJ
bjos-8668998	97	21	aplastic	aplastic	ADJ
bjos-8668998	97	22	anemia	anemia	NOUN
bjos-8668998	97	23	2(16,7	2(16,7	NOUN
bjos-8668998	97	24	)	)	PUNCT
bjos-8668998	97	25	10(83,3	10(83,3	NUM
bjos-8668998	97	26	)	)	PUNCT
bjos-8668998	97	27	12(100	12(100	NOUN
bjos-8668998	97	28	)	)	PUNCT
bjos-8668998	98	1	others	other	NOUN
bjos-8668998	98	2	0(0	0(0	NUM
bjos-8668998	98	3	)	)	PUNCT
bjos-8668998	98	4	1(100	1(100	NUM
bjos-8668998	98	5	)	)	PUNCT
bjos-8668998	98	6	1(100	1(100	PROPN
bjos-8668998	98	7	)	)	PUNCT
bjos-8668998	98	8	total	total	NOUN
bjos-8668998	98	9	12(37,5	12(37,5	NUM
bjos-8668998	98	10	)	)	PUNCT
bjos-8668998	98	11	20(62,5	20(62,5	NUM
bjos-8668998	98	12	)	)	PUNCT
bjos-8668998	98	13	32(100	32(100	NOUN
bjos-8668998	98	14	)	)	PUNCT
bjos-8668998	98	15	donor	donor	NOUN
bjos-8668998	98	16	relation	relation	NOUN
bjos-8668998	98	17	n(%	n(%	NOUN
bjos-8668998	98	18	)	)	PUNCT
bjos-8668998	98	19	related	relate	VERB
bjos-8668998	98	20	12(48	12(48	NUM
bjos-8668998	98	21	)	)	PUNCT
bjos-8668998	98	22	13(52	13(52	NUM
bjos-8668998	98	23	)	)	PUNCT
bjos-8668998	98	24	25(100	25(100	NOUN
bjos-8668998	98	25	)	)	PUNCT
bjos-8668998	98	26	unrelated	unrelated	ADJ
bjos-8668998	98	27	0(0	0(0	PROPN
bjos-8668998	98	28	)	)	PUNCT
bjos-8668998	98	29	7(100	7(100	X
bjos-8668998	98	30	)	)	PUNCT
bjos-8668998	98	31	7(100	7(100	NUM
bjos-8668998	98	32	)	)	PUNCT
bjos-8668998	98	33	0,029	0,029	NUM
bjos-8668998	98	34	*	*	SYM
bjos-8668998	98	35	total	total	NOUN
bjos-8668998	98	36	12(37,5	12(37,5	NUM
bjos-8668998	98	37	)	)	PUNCT
bjos-8668998	98	38	20(62,5	20(62,5	NUM
bjos-8668998	98	39	)	)	PUNCT
bjos-8668998	98	40	32(100	32(100	ADJ
bjos-8668998	98	41	)	)	PUNCT
bjos-8668998	98	42	matchn(%	matchn(%	NOUN
bjos-8668998	98	43	)	)	PUNCT
bjos-8668998	98	44	matched	match	VERB
bjos-8668998	98	45	8(42,1	8(42,1	NOUN
bjos-8668998	98	46	)	)	PUNCT
bjos-8668998	98	47	11(57,9	11(57,9	NUM
bjos-8668998	98	48	)	)	PUNCT
bjos-8668998	98	49	19(100	19(100	NOUN
bjos-8668998	98	50	)	)	PUNCT
bjos-8668998	98	51	unmatched	unmatched	ADJ
bjos-8668998	98	52	4(30,8	4(30,8	NUM
bjos-8668998	98	53	)	)	PUNCT
bjos-8668998	98	54	9(69,2	9(69,2	NOUN
bjos-8668998	98	55	)	)	PUNCT
bjos-8668998	98	56	13(100	13(100	NOUN
bjos-8668998	98	57	)	)	PUNCT
bjos-8668998	99	1	0,713	0,713	NUM
bjos-8668998	99	2	*	*	PUNCT
bjos-8668998	100	1	total	total	ADJ
bjos-8668998	100	2	12(37,5	12(37,5	NUM
bjos-8668998	100	3	)	)	PUNCT
bjos-8668998	100	4	20(62,5	20(62,5	NUM
bjos-8668998	100	5	)	)	PUNCT
bjos-8668998	100	6	32(100	32(100	ADJ
bjos-8668998	100	7	)	)	PUNCT
bjos-8668998	100	8	age	age	NOUN
bjos-8668998	100	9	–	–	PUNCT
bjos-8668998	100	10	median	median	NOUN
bjos-8668998	100	11	(	(	PUNCT
bjos-8668998	100	12	min	min	NOUN
bjos-8668998	100	13	-	-	PUNCT
bjos-8668998	100	14	max	max	NOUN
bjos-8668998	100	15	)	)	PUNCT
bjos-8668998	100	16	45(21	45(21	NUM
bjos-8668998	100	17	-	-	NUM
bjos-8668998	100	18	62	62	NUM
bjos-8668998	100	19	)	)	PUNCT
bjos-8668998	100	20	32(19	32(19	NUM
bjos-8668998	100	21	-	-	SYM
bjos-8668998	100	22	60	60	NUM
bjos-8668998	100	23	)	)	PUNCT
bjos-8668998	100	24	0,520	0,520	NUM
bjos-8668998	101	1	*	*	PUNCT
bjos-8668998	101	2	*	*	PUNCT
bjos-8668998	101	3	nlr	nlr	PROPN
bjos-8668998	101	4	–	–	PUNCT
bjos-8668998	101	5	median	median	NOUN
bjos-8668998	101	6	(	(	PUNCT
bjos-8668998	101	7	min	min	NOUN
bjos-8668998	101	8	-	-	PUNCT
bjos-8668998	101	9	max	max	NOUN
bjos-8668998	101	10	)	)	PUNCT
bjos-8668998	101	11	3,19(0,43	3,19(0,43	NUM
bjos-8668998	101	12	-	-	PUNCT
bjos-8668998	101	13	5,69	5,69	NUM
bjos-8668998	101	14	)	)	PUNCT
bjos-8668998	101	15	1,43(0,00	1,43(0,00	NUM
bjos-8668998	101	16	-	-	PUNCT
bjos-8668998	101	17	14,50	14,50	NUM
bjos-8668998	101	18	)	)	PUNCT
bjos-8668998	101	19	0,302	0,302	PROPN
bjos-8668998	101	20	*	*	PUNCT
bjos-8668998	101	21	*	*	PUNCT
bjos-8668998	101	22	*	*	PUNCT
bjos-8668998	101	23	fisher	fisher	PROPN
bjos-8668998	101	24	’s	’s	PART
bjos-8668998	101	25	exact	exact	ADJ
bjos-8668998	101	26	test	test	NOUN
bjos-8668998	101	27	.	.	PUNCT
bjos-8668998	102	1	*	*	PUNCT
bjos-8668998	102	2	*	*	PUNCT
bjos-8668998	102	3	mann	mann	PROPN
bjos-8668998	102	4	whitney	whitney	PROPN
bjos-8668998	102	5	u	u	PROPN
bjos-8668998	102	6	test	test	NOUN
bjos-8668998	102	7	.	.	PUNCT
bjos-8668998	103	1	discussion	discussion	NOUN
bjos-8668998	103	2	nlr	nlr	PROPN
bjos-8668998	103	3	is	be	AUX
bjos-8668998	103	4	a	a	DET
bjos-8668998	103	5	simple	simple	ADJ
bjos-8668998	103	6	parameter	parameter	NOUN
bjos-8668998	103	7	that	that	PRON
bjos-8668998	103	8	assesses	assess	VERB
bjos-8668998	103	9	a	a	DET
bjos-8668998	103	10	subject	subject	NOUN
bjos-8668998	103	11	’s	’s	PART
bjos-8668998	103	12	inflammatory	inflammatory	ADJ
bjos-8668998	103	13	state	state	NOUN
bjos-8668998	103	14	.	.	PUNCT
bjos-8668998	104	1	it	it	PRON
bjos-8668998	104	2	has	have	AUX
bjos-8668998	104	3	been	be	AUX
bjos-8668998	104	4	proven	prove	VERB
bjos-8668998	104	5	to	to	PART
bjos-8668998	104	6	be	be	AUX
bjos-8668998	104	7	a	a	DET
bjos-8668998	104	8	strong	strong	ADJ
bjos-8668998	104	9	prognostic	prognostic	ADJ
bjos-8668998	104	10	factor	factor	NOUN
bjos-8668998	104	11	in	in	ADP
bjos-8668998	104	12	several	several	ADJ
bjos-8668998	104	13	types	type	NOUN
bjos-8668998	104	14	of	of	ADP
bjos-8668998	104	15	cancer	cancer	NOUN
bjos-8668998	104	16	,	,	PUNCT
bjos-8668998	104	17	major	major	ADJ
bjos-8668998	104	18	cardiac	cardiac	ADJ
bjos-8668998	104	19	events	event	NOUN
bjos-8668998	104	20	,	,	PUNCT
bjos-8668998	104	21	and	and	CCONJ
bjos-8668998	104	22	markers	marker	NOUN
bjos-8668998	104	23	of	of	ADP
bjos-8668998	104	24	inflammation	inflammation	NOUN
bjos-8668998	104	25	,	,	PUNCT
bjos-8668998	104	26	infectious	infectious	ADJ
bjos-8668998	104	27	diseases	disease	NOUN
bjos-8668998	104	28	,	,	PUNCT
bjos-8668998	104	29	and	and	CCONJ
bjos-8668998	104	30	postoperative	postoperative	ADJ
bjos-8668998	104	31	complications26,27	complications26,27	PROPN
bjos-8668998	104	32	.	.	PUNCT
bjos-8668998	105	1	therefore	therefore	ADV
bjos-8668998	105	2	,	,	PUNCT
bjos-8668998	105	3	this	this	DET
bjos-8668998	105	4	study	study	NOUN
bjos-8668998	105	5	aimed	aim	VERB
bjos-8668998	105	6	to	to	PART
bjos-8668998	105	7	evaluate	evaluate	VERB
bjos-8668998	105	8	the	the	DET
bjos-8668998	105	9	association	association	NOUN
bjos-8668998	105	10	of	of	ADP
bjos-8668998	105	11	nlr	nlr	PROPN
bjos-8668998	105	12	with	with	ADP
bjos-8668998	105	13	om	om	PROPN
bjos-8668998	105	14	and	and	CCONJ
bjos-8668998	105	15	gvhd	gvhd	PROPN
bjos-8668998	105	16	in	in	ADP
bjos-8668998	105	17	patients	patient	NOUN
bjos-8668998	105	18	undergoing	undergo	VERB
bjos-8668998	105	19	allogeneic	allogeneic	ADJ
bjos-8668998	105	20	hsct	hsct	NOUN
bjos-8668998	105	21	.	.	PUNCT
bjos-8668998	106	1	no	no	DET
bjos-8668998	106	2	association	association	NOUN
bjos-8668998	106	3	was	be	AUX
bjos-8668998	106	4	observed	observe	VERB
bjos-8668998	106	5	between	between	ADP
bjos-8668998	106	6	om	om	PROPN
bjos-8668998	106	7	,	,	PUNCT
bjos-8668998	106	8	gvhd	gvhd	PROPN
bjos-8668998	106	9	,	,	PUNCT
bjos-8668998	106	10	and	and	CCONJ
bjos-8668998	106	11	nlr	nlr	PROPN
bjos-8668998	106	12	.	.	PUNCT
bjos-8668998	107	1	considering	consider	VERB
bjos-8668998	107	2	the	the	DET
bjos-8668998	107	3	association	association	NOUN
bjos-8668998	107	4	of	of	ADP
bjos-8668998	107	5	nlr	nlr	PROPN
bjos-8668998	107	6	with	with	ADP
bjos-8668998	107	7	inflammatory	inflammatory	ADJ
bjos-8668998	107	8	diseases	disease	NOUN
bjos-8668998	107	9	and	and	CCONJ
bjos-8668998	107	10	that	that	SCONJ
bjos-8668998	107	11	om	om	PROPN
bjos-8668998	107	12	and	and	CCONJ
bjos-8668998	107	13	gvhd	gvhd	PROPN
bjos-8668998	107	14	are	be	AUX
bjos-8668998	107	15	also	also	ADV
bjos-8668998	107	16	associated	associate	VERB
bjos-8668998	107	17	with	with	ADP
bjos-8668998	107	18	the	the	DET
bjos-8668998	107	19	activity	activity	NOUN
bjos-8668998	107	20	of	of	ADP
bjos-8668998	107	21	inflammatory	inflammatory	ADJ
bjos-8668998	107	22	cells	cell	NOUN
bjos-8668998	107	23	,	,	PUNCT
bjos-8668998	107	24	we	we	PRON
bjos-8668998	107	25	hypothesized	hypothesize	VERB
bjos-8668998	107	26	that	that	SCONJ
bjos-8668998	107	27	nlr	nlr	PROPN
bjos-8668998	107	28	could	could	AUX
bjos-8668998	107	29	serve	serve	VERB
bjos-8668998	107	30	as	as	ADP
bjos-8668998	107	31	a	a	DET
bjos-8668998	107	32	biomarker	biomarker	NOUN
bjos-8668998	107	33	for	for	ADP
bjos-8668998	107	34	these	these	DET
bjos-8668998	107	35	manifestations	manifestation	NOUN
bjos-8668998	107	36	.	.	PUNCT
bjos-8668998	108	1	nonetheless	nonetheless	ADV
bjos-8668998	108	2	,	,	PUNCT
bjos-8668998	108	3	to	to	ADP
bjos-8668998	108	4	the	the	DET
bjos-8668998	108	5	best	good	ADJ
bjos-8668998	108	6	of	of	ADP
bjos-8668998	108	7	our	our	PRON
bjos-8668998	108	8	knowledge	knowledge	NOUN
bjos-8668998	108	9	,	,	PUNCT
bjos-8668998	108	10	this	this	PRON
bjos-8668998	108	11	is	be	AUX
bjos-8668998	108	12	the	the	DET
bjos-8668998	108	13	first	first	ADJ
bjos-8668998	108	14	study	study	NOUN
bjos-8668998	108	15	to	to	PART
bjos-8668998	108	16	associate	associate	VERB
bjos-8668998	108	17	nlr	nlr	PROPN
bjos-8668998	108	18	with	with	ADP
bjos-8668998	108	19	complications	complication	NOUN
bjos-8668998	108	20	related	relate	VERB
bjos-8668998	108	21	to	to	ADP
bjos-8668998	108	22	allogeneic	allogeneic	VERB
bjos-8668998	108	23	hsct	hsct	NOUN
bjos-8668998	108	24	.	.	PUNCT
bjos-8668998	109	1	7	7	NUM
bjos-8668998	109	2	quadras	quadra	NOUN
bjos-8668998	109	3	et	et	PROPN
bjos-8668998	109	4	al	al	PROPN
bjos-8668998	109	5	.	.	PROPN
bjos-8668998	109	6	braz	braz	PROPN
bjos-8668998	109	7	j	j	PROPN
bjos-8668998	109	8	oral	oral	PROPN
bjos-8668998	109	9	sci	sci	PROPN
bjos-8668998	109	10	.	.	PUNCT
bjos-8668998	110	1	2023;22	2023;22	NUM
bjos-8668998	110	2	:	:	PUNCT
bjos-8668998	110	3	e238998	e238998	VERB
bjos-8668998	110	4	lesions	lesion	NOUN
bjos-8668998	110	5	in	in	ADP
bjos-8668998	110	6	oral	oral	ADJ
bjos-8668998	110	7	tissues	tissue	NOUN
bjos-8668998	110	8	can	can	AUX
bjos-8668998	110	9	serve	serve	VERB
bjos-8668998	110	10	as	as	ADP
bjos-8668998	110	11	an	an	DET
bjos-8668998	110	12	entry	entry	NOUN
bjos-8668998	110	13	vehicle	vehicle	NOUN
bjos-8668998	110	14	for	for	ADP
bjos-8668998	110	15	the	the	DET
bjos-8668998	110	16	spread	spread	NOUN
bjos-8668998	110	17	of	of	ADP
bjos-8668998	110	18	bacterial	bacterial	ADJ
bjos-8668998	110	19	,	,	PUNCT
bjos-8668998	110	20	fungal	fungal	ADJ
bjos-8668998	110	21	and	and	CCONJ
bjos-8668998	110	22	viral	viral	ADJ
bjos-8668998	110	23	infections	infection	NOUN
bjos-8668998	110	24	,	,	PUNCT
bjos-8668998	110	25	especially	especially	ADV
bjos-8668998	110	26	in	in	ADP
bjos-8668998	110	27	patients	patient	NOUN
bjos-8668998	110	28	undergoing	undergo	VERB
bjos-8668998	110	29	myelosuppressive	myelosuppressive	ADJ
bjos-8668998	110	30	or	or	CCONJ
bjos-8668998	110	31	immunosuppressive	immunosuppressive	ADJ
bjos-8668998	110	32	chemotherapy	chemotherapy	NOUN
bjos-8668998	110	33	regimens	regimen	NOUN
bjos-8668998	110	34	for	for	ADP
bjos-8668998	110	35	cancer	cancer	NOUN
bjos-8668998	110	36	treatment28	treatment28	NOUN
bjos-8668998	110	37	.	.	PUNCT
bjos-8668998	111	1	these	these	DET
bjos-8668998	111	2	patients	patient	NOUN
bjos-8668998	111	3	develop	develop	VERB
bjos-8668998	111	4	oral	oral	ADJ
bjos-8668998	111	5	problems	problem	NOUN
bjos-8668998	111	6	2	2	NUM
bjos-8668998	111	7	to	to	ADP
bjos-8668998	111	8	3	3	NUM
bjos-8668998	111	9	times	time	NOUN
bjos-8668998	111	10	more	more	ADV
bjos-8668998	111	11	often	often	ADV
bjos-8668998	111	12	than	than	ADP
bjos-8668998	111	13	patients	patient	NOUN
bjos-8668998	111	14	undergoing	undergo	VERB
bjos-8668998	111	15	treatment	treatment	NOUN
bjos-8668998	111	16	for	for	ADP
bjos-8668998	111	17	solid	solid	ADJ
bjos-8668998	111	18	tumors	tumor	NOUN
bjos-8668998	111	19	.	.	PUNCT
bjos-8668998	112	1	the	the	DET
bjos-8668998	112	2	results	result	NOUN
bjos-8668998	112	3	of	of	ADP
bjos-8668998	112	4	the	the	DET
bjos-8668998	112	5	present	present	ADJ
bjos-8668998	112	6	study	study	NOUN
bjos-8668998	112	7	corroborate	corroborate	VERB
bjos-8668998	112	8	this	this	DET
bjos-8668998	112	9	statement	statement	NOUN
bjos-8668998	112	10	,	,	PUNCT
bjos-8668998	112	11	since	since	SCONJ
bjos-8668998	112	12	the	the	DET
bjos-8668998	112	13	vast	vast	ADJ
bjos-8668998	112	14	majority	majority	NOUN
bjos-8668998	112	15	of	of	ADP
bjos-8668998	112	16	patients	patient	NOUN
bjos-8668998	112	17	with	with	ADP
bjos-8668998	112	18	malignant	malignant	ADJ
bjos-8668998	112	19	blood	blood	NOUN
bjos-8668998	112	20	diseases	disease	NOUN
bjos-8668998	112	21	manifested	manifest	VERB
bjos-8668998	112	22	om	om	PROPN
bjos-8668998	112	23	(	(	PUNCT
bjos-8668998	112	24	86.7	86.7	NUM
bjos-8668998	112	25	%	%	NOUN
bjos-8668998	112	26	)	)	PUNCT
bjos-8668998	112	27	,	,	PUNCT
bjos-8668998	112	28	a	a	DET
bjos-8668998	112	29	prognostic	prognostic	ADJ
bjos-8668998	112	30	biomarker	biomarker	NOUN
bjos-8668998	112	31	can	can	AUX
bjos-8668998	112	32	help	help	VERB
bjos-8668998	112	33	in	in	ADP
bjos-8668998	112	34	the	the	DET
bjos-8668998	112	35	management	management	NOUN
bjos-8668998	112	36	of	of	ADP
bjos-8668998	112	37	the	the	DET
bjos-8668998	112	38	condition	condition	NOUN
bjos-8668998	112	39	.	.	PUNCT
bjos-8668998	113	1	there	there	PRON
bjos-8668998	113	2	is	be	VERB
bjos-8668998	113	3	evidence	evidence	NOUN
bjos-8668998	113	4	that	that	SCONJ
bjos-8668998	113	5	patients	patient	NOUN
bjos-8668998	113	6	undergoing	undergo	VERB
bjos-8668998	113	7	allogeneic	allogeneic	ADJ
bjos-8668998	113	8	hsct	hsct	NOUN
bjos-8668998	113	9	develop	develop	VERB
bjos-8668998	113	10	om	om	PROPN
bjos-8668998	113	11	more	more	ADV
bjos-8668998	113	12	often	often	ADV
bjos-8668998	113	13	and	and	CCONJ
bjos-8668998	113	14	more	more	ADV
bjos-8668998	113	15	severely	severely	ADV
bjos-8668998	113	16	than	than	ADP
bjos-8668998	113	17	autologous	autologous	ADJ
bjos-8668998	113	18	transplant	transplant	NOUN
bjos-8668998	113	19	recipients12	recipients12	NOUN
bjos-8668998	113	20	.	.	PUNCT
bjos-8668998	114	1	but	but	CCONJ
bjos-8668998	114	2	to	to	ADP
bjos-8668998	114	3	the	the	DET
bjos-8668998	114	4	best	good	ADJ
bjos-8668998	114	5	of	of	ADP
bjos-8668998	114	6	our	our	PRON
bjos-8668998	114	7	knowledge	knowledge	NOUN
bjos-8668998	114	8	,	,	PUNCT
bjos-8668998	114	9	no	no	DET
bjos-8668998	114	10	studies	study	NOUN
bjos-8668998	114	11	have	have	AUX
bjos-8668998	114	12	compared	compare	VERB
bjos-8668998	114	13	related	relate	VERB
bjos-8668998	114	14	and	and	CCONJ
bjos-8668998	114	15	unrelated	unrelated	ADJ
bjos-8668998	114	16	grafts	graft	NOUN
bjos-8668998	114	17	in	in	ADP
bjos-8668998	114	18	allogeneic	allogeneic	ADJ
bjos-8668998	114	19	hsct	hsct	NOUN
bjos-8668998	114	20	.	.	PUNCT
bjos-8668998	115	1	in	in	ADP
bjos-8668998	115	2	the	the	DET
bjos-8668998	115	3	present	present	ADJ
bjos-8668998	115	4	study	study	NOUN
bjos-8668998	115	5	,	,	PUNCT
bjos-8668998	115	6	related	relate	VERB
bjos-8668998	115	7	hsct	hsct	NOUN
bjos-8668998	115	8	constituted	constitute	VERB
bjos-8668998	115	9	the	the	DET
bjos-8668998	115	10	majority	majority	NOUN
bjos-8668998	115	11	of	of	ADP
bjos-8668998	115	12	allogeneic	allogeneic	ADJ
bjos-8668998	115	13	transplants	transplant	NOUN
bjos-8668998	115	14	(	(	PUNCT
bjos-8668998	115	15	66.66	66.66	NUM
bjos-8668998	115	16	%	%	NOUN
bjos-8668998	115	17	)	)	PUNCT
bjos-8668998	115	18	,	,	PUNCT
bjos-8668998	115	19	which	which	PRON
bjos-8668998	115	20	explains	explain	VERB
bjos-8668998	115	21	the	the	DET
bjos-8668998	115	22	large	large	ADJ
bjos-8668998	115	23	number	number	NOUN
bjos-8668998	115	24	of	of	ADP
bjos-8668998	115	25	patients	patient	NOUN
bjos-8668998	115	26	with	with	ADP
bjos-8668998	115	27	om	om	PROPN
bjos-8668998	115	28	who	who	PRON
bjos-8668998	115	29	received	receive	VERB
bjos-8668998	115	30	hsct	hsct	NOUN
bjos-8668998	115	31	from	from	ADP
bjos-8668998	115	32	a	a	DET
bjos-8668998	115	33	related	related	ADJ
bjos-8668998	115	34	donor	donor	NOUN
bjos-8668998	115	35	compared	compare	VERB
bjos-8668998	115	36	to	to	ADP
bjos-8668998	115	37	unrelated	unrelated	ADJ
bjos-8668998	115	38	hsct	hsct	NOUN
bjos-8668998	115	39	.	.	PUNCT
bjos-8668998	116	1	we	we	PRON
bjos-8668998	116	2	did	do	AUX
bjos-8668998	116	3	not	not	PART
bjos-8668998	116	4	find	find	VERB
bjos-8668998	116	5	any	any	DET
bjos-8668998	116	6	statistically	statistically	ADV
bjos-8668998	116	7	significant	significant	ADJ
bjos-8668998	116	8	difference	difference	NOUN
bjos-8668998	116	9	associated	associate	VERB
bjos-8668998	116	10	with	with	ADP
bjos-8668998	116	11	gender	gender	NOUN
bjos-8668998	116	12	when	when	SCONJ
bjos-8668998	116	13	evaluating	evaluate	VERB
bjos-8668998	116	14	patients	patient	NOUN
bjos-8668998	116	15	who	who	PRON
bjos-8668998	116	16	developed	develop	VERB
bjos-8668998	116	17	oral	oral	ADJ
bjos-8668998	116	18	and	and	CCONJ
bjos-8668998	116	19	non	non	ADJ
bjos-8668998	116	20	-	-	ADJ
bjos-8668998	116	21	oral	oral	ADJ
bjos-8668998	116	22	gvhd	gvhd	NOUN
bjos-8668998	116	23	,	,	PUNCT
bjos-8668998	116	24	as	as	ADV
bjos-8668998	116	25	well	well	ADV
bjos-8668998	116	26	as	as	ADP
bjos-8668998	116	27	with	with	ADP
bjos-8668998	116	28	sex	sex	NOUN
bjos-8668998	116	29	.	.	PUNCT
bjos-8668998	117	1	however	however	ADV
bjos-8668998	117	2	,	,	PUNCT
bjos-8668998	117	3	when	when	SCONJ
bjos-8668998	117	4	hsct	hsct	PROPN
bjos-8668998	117	5	occurs	occur	VERB
bjos-8668998	117	6	from	from	ADP
bjos-8668998	117	7	a	a	DET
bjos-8668998	117	8	female	female	ADJ
bjos-8668998	117	9	donor	donor	NOUN
bjos-8668998	117	10	to	to	ADP
bjos-8668998	117	11	a	a	DET
bjos-8668998	117	12	male	male	ADJ
bjos-8668998	117	13	host	host	NOUN
bjos-8668998	117	14	,	,	PUNCT
bjos-8668998	117	15	the	the	DET
bjos-8668998	117	16	risk	risk	NOUN
bjos-8668998	117	17	of	of	ADP
bjos-8668998	117	18	gvhd	gvhd	PROPN
bjos-8668998	117	19	development	development	PROPN
bjos-8668998	117	20	increases29	increases29	PROPN
bjos-8668998	117	21	.	.	PUNCT
bjos-8668998	118	1	the	the	DET
bjos-8668998	118	2	most	most	ADV
bjos-8668998	118	3	common	common	ADJ
bjos-8668998	118	4	underlying	underlying	ADJ
bjos-8668998	118	5	disease	disease	NOUN
bjos-8668998	118	6	in	in	ADP
bjos-8668998	118	7	patients	patient	NOUN
bjos-8668998	118	8	with	with	ADP
bjos-8668998	118	9	manifestations	manifestation	NOUN
bjos-8668998	118	10	of	of	ADP
bjos-8668998	118	11	oral	oral	ADJ
bjos-8668998	118	12	and	and	CCONJ
bjos-8668998	118	13	non	non	ADJ
bjos-8668998	118	14	-	-	ADJ
bjos-8668998	118	15	oral	oral	ADJ
bjos-8668998	118	16	gvhd	gvhd	NOUN
bjos-8668998	118	17	after	after	ADP
bjos-8668998	118	18	allogeneic	allogeneic	ADJ
bjos-8668998	118	19	hsct	hsct	PROPN
bjos-8668998	118	20	was	be	AUX
bjos-8668998	118	21	acute	acute	ADJ
bjos-8668998	118	22	myeloid	myeloid	NOUN
bjos-8668998	118	23	leukemia	leukemia	NOUN
bjos-8668998	118	24	(	(	PUNCT
bjos-8668998	118	25	aml	aml	PROPN
bjos-8668998	118	26	)	)	PUNCT
bjos-8668998	118	27	,	,	PUNCT
bjos-8668998	118	28	corresponding	correspond	VERB
bjos-8668998	118	29	to	to	ADP
bjos-8668998	118	30	40	40	NUM
bjos-8668998	118	31	%	%	NOUN
bjos-8668998	118	32	of	of	ADP
bjos-8668998	118	33	oral	oral	ADJ
bjos-8668998	118	34	gvhd	gvhd	NOUN
bjos-8668998	118	35	and	and	CCONJ
bjos-8668998	118	36	50	50	NUM
bjos-8668998	118	37	%	%	NOUN
bjos-8668998	118	38	of	of	ADP
bjos-8668998	118	39	non	non	ADJ
bjos-8668998	118	40	-	-	ADJ
bjos-8668998	118	41	oral	oral	ADJ
bjos-8668998	118	42	gvhd	gvhd	NOUN
bjos-8668998	118	43	.	.	PUNCT
bjos-8668998	119	1	this	this	DET
bjos-8668998	119	2	result	result	NOUN
bjos-8668998	119	3	corroborates	corroborate	VERB
bjos-8668998	119	4	with	with	ADP
bjos-8668998	119	5	others29	others29	NOUN
bjos-8668998	119	6	.	.	PUNCT
bjos-8668998	120	1	carlens	carlen	NOUN
bjos-8668998	120	2	et	et	NOUN
bjos-8668998	120	3	al.29	al.29	NOUN
bjos-8668998	120	4	(	(	PUNCT
bjos-8668998	120	5	1998	1998	NUM
bjos-8668998	120	6	)	)	PUNCT
bjos-8668998	120	7	suggests	suggest	VERB
bjos-8668998	120	8	that	that	SCONJ
bjos-8668998	120	9	aml	aml	PROPN
bjos-8668998	120	10	is	be	AUX
bjos-8668998	120	11	a	a	DET
bjos-8668998	120	12	risk	risk	NOUN
bjos-8668998	120	13	factor	factor	NOUN
bjos-8668998	120	14	for	for	ADP
bjos-8668998	120	15	acute	acute	PROPN
bjos-8668998	120	16	gvhd	gvhd	PROPN
bjos-8668998	120	17	.	.	PUNCT
bjos-8668998	121	1	although	although	SCONJ
bjos-8668998	121	2	we	we	PRON
bjos-8668998	121	3	did	do	AUX
bjos-8668998	121	4	not	not	PART
bjos-8668998	121	5	observe	observe	VERB
bjos-8668998	121	6	a	a	DET
bjos-8668998	121	7	statistically	statistically	ADV
bjos-8668998	121	8	significant	significant	ADJ
bjos-8668998	121	9	difference	difference	NOUN
bjos-8668998	121	10	in	in	ADP
bjos-8668998	121	11	terms	term	NOUN
bjos-8668998	121	12	of	of	ADP
bjos-8668998	121	13	age	age	NOUN
bjos-8668998	121	14	,	,	PUNCT
bjos-8668998	121	15	donor	donor	NOUN
bjos-8668998	121	16	relationship	relationship	NOUN
bjos-8668998	121	17	,	,	PUNCT
bjos-8668998	121	18	and	and	CCONJ
bjos-8668998	121	19	match	match	VERB
bjos-8668998	121	20	in	in	ADP
bjos-8668998	121	21	oral	oral	ADJ
bjos-8668998	121	22	and	and	CCONJ
bjos-8668998	121	23	non	non	ADJ
bjos-8668998	121	24	-	-	ADJ
bjos-8668998	121	25	oral	oral	ADJ
bjos-8668998	121	26	gvhd	gvhd	NOUN
bjos-8668998	121	27	,	,	PUNCT
bjos-8668998	121	28	a	a	DET
bjos-8668998	121	29	lower	low	ADJ
bjos-8668998	121	30	frequency	frequency	NOUN
bjos-8668998	121	31	was	be	AUX
bjos-8668998	121	32	observed	observe	VERB
bjos-8668998	121	33	in	in	ADP
bjos-8668998	121	34	individuals	individual	NOUN
bjos-8668998	121	35	who	who	PRON
bjos-8668998	121	36	were	be	AUX
bjos-8668998	121	37	younger	young	ADJ
bjos-8668998	121	38	,	,	PUNCT
bjos-8668998	121	39	had	have	VERB
bjos-8668998	121	40	a	a	DET
bjos-8668998	121	41	related	related	ADJ
bjos-8668998	121	42	donor	donor	NOUN
bjos-8668998	121	43	,	,	PUNCT
bjos-8668998	121	44	and	and	CCONJ
bjos-8668998	121	45	received	receive	VERB
bjos-8668998	121	46	a	a	DET
bjos-8668998	121	47	matched	match	VERB
bjos-8668998	121	48	transplant	transplant	NOUN
bjos-8668998	121	49	.	.	PUNCT
bjos-8668998	122	1	these	these	DET
bjos-8668998	122	2	data	datum	NOUN
bjos-8668998	122	3	reaffirm	reaffirm	VERB
bjos-8668998	122	4	the	the	DET
bjos-8668998	122	5	results	result	NOUN
bjos-8668998	122	6	of	of	ADP
bjos-8668998	122	7	other	other	ADJ
bjos-8668998	122	8	studies	study	NOUN
bjos-8668998	122	9	by	by	ADP
bjos-8668998	122	10	indicating	indicate	VERB
bjos-8668998	122	11	that	that	SCONJ
bjos-8668998	122	12	the	the	DET
bjos-8668998	122	13	age	age	NOUN
bjos-8668998	122	14	of	of	ADP
bjos-8668998	122	15	the	the	DET
bjos-8668998	122	16	recipient	recipient	NOUN
bjos-8668998	122	17	and	and	CCONJ
bjos-8668998	122	18	donor	donor	NOUN
bjos-8668998	122	19	,	,	PUNCT
bjos-8668998	122	20	the	the	DET
bjos-8668998	122	21	mismatch	mismatch	NOUN
bjos-8668998	122	22	of	of	ADP
bjos-8668998	122	23	human	human	ADJ
bjos-8668998	122	24	leukocyte	leukocyte	NOUN
bjos-8668998	122	25	antigens	antigen	NOUN
bjos-8668998	122	26	(	(	PUNCT
bjos-8668998	122	27	hla	hla	NOUN
bjos-8668998	122	28	)	)	PUNCT
bjos-8668998	122	29	or	or	CCONJ
bjos-8668998	122	30	hla	hla	NOUN
bjos-8668998	122	31	disparity	disparity	NOUN
bjos-8668998	122	32	between	between	ADP
bjos-8668998	122	33	donor	donor	NOUN
bjos-8668998	122	34	and	and	CCONJ
bjos-8668998	122	35	recipient	recipient	NOUN
bjos-8668998	122	36	,	,	PUNCT
bjos-8668998	122	37	and	and	CCONJ
bjos-8668998	122	38	unrelated	unrelated	ADJ
bjos-8668998	122	39	donors	donor	NOUN
bjos-8668998	122	40	are	be	AUX
bjos-8668998	122	41	clinical	clinical	ADJ
bjos-8668998	122	42	risk	risk	NOUN
bjos-8668998	122	43	factors	factor	NOUN
bjos-8668998	122	44	that	that	PRON
bjos-8668998	122	45	increase	increase	VERB
bjos-8668998	122	46	the	the	DET
bjos-8668998	122	47	chance	chance	NOUN
bjos-8668998	122	48	for	for	ADP
bjos-8668998	122	49	the	the	DET
bjos-8668998	122	50	development	development	NOUN
bjos-8668998	122	51	of	of	ADP
bjos-8668998	122	52	gvhd3,29	gvhd3,29	PROPN
bjos-8668998	122	53	.	.	PUNCT
bjos-8668998	123	1	according	accord	VERB
bjos-8668998	123	2	to	to	ADP
bjos-8668998	123	3	bassim	bassim	PROPN
bjos-8668998	123	4	et	et	PROPN
bjos-8668998	123	5	al.8	al.8	PROPN
bjos-8668998	123	6	(	(	PUNCT
bjos-8668998	123	7	2015	2015	NUM
bjos-8668998	123	8	)	)	PUNCT
bjos-8668998	123	9	,	,	PUNCT
bjos-8668998	123	10	patients	patient	NOUN
bjos-8668998	123	11	undergoing	undergo	VERB
bjos-8668998	123	12	transplantation	transplantation	NOUN
bjos-8668998	123	13	with	with	ADP
bjos-8668998	123	14	unrelated	unrelated	ADJ
bjos-8668998	123	15	donors	donor	NOUN
bjos-8668998	123	16	are	be	AUX
bjos-8668998	123	17	at	at	ADP
bjos-8668998	123	18	a	a	DET
bjos-8668998	123	19	risk	risk	NOUN
bjos-8668998	123	20	of	of	ADP
bjos-8668998	123	21	up	up	ADP
bjos-8668998	123	22	to	to	PART
bjos-8668998	123	23	80	80	NUM
bjos-8668998	123	24	%	%	NOUN
bjos-8668998	123	25	to	to	PART
bjos-8668998	123	26	develop	develop	VERB
bjos-8668998	123	27	gvhd8	gvhd8	NOUN
bjos-8668998	123	28	.	.	PUNCT
bjos-8668998	124	1	an	an	DET
bjos-8668998	124	2	exception	exception	NOUN
bjos-8668998	124	3	was	be	AUX
bjos-8668998	124	4	the	the	DET
bjos-8668998	124	5	donor	donor	NOUN
bjos-8668998	124	6	relationship	relationship	NOUN
bjos-8668998	124	7	in	in	ADP
bjos-8668998	124	8	non	non	ADJ
bjos-8668998	124	9	-	-	ADJ
bjos-8668998	124	10	oral	oral	ADJ
bjos-8668998	124	11	gvhd	gvhd	NOUN
bjos-8668998	124	12	,	,	PUNCT
bjos-8668998	124	13	in	in	ADP
bjos-8668998	124	14	which	which	PRON
bjos-8668998	124	15	a	a	DET
bjos-8668998	124	16	statistically	statistically	ADV
bjos-8668998	124	17	significant	significant	ADJ
bjos-8668998	124	18	difference	difference	NOUN
bjos-8668998	124	19	was	be	AUX
bjos-8668998	124	20	observed	observe	VERB
bjos-8668998	124	21	(	(	PUNCT
bjos-8668998	124	22	p	p	X
bjos-8668998	124	23	=	=	NOUN
bjos-8668998	124	24	0.029	0.029	NUM
bjos-8668998	124	25	)	)	PUNCT
bjos-8668998	124	26	,	,	PUNCT
bjos-8668998	124	27	since	since	SCONJ
bjos-8668998	124	28	none	none	NOUN
bjos-8668998	124	29	of	of	ADP
bjos-8668998	124	30	the	the	DET
bjos-8668998	124	31	patients	patient	NOUN
bjos-8668998	124	32	who	who	PRON
bjos-8668998	124	33	received	receive	VERB
bjos-8668998	124	34	the	the	DET
bjos-8668998	124	35	unrelated	unrelated	ADJ
bjos-8668998	124	36	transplant	transplant	NOUN
bjos-8668998	124	37	developed	develop	VERB
bjos-8668998	124	38	gvhd	gvhd	NOUN
bjos-8668998	124	39	.	.	PUNCT
bjos-8668998	125	1	however	however	ADV
bjos-8668998	125	2	,	,	PUNCT
bjos-8668998	125	3	these	these	DET
bjos-8668998	125	4	data	datum	NOUN
bjos-8668998	125	5	contradict	contradict	VERB
bjos-8668998	125	6	the	the	DET
bjos-8668998	125	7	results	result	NOUN
bjos-8668998	125	8	of	of	ADP
bjos-8668998	125	9	other	other	ADJ
bjos-8668998	125	10	studies3,29	studies3,29	PROPN
bjos-8668998	125	11	that	that	PRON
bjos-8668998	125	12	show	show	VERB
bjos-8668998	125	13	that	that	SCONJ
bjos-8668998	125	14	gvhd	gvhd	PROPN
bjos-8668998	125	15	occurs	occur	VERB
bjos-8668998	125	16	more	more	ADV
bjos-8668998	125	17	frequently	frequently	ADV
bjos-8668998	125	18	as	as	ADP
bjos-8668998	125	19	a	a	DET
bjos-8668998	125	20	result	result	NOUN
bjos-8668998	125	21	of	of	ADP
bjos-8668998	125	22	unrelated	unrelated	ADJ
bjos-8668998	125	23	donors	donor	NOUN
bjos-8668998	125	24	.	.	PUNCT
bjos-8668998	126	1	we	we	PRON
bjos-8668998	126	2	believe	believe	VERB
bjos-8668998	126	3	that	that	SCONJ
bjos-8668998	126	4	our	our	PRON
bjos-8668998	126	5	results	result	NOUN
bjos-8668998	126	6	do	do	AUX
bjos-8668998	126	7	not	not	PART
bjos-8668998	126	8	indicate	indicate	VERB
bjos-8668998	126	9	causality	causality	NOUN
bjos-8668998	126	10	in	in	ADP
bjos-8668998	126	11	this	this	DET
bjos-8668998	126	12	sample	sample	NOUN
bjos-8668998	126	13	,	,	PUNCT
bjos-8668998	126	14	since	since	SCONJ
bjos-8668998	126	15	the	the	DET
bjos-8668998	126	16	small	small	ADJ
bjos-8668998	126	17	number	number	NOUN
bjos-8668998	126	18	of	of	ADP
bjos-8668998	126	19	patients	patient	NOUN
bjos-8668998	126	20	with	with	ADP
bjos-8668998	126	21	manifestations	manifestation	NOUN
bjos-8668998	126	22	of	of	ADP
bjos-8668998	126	23	oral	oral	ADJ
bjos-8668998	126	24	and	and	CCONJ
bjos-8668998	126	25	non	non	ADJ
bjos-8668998	126	26	-	-	ADJ
bjos-8668998	126	27	oral	oral	ADJ
bjos-8668998	126	28	gvhd	gvhd	NOUN
bjos-8668998	126	29	can	can	AUX
bjos-8668998	126	30	be	be	AUX
bjos-8668998	126	31	explained	explain	VERB
bjos-8668998	126	32	by	by	ADP
bjos-8668998	126	33	the	the	DET
bjos-8668998	126	34	fact	fact	NOUN
bjos-8668998	126	35	that	that	SCONJ
bjos-8668998	126	36	a	a	DET
bjos-8668998	126	37	large	large	ADJ
bjos-8668998	126	38	part	part	NOUN
bjos-8668998	126	39	of	of	ADP
bjos-8668998	126	40	the	the	DET
bjos-8668998	126	41	sample	sample	NOUN
bjos-8668998	126	42	was	be	AUX
bjos-8668998	126	43	composed	compose	VERB
bjos-8668998	126	44	of	of	ADP
bjos-8668998	126	45	young	young	ADJ
bjos-8668998	126	46	adults	adult	NOUN
bjos-8668998	126	47	and	and	CCONJ
bjos-8668998	126	48	the	the	DET
bjos-8668998	126	49	majority	majority	NOUN
bjos-8668998	126	50	of	of	ADP
bjos-8668998	126	51	the	the	DET
bjos-8668998	126	52	individuals	individual	NOUN
bjos-8668998	126	53	received	receive	VERB
bjos-8668998	126	54	related	related	ADJ
bjos-8668998	126	55	and	and	CCONJ
bjos-8668998	126	56	matched	match	VERB
bjos-8668998	126	57	transplants	transplant	NOUN
bjos-8668998	126	58	.	.	PUNCT
bjos-8668998	127	1	in	in	ADP
bjos-8668998	127	2	our	our	PRON
bjos-8668998	127	3	sample	sample	NOUN
bjos-8668998	127	4	,	,	PUNCT
bjos-8668998	127	5	we	we	PRON
bjos-8668998	127	6	did	do	AUX
bjos-8668998	127	7	not	not	PART
bjos-8668998	127	8	find	find	VERB
bjos-8668998	127	9	a	a	DET
bjos-8668998	127	10	statistically	statistically	ADV
bjos-8668998	127	11	significant	significant	ADJ
bjos-8668998	127	12	difference	difference	NOUN
bjos-8668998	127	13	in	in	ADP
bjos-8668998	127	14	nlr	nlr	PROPN
bjos-8668998	127	15	associated	associate	VERB
bjos-8668998	127	16	with	with	ADP
bjos-8668998	127	17	om	om	PROPN
bjos-8668998	127	18	,	,	PUNCT
bjos-8668998	127	19	oral	oral	ADJ
bjos-8668998	127	20	gvhd	gvhd	NOUN
bjos-8668998	127	21	,	,	PUNCT
bjos-8668998	127	22	and	and	CCONJ
bjos-8668998	127	23	non	non	ADJ
bjos-8668998	127	24	-	-	ADJ
bjos-8668998	127	25	oral	oral	ADJ
bjos-8668998	127	26	gvhd	gvhd	NOUN
bjos-8668998	127	27	.	.	PUNCT
bjos-8668998	128	1	to	to	ADP
bjos-8668998	128	2	the	the	DET
bjos-8668998	128	3	best	good	ADJ
bjos-8668998	128	4	of	of	ADP
bjos-8668998	128	5	our	our	PRON
bjos-8668998	128	6	knowledge	knowledge	NOUN
bjos-8668998	128	7	,	,	PUNCT
bjos-8668998	128	8	this	this	PRON
bjos-8668998	128	9	is	be	AUX
bjos-8668998	128	10	the	the	DET
bjos-8668998	128	11	first	first	ADJ
bjos-8668998	128	12	study	study	NOUN
bjos-8668998	128	13	to	to	PART
bjos-8668998	128	14	analyze	analyze	VERB
bjos-8668998	128	15	this	this	DET
bjos-8668998	128	16	association	association	NOUN
bjos-8668998	128	17	.	.	PUNCT
bjos-8668998	129	1	the	the	DET
bjos-8668998	129	2	search	search	NOUN
bjos-8668998	129	3	for	for	ADP
bjos-8668998	129	4	biomarkers	biomarker	NOUN
bjos-8668998	129	5	with	with	ADP
bjos-8668998	129	6	easy	easy	ADJ
bjos-8668998	129	7	access	access	NOUN
bjos-8668998	129	8	,	,	PUNCT
bjos-8668998	129	9	low	low	ADJ
bjos-8668998	129	10	cost	cost	NOUN
bjos-8668998	129	11	,	,	PUNCT
bjos-8668998	129	12	and	and	CCONJ
bjos-8668998	129	13	that	that	PRON
bjos-8668998	129	14	can	can	AUX
bjos-8668998	129	15	provide	provide	VERB
bjos-8668998	129	16	important	important	ADJ
bjos-8668998	129	17	answers	answer	NOUN
bjos-8668998	129	18	in	in	ADP
bjos-8668998	129	19	the	the	DET
bjos-8668998	129	20	diagnosis	diagnosis	NOUN
bjos-8668998	129	21	,	,	PUNCT
bjos-8668998	129	22	treatment	treatment	NOUN
bjos-8668998	129	23	,	,	PUNCT
bjos-8668998	129	24	and	and	CCONJ
bjos-8668998	129	25	8	8	NUM
bjos-8668998	129	26	quadras	quadra	NOUN
bjos-8668998	129	27	et	et	PROPN
bjos-8668998	129	28	al	al	PROPN
bjos-8668998	129	29	.	.	PROPN
bjos-8668998	129	30	braz	braz	PROPN
bjos-8668998	129	31	j	j	PROPN
bjos-8668998	129	32	oral	oral	PROPN
bjos-8668998	129	33	sci	sci	PROPN
bjos-8668998	129	34	.	.	PUNCT
bjos-8668998	130	1	2023;22	2023;22	NUM
bjos-8668998	130	2	:	:	PUNCT
bjos-8668998	130	3	e238998	e238998	VERB
bjos-8668998	130	4	prognosis	prognosis	NOUN
bjos-8668998	130	5	of	of	ADP
bjos-8668998	130	6	consequent	consequent	ADJ
bjos-8668998	130	7	manifestations	manifestation	NOUN
bjos-8668998	130	8	of	of	ADP
bjos-8668998	130	9	allogeneic	allogeneic	ADJ
bjos-8668998	130	10	hsct	hsct	NOUN
bjos-8668998	130	11	is	be	AUX
bjos-8668998	130	12	of	of	ADP
bjos-8668998	130	13	paramount	paramount	ADJ
bjos-8668998	130	14	relevance	relevance	NOUN
bjos-8668998	130	15	.	.	PUNCT
bjos-8668998	131	1	finding	find	VERB
bjos-8668998	131	2	a	a	DET
bjos-8668998	131	3	larger	large	ADJ
bjos-8668998	131	4	sample	sample	NOUN
bjos-8668998	131	5	,	,	PUNCT
bjos-8668998	131	6	in	in	ADP
bjos-8668998	131	7	which	which	PRON
bjos-8668998	131	8	nlr	nlr	PROPN
bjos-8668998	131	9	could	could	AUX
bjos-8668998	131	10	be	be	AUX
bjos-8668998	131	11	paired	pair	VERB
bjos-8668998	131	12	by	by	ADP
bjos-8668998	131	13	age	age	NOUN
bjos-8668998	131	14	,	,	PUNCT
bjos-8668998	131	15	underlying	underlying	ADJ
bjos-8668998	131	16	disease	disease	NOUN
bjos-8668998	131	17	,	,	PUNCT
bjos-8668998	131	18	conditioning	conditioning	NOUN
bjos-8668998	131	19	regime	regime	NOUN
bjos-8668998	131	20	,	,	PUNCT
bjos-8668998	131	21	donor	donor	NOUN
bjos-8668998	131	22	relation	relation	NOUN
bjos-8668998	131	23	,	,	PUNCT
bjos-8668998	131	24	and	and	CCONJ
bjos-8668998	131	25	match	match	VERB
bjos-8668998	131	26	between	between	ADP
bjos-8668998	131	27	patients	patient	NOUN
bjos-8668998	131	28	who	who	PRON
bjos-8668998	131	29	develop	develop	VERB
bjos-8668998	131	30	om	om	PROPN
bjos-8668998	131	31	,	,	PUNCT
bjos-8668998	131	32	oral	oral	ADJ
bjos-8668998	131	33	gvhd	gvhd	NOUN
bjos-8668998	131	34	,	,	PUNCT
bjos-8668998	131	35	and	and	CCONJ
bjos-8668998	131	36	non	non	ADJ
bjos-8668998	131	37	-	-	ADJ
bjos-8668998	131	38	oral	oral	ADJ
bjos-8668998	131	39	gvhd	gvhd	NOUN
bjos-8668998	131	40	,	,	PUNCT
bjos-8668998	131	41	is	be	AUX
bjos-8668998	131	42	a	a	DET
bjos-8668998	131	43	great	great	ADJ
bjos-8668998	131	44	challenge	challenge	NOUN
bjos-8668998	131	45	;	;	PUNCT
bjos-8668998	131	46	for	for	ADP
bjos-8668998	131	47	this	this	DET
bjos-8668998	131	48	reason	reason	NOUN
bjos-8668998	131	49	,	,	PUNCT
bjos-8668998	131	50	we	we	PRON
bjos-8668998	131	51	believe	believe	VERB
bjos-8668998	131	52	that	that	SCONJ
bjos-8668998	131	53	future	future	ADJ
bjos-8668998	131	54	multicenter	multicenter	NOUN
bjos-8668998	131	55	studies	study	NOUN
bjos-8668998	131	56	can	can	AUX
bjos-8668998	131	57	help	help	VERB
bjos-8668998	131	58	infer	infer	VERB
bjos-8668998	131	59	the	the	DET
bjos-8668998	131	60	results	result	NOUN
bjos-8668998	131	61	of	of	ADP
bjos-8668998	131	62	the	the	DET
bjos-8668998	131	63	nlr	nlr	PROPN
bjos-8668998	131	64	associations	association	NOUN
bjos-8668998	131	65	with	with	ADP
bjos-8668998	131	66	om	om	PROPN
bjos-8668998	131	67	,	,	PUNCT
bjos-8668998	131	68	oral	oral	ADJ
bjos-8668998	131	69	gvhd	gvhd	NOUN
bjos-8668998	131	70	,	,	PUNCT
bjos-8668998	131	71	and	and	CCONJ
bjos-8668998	131	72	non	non	ADJ
bjos-8668998	131	73	-	-	ADJ
bjos-8668998	131	74	oral	oral	ADJ
bjos-8668998	131	75	gvhd	gvhd	NOUN
bjos-8668998	131	76	for	for	ADP
bjos-8668998	131	77	the	the	DET
bjos-8668998	131	78	general	general	ADJ
bjos-8668998	131	79	population	population	NOUN
bjos-8668998	131	80	of	of	ADP
bjos-8668998	131	81	patients	patient	NOUN
bjos-8668998	131	82	undergoing	undergo	VERB
bjos-8668998	131	83	allogeneic	allogeneic	ADJ
bjos-8668998	131	84	hsct	hsct	NOUN
bjos-8668998	131	85	.	.	PUNCT
bjos-8668998	132	1	in	in	ADP
bjos-8668998	132	2	conclusion	conclusion	NOUN
bjos-8668998	132	3	,	,	PUNCT
bjos-8668998	132	4	although	although	SCONJ
bjos-8668998	132	5	both	both	PRON
bjos-8668998	132	6	om	om	PROPN
bjos-8668998	132	7	and	and	CCONJ
bjos-8668998	132	8	gvhd	gvhd	PROPN
bjos-8668998	132	9	are	be	AUX
bjos-8668998	132	10	associated	associate	VERB
bjos-8668998	132	11	with	with	ADP
bjos-8668998	132	12	the	the	DET
bjos-8668998	132	13	inflammatory	inflammatory	ADJ
bjos-8668998	132	14	response	response	NOUN
bjos-8668998	132	15	as	as	ADV
bjos-8668998	132	16	well	well	ADV
bjos-8668998	132	17	as	as	ADP
bjos-8668998	132	18	the	the	DET
bjos-8668998	132	19	immune	immune	ADJ
bjos-8668998	132	20	system	system	NOUN
bjos-8668998	132	21	,	,	PUNCT
bjos-8668998	132	22	they	they	PRON
bjos-8668998	132	23	are	be	AUX
bjos-8668998	132	24	not	not	PART
bjos-8668998	132	25	associated	associate	VERB
bjos-8668998	132	26	with	with	ADP
bjos-8668998	132	27	nlr	nlr	PROPN
bjos-8668998	132	28	.	.	PUNCT
bjos-8668998	133	1	declarations	declaration	NOUN
bjos-8668998	133	2	of	of	ADP
bjos-8668998	133	3	interest	interest	NOUN
bjos-8668998	133	4	none	none	NOUN
bjos-8668998	133	5	.	.	PUNCT
bjos-8668998	134	1	this	this	DET
bjos-8668998	134	2	research	research	NOUN
bjos-8668998	134	3	did	do	AUX
bjos-8668998	134	4	not	not	PART
bjos-8668998	134	5	receive	receive	VERB
bjos-8668998	134	6	any	any	DET
bjos-8668998	134	7	specific	specific	ADJ
bjos-8668998	134	8	grant	grant	NOUN
bjos-8668998	134	9	from	from	ADP
bjos-8668998	134	10	funding	fund	VERB
bjos-8668998	134	11	agencies	agency	NOUN
bjos-8668998	134	12	in	in	ADP
bjos-8668998	134	13	the	the	DET
bjos-8668998	134	14	public	public	ADJ
bjos-8668998	134	15	,	,	PUNCT
bjos-8668998	134	16	commercial	commercial	ADJ
bjos-8668998	134	17	,	,	PUNCT
bjos-8668998	134	18	or	or	CCONJ
bjos-8668998	134	19	not	not	PART
bjos-8668998	134	20	-	-	PUNCT
bjos-8668998	134	21	for	for	ADP
bjos-8668998	134	22	-	-	PUNCT
bjos-8668998	134	23	profit	profit	NOUN
bjos-8668998	134	24	sectors	sector	NOUN
bjos-8668998	134	25	.	.	PUNCT
bjos-8668998	135	1	ethics	ethic	NOUN
bjos-8668998	135	2	approval	approval	VERB
bjos-8668998	135	3	all	all	DET
bjos-8668998	135	4	procedures	procedure	NOUN
bjos-8668998	135	5	carried	carry	VERB
bjos-8668998	135	6	out	out	ADP
bjos-8668998	135	7	in	in	ADP
bjos-8668998	135	8	studies	study	NOUN
bjos-8668998	135	9	involving	involve	VERB
bjos-8668998	135	10	human	human	ADJ
bjos-8668998	135	11	participants	participant	NOUN
bjos-8668998	135	12	were	be	AUX
bjos-8668998	135	13	in	in	ADP
bjos-8668998	135	14	accordance	accordance	NOUN
bjos-8668998	135	15	with	with	ADP
bjos-8668998	135	16	the	the	DET
bjos-8668998	135	17	ethical	ethical	ADJ
bjos-8668998	135	18	standards	standard	NOUN
bjos-8668998	135	19	of	of	ADP
bjos-8668998	135	20	the	the	DET
bjos-8668998	135	21	institutional	institutional	ADJ
bjos-8668998	135	22	research	research	NOUN
bjos-8668998	135	23	committee	committee	NOUN
bjos-8668998	135	24	and	and	CCONJ
bjos-8668998	135	25	the	the	DET
bjos-8668998	135	26	helsinki	helsinki	PROPN
bjos-8668998	135	27	declaration	declaration	PROPN
bjos-8668998	135	28	of	of	ADP
bjos-8668998	135	29	1964	1964	NUM
bjos-8668998	135	30	and	and	CCONJ
bjos-8668998	135	31	its	its	PRON
bjos-8668998	135	32	subsequent	subsequent	ADJ
bjos-8668998	135	33	amendments	amendment	NOUN
bjos-8668998	135	34	or	or	CCONJ
bjos-8668998	135	35	comparable	comparable	ADJ
bjos-8668998	135	36	ethical	ethical	ADJ
bjos-8668998	135	37	standards	standard	NOUN
bjos-8668998	135	38	.	.	PUNCT
bjos-8668998	136	1	the	the	DET
bjos-8668998	136	2	study	study	NOUN
bjos-8668998	136	3	was	be	AUX
bjos-8668998	136	4	approved	approve	VERB
bjos-8668998	136	5	by	by	ADP
bjos-8668998	136	6	the	the	DET
bjos-8668998	136	7	research	research	NOUN
bjos-8668998	136	8	ethics	ethic	NOUN
bjos-8668998	136	9	committee	committee	PROPN
bjos-8668998	136	10	of	of	ADP
bjos-8668998	136	11	the	the	DET
bjos-8668998	136	12	complexo	complexo	PROPN
bjos-8668998	136	13	hospital	hospital	PROPN
bjos-8668998	136	14	de	de	ADP
bjos-8668998	136	15	clínicas	clínicas	PROPN
bjos-8668998	136	16	of	of	ADP
bjos-8668998	136	17	the	the	DET
bjos-8668998	136	18	universidade	universidade	PROPN
bjos-8668998	136	19	federal	federal	PROPN
bjos-8668998	136	20	do	do	VERB
bjos-8668998	136	21	paraná	paraná	PROPN
bjos-8668998	136	22	(	(	PUNCT
bjos-8668998	136	23	no	no	INTJ
bjos-8668998	136	24	.	.	PUNCT
bjos-8668998	137	1	4.414.355	4.414.355	NUM
bjos-8668998	137	2	)	)	PUNCT
bjos-8668998	137	3	.	.	PUNCT
bjos-8668998	138	1	consent	consent	NOUN
bjos-8668998	138	2	to	to	PART
bjos-8668998	138	3	participate	participate	VERB
bjos-8668998	138	4	free	free	ADJ
bjos-8668998	138	5	and	and	CCONJ
bjos-8668998	138	6	informed	informed	ADJ
bjos-8668998	138	7	consent	consent	NOUN
bjos-8668998	138	8	was	be	AUX
bjos-8668998	138	9	obtained	obtain	VERB
bjos-8668998	138	10	from	from	ADP
bjos-8668998	138	11	all	all	DET
bjos-8668998	138	12	individual	individual	ADJ
bjos-8668998	138	13	participants	participant	NOUN
bjos-8668998	138	14	included	include	VERB
bjos-8668998	138	15	in	in	ADP
bjos-8668998	138	16	the	the	DET
bjos-8668998	138	17	study	study	NOUN
bjos-8668998	138	18	.	.	PUNCT
bjos-8668998	139	1	consent	consent	NOUN
bjos-8668998	139	2	for	for	ADP
bjos-8668998	139	3	publication	publication	NOUN
bjos-8668998	139	4	free	free	ADJ
bjos-8668998	139	5	and	and	CCONJ
bjos-8668998	139	6	informed	informed	ADJ
bjos-8668998	139	7	consent	consent	NOUN
bjos-8668998	139	8	was	be	AUX
bjos-8668998	139	9	obtained	obtain	VERB
bjos-8668998	139	10	from	from	ADP
bjos-8668998	139	11	all	all	DET
bjos-8668998	139	12	individual	individual	ADJ
bjos-8668998	139	13	participants	participant	NOUN
bjos-8668998	139	14	included	include	VERB
bjos-8668998	139	15	in	in	ADP
bjos-8668998	139	16	the	the	DET
bjos-8668998	139	17	study	study	NOUN
bjos-8668998	139	18	.	.	PUNCT
bjos-8668998	140	1	author	author	NOUN
bjos-8668998	140	2	contribution	contribution	PROPN
bjos-8668998	140	3	•	•	PROPN
bjos-8668998	140	4	isabella	isabella	PROPN
bjos-8668998	140	5	christina	christina	PROPN
bjos-8668998	140	6	costa	costa	PROPN
bjos-8668998	140	7	quadras	quadras	PROPN
bjos-8668998	140	8	:	:	PUNCT
bjos-8668998	140	9	conceptualization	conceptualization	NOUN
bjos-8668998	140	10	,	,	PUNCT
bjos-8668998	140	11	methodology	methodology	NOUN
bjos-8668998	140	12	,	,	PUNCT
bjos-8668998	140	13	data	data	NOUN
bjos-8668998	140	14	curation	curation	NOUN
bjos-8668998	140	15	,	,	PUNCT
bjos-8668998	140	16	writing	write	VERB
bjos-8668998	140	17	original	original	ADJ
bjos-8668998	140	18	draft	draft	NOUN
bjos-8668998	140	19	preparation	preparation	NOUN
bjos-8668998	140	20	.	.	PUNCT
bjos-8668998	141	1	•	•	NUM
bjos-8668998	141	2	fernanda	fernanda	PROPN
bjos-8668998	141	3	aparecida	aparecida	PROPN
bjos-8668998	141	4	stresser	stresser	NOUN
bjos-8668998	141	5	:	:	PUNCT
bjos-8668998	142	1	conceptualization	conceptualization	NOUN
bjos-8668998	142	2	,	,	PUNCT
bjos-8668998	142	3	methodology	methodology	NOUN
bjos-8668998	142	4	,	,	PUNCT
bjos-8668998	142	5	data	data	NOUN
bjos-8668998	142	6	curation	curation	NOUN
bjos-8668998	142	7	,	,	PUNCT
bjos-8668998	142	8	writing	write	VERB
bjos-8668998	142	9	original	original	ADJ
bjos-8668998	142	10	draft	draft	NOUN
bjos-8668998	142	11	preparation	preparation	NOUN
bjos-8668998	142	12	.	.	PUNCT
bjos-8668998	143	1	•	•	NUM
bjos-8668998	143	2	stephanie	stephanie	PROPN
bjos-8668998	143	3	von	von	PROPN
bjos-8668998	143	4	stein	stein	PROPN
bjos-8668998	143	5	cubas	cubas	PROPN
bjos-8668998	143	6	warnavin	warnavin	PROPN
bjos-8668998	143	7	:	:	PUNCT
bjos-8668998	143	8	conceptualization	conceptualization	NOUN
bjos-8668998	143	9	,	,	PUNCT
bjos-8668998	143	10	methodology	methodology	NOUN
bjos-8668998	143	11	,	,	PUNCT
bjos-8668998	143	12	data	data	NOUN
bjos-8668998	143	13	curation	curation	NOUN
bjos-8668998	143	14	,	,	PUNCT
bjos-8668998	143	15	writing	write	VERB
bjos-8668998	143	16	original	original	ADJ
bjos-8668998	143	17	draft	draft	NOUN
bjos-8668998	143	18	preparation	preparation	NOUN
bjos-8668998	143	19	,	,	PUNCT
bjos-8668998	143	20	review	review	NOUN
bjos-8668998	143	21	&	&	CCONJ
bjos-8668998	143	22	editing	editing	NOUN
bjos-8668998	143	23	.	.	PUNCT
bjos-8668998	144	1	•	•	NUM
bjos-8668998	144	2	sandra	sandra	PROPN
bjos-8668998	144	3	regina	regina	PROPN
bjos-8668998	144	4	da	da	PROPN
bjos-8668998	144	5	silva	silva	PROPN
bjos-8668998	144	6	:	:	PUNCT
bjos-8668998	144	7	conceptualization	conceptualization	NOUN
bjos-8668998	144	8	,	,	PUNCT
bjos-8668998	144	9	writing	write	VERB
bjos-8668998	144	10	review	review	NOUN
bjos-8668998	144	11	&	&	CCONJ
bjos-8668998	144	12	editing	editing	NOUN
bjos-8668998	144	13	.	.	PUNCT
bjos-8668998	145	1	•	•	NUM
bjos-8668998	145	2	vaneuza	vaneuza	NOUN
bjos-8668998	145	3	araújo	araújo	PROPN
bjos-8668998	145	4	moreira	moreira	PROPN
bjos-8668998	145	5	funke	funke	PROPN
bjos-8668998	145	6	:	:	PUNCT
bjos-8668998	145	7	conceptualization	conceptualization	NOUN
bjos-8668998	145	8	,	,	PUNCT
bjos-8668998	145	9	writing	write	VERB
bjos-8668998	145	10	review	review	NOUN
bjos-8668998	145	11	&	&	CCONJ
bjos-8668998	145	12	editing	editing	PROPN
bjos-8668998	145	13	.	.	PUNCT
bjos-8668998	146	1	•	•	NUM
bjos-8668998	146	2	rafael	rafael	PROPN
bjos-8668998	146	3	zancan	zancan	PROPN
bjos-8668998	146	4	mobile	mobile	NOUN
bjos-8668998	146	5	:	:	PUNCT
bjos-8668998	146	6	conceptualization	conceptualization	NOUN
bjos-8668998	146	7	,	,	PUNCT
bjos-8668998	146	8	methodology	methodology	NOUN
bjos-8668998	146	9	,	,	PUNCT
bjos-8668998	146	10	data	data	NOUN
bjos-8668998	146	11	curation	curation	NOUN
bjos-8668998	146	12	,	,	PUNCT
bjos-8668998	146	13	writing	write	VERB
bjos-8668998	146	14	original	original	ADJ
bjos-8668998	146	15	draft	draft	NOUN
bjos-8668998	146	16	preparation	preparation	NOUN
bjos-8668998	146	17	,	,	PUNCT
bjos-8668998	146	18	review	review	NOUN
bjos-8668998	146	19	&	&	CCONJ
bjos-8668998	146	20	editing	editing	NOUN
bjos-8668998	146	21	.	.	PUNCT
bjos-8668998	147	1	9	9	NUM
bjos-8668998	147	2	quadras	quadra	NOUN
bjos-8668998	147	3	et	et	PROPN
bjos-8668998	147	4	al	al	PROPN
bjos-8668998	147	5	.	.	PROPN
bjos-8668998	148	1	braz	braz	PROPN
bjos-8668998	148	2	j	j	PROPN
bjos-8668998	148	3	oral	oral	PROPN
bjos-8668998	148	4	sci	sci	PROPN
bjos-8668998	148	5	.	.	PUNCT
bjos-8668998	149	1	2023;22	2023;22	NUM
bjos-8668998	149	2	:	:	PUNCT
bjos-8668998	149	3	e238998	e238998	PROPN
bjos-8668998	149	4	•	•	NUM
bjos-8668998	149	5	juliana	juliana	PROPN
bjos-8668998	149	6	lucena	lucena	PROPN
bjos-8668998	149	7	schussel	schussel	PROPN
bjos-8668998	149	8	:	:	PUNCT
bjos-8668998	149	9	supervision	supervision	NOUN
bjos-8668998	149	10	,	,	PUNCT
bjos-8668998	149	11	conceptualization	conceptualization	NOUN
bjos-8668998	149	12	,	,	PUNCT
bjos-8668998	149	13	methodology	methodology	NOUN
bjos-8668998	149	14	,	,	PUNCT
bjos-8668998	149	15	data	data	NOUN
bjos-8668998	149	16	curation	curation	NOUN
bjos-8668998	149	17	,	,	PUNCT
bjos-8668998	149	18	writing	write	VERB
bjos-8668998	149	19	review	review	NOUN
bjos-8668998	149	20	&	&	CCONJ
bjos-8668998	149	21	editing	editing	NOUN
bjos-8668998	149	22	.	.	PUNCT
bjos-8668998	150	1	all	all	DET
bjos-8668998	150	2	authors	author	NOUN
bjos-8668998	150	3	actively	actively	ADV
bjos-8668998	150	4	participated	participate	VERB
bjos-8668998	150	5	in	in	ADP
bjos-8668998	150	6	the	the	DET
bjos-8668998	150	7	manuscript	manuscript	NOUN
bjos-8668998	150	8	’s	’s	PART
bjos-8668998	150	9	findings	finding	NOUN
bjos-8668998	150	10	,	,	PUNCT
bjos-8668998	150	11	revised	revise	VERB
bjos-8668998	150	12	,	,	PUNCT
bjos-8668998	150	13	and	and	CCONJ
bjos-8668998	150	14	approved	approve	VERB
bjos-8668998	150	15	the	the	DET
bjos-8668998	150	16	final	final	ADJ
bjos-8668998	150	17	version	version	NOUN
bjos-8668998	150	18	of	of	ADP
bjos-8668998	150	19	the	the	DET
bjos-8668998	150	20	manuscript	manuscript	NOUN
bjos-8668998	150	21	.	.	PUNCT
bjos-8668998	151	1	references	reference	NOUN
bjos-8668998	151	2	1	1	NUM
bjos-8668998	151	3	.	.	PUNCT
bjos-8668998	152	1	cavalcanti	cavalcanti	PROPN
bjos-8668998	152	2	lg	lg	PROPN
bjos-8668998	152	3	,	,	PUNCT
bjos-8668998	152	4	araújo	araújo	PROPN
bjos-8668998	152	5	rlf	rlf	PROPN
bjos-8668998	152	6	,	,	PUNCT
bjos-8668998	152	7	bonfim	bonfim	NOUN
bjos-8668998	152	8	c	c	NOUN
bjos-8668998	152	9	,	,	PUNCT
bjos-8668998	152	10	torres	torres	PROPN
bjos-8668998	152	11	-	-	PUNCT
bjos-8668998	152	12	pereira	pereira	PROPN
bjos-8668998	152	13	cc	cc	PROPN
bjos-8668998	152	14	.	.	PROPN
bjos-8668998	152	15	oral	oral	ADJ
bjos-8668998	152	16	manifestations	manifestation	NOUN
bjos-8668998	152	17	compatible	compatible	ADJ
bjos-8668998	152	18	with	with	ADP
bjos-8668998	152	19	chronic	chronic	ADJ
bjos-8668998	152	20	graft	graft	NOUN
bjos-8668998	152	21	-	-	PUNCT
bjos-8668998	152	22	versus	versus	ADP
bjos-8668998	152	23	-	-	PUNCT
bjos-8668998	152	24	host	host	NOUN
bjos-8668998	152	25	disease	disease	NOUN
bjos-8668998	152	26	in	in	ADP
bjos-8668998	152	27	patients	patient	NOUN
bjos-8668998	152	28	with	with	ADP
bjos-8668998	152	29	fanconi	fanconi	PROPN
bjos-8668998	152	30	anemia	anemia	NOUN
bjos-8668998	152	31	.	.	PUNCT
bjos-8668998	153	1	biol	biol	PROPN
bjos-8668998	153	2	blood	blood	NOUN
bjos-8668998	153	3	marrow	marrow	PROPN
bjos-8668998	153	4	transplant	transplant	NOUN
bjos-8668998	153	5	.	.	PUNCT
bjos-8668998	154	1	2015	2015	NUM
bjos-8668998	154	2	feb;21(2):275	feb;21(2):275	NUM
bjos-8668998	154	3	-	-	SYM
bjos-8668998	154	4	80	80	NUM
bjos-8668998	154	5	.	.	PUNCT
bjos-8668998	155	1	doi	doi	NOUN
bjos-8668998	155	2	:	:	PUNCT
bjos-8668998	155	3	10.1016	10.1016	NUM
bjos-8668998	155	4	/	/	SYM
bjos-8668998	155	5	j.bbmt.2014.10.009	j.bbmt.2014.10.009	PROPN
bjos-8668998	155	6	.	.	PROPN
bjos-8668998	156	1	2	2	NUM
bjos-8668998	156	2	.	.	NUM
bjos-8668998	156	3	mcmanigle	mcmanigle	PROPN
bjos-8668998	156	4	w	w	PROPN
bjos-8668998	156	5	,	,	PUNCT
bjos-8668998	156	6	youssef	youssef	PROPN
bjos-8668998	156	7	a	a	PROPN
bjos-8668998	156	8	,	,	PUNCT
bjos-8668998	156	9	sarantopoulos	sarantopoulos	PROPN
bjos-8668998	156	10	s.	s.	PROPN
bjos-8668998	156	11	b	b	PROPN
bjos-8668998	156	12	cells	cell	NOUN
bjos-8668998	156	13	in	in	ADP
bjos-8668998	156	14	chronic	chronic	ADJ
bjos-8668998	156	15	graft	graft	NOUN
bjos-8668998	156	16	-	-	PUNCT
bjos-8668998	156	17	versus	versus	ADP
bjos-8668998	156	18	-	-	PUNCT
bjos-8668998	156	19	host	host	NOUN
bjos-8668998	156	20	disease	disease	NOUN
bjos-8668998	156	21	.	.	PUNCT
bjos-8668998	157	1	human	human	ADJ
bjos-8668998	157	2	immunol	immunol	NOUN
bjos-8668998	157	3	.	.	PUNCT
bjos-8668998	158	1	2019	2019	NUM
bjos-8668998	158	2	jun;80(3):393	jun;80(3):393	PROPN
bjos-8668998	158	3	-	-	PUNCT
bjos-8668998	158	4	99	99	NUM
bjos-8668998	158	5	.	.	PUNCT
bjos-8668998	159	1	doi	doi	NOUN
bjos-8668998	159	2	:	:	PUNCT
bjos-8668998	159	3	10.1016	10.1016	NUM
bjos-8668998	159	4	/	/	SYM
bjos-8668998	159	5	j.humimm.2019.03.003	j.humimm.2019.03.003	PROPN
bjos-8668998	159	6	.	.	PUNCT
bjos-8668998	160	1	3	3	X
bjos-8668998	160	2	.	.	X
bjos-8668998	160	3	kuten	kuten	PROPN
bjos-8668998	160	4	-	-	PUNCT
bjos-8668998	160	5	shorrer	shorrer	NOUN
bjos-8668998	160	6	m	m	NOUN
bjos-8668998	160	7	,	,	PUNCT
bjos-8668998	160	8	woo	woo	VERB
bjos-8668998	160	9	sb	sb	PROPN
bjos-8668998	160	10	,	,	PUNCT
bjos-8668998	160	11	treister	treister	NOUN
bjos-8668998	160	12	ns	ns	ADJ
bjos-8668998	160	13	.	.	PROPN
bjos-8668998	160	14	oral	oral	ADJ
bjos-8668998	160	15	graft	graft	NOUN
bjos-8668998	160	16	-	-	PUNCT
bjos-8668998	160	17	versus	versus	ADP
bjos-8668998	160	18	-	-	PUNCT
bjos-8668998	160	19	host	host	NOUN
bjos-8668998	160	20	disease	disease	NOUN
bjos-8668998	160	21	.	.	PUNCT
bjos-8668998	161	1	dent	dent	PROPN
bjos-8668998	161	2	clin	clin	PROPN
bjos-8668998	161	3	north	north	PROPN
bjos-8668998	161	4	am	am	PROPN
bjos-8668998	161	5	.	.	PUNCT
bjos-8668998	162	1	2014	2014	NUM
bjos-8668998	162	2	apr;58(2):351	apr;58(2):351	NOUN
bjos-8668998	162	3	-	-	SYM
bjos-8668998	162	4	68	68	NUM
bjos-8668998	162	5	.	.	PUNCT
bjos-8668998	163	1	doi	doi	NOUN
bjos-8668998	163	2	:	:	PUNCT
bjos-8668998	163	3	10.1016	10.1016	NUM
bjos-8668998	163	4	/	/	SYM
bjos-8668998	163	5	j.cden.2013.12.007	j.cden.2013.12.007	PROPN
bjos-8668998	163	6	.	.	PUNCT
bjos-8668998	164	1	4	4	X
bjos-8668998	164	2	.	.	X
bjos-8668998	164	3	armitage	armitage	PROPN
bjos-8668998	164	4	jo	jo	PROPN
bjos-8668998	164	5	.	.	PROPN
bjos-8668998	164	6	bone	bone	PROPN
bjos-8668998	164	7	marrow	marrow	PROPN
bjos-8668998	164	8	transplantation	transplantation	NOUN
bjos-8668998	164	9	.	.	PUNCT
bjos-8668998	165	1	n	n	CCONJ
bjos-8668998	165	2	engl	engl	PROPN
bjos-8668998	165	3	j	j	PROPN
bjos-8668998	165	4	med	med	PROPN
bjos-8668998	165	5	.	.	PROPN
bjos-8668998	165	6	1994	1994	NUM
bjos-8668998	165	7	mar;330(12):827	mar;330(12):827	PROPN
bjos-8668998	165	8	-	-	PUNCT
bjos-8668998	165	9	38	38	NUM
bjos-8668998	165	10	.	.	PUNCT
bjos-8668998	166	1	doi	doi	NOUN
bjos-8668998	166	2	:	:	PUNCT
bjos-8668998	166	3	10.1056	10.1056	NUM
bjos-8668998	166	4	/	/	SYM
bjos-8668998	166	5	nejm199403243301206	nejm199403243301206	PROPN
bjos-8668998	166	6	.	.	PUNCT
bjos-8668998	167	1	5	5	NUM
bjos-8668998	167	2	.	.	X
bjos-8668998	168	1	amadori	amadori	PROPN
bjos-8668998	168	2	f	f	PROPN
bjos-8668998	168	3	,	,	PUNCT
bjos-8668998	168	4	bardellini	bardellini	PROPN
bjos-8668998	168	5	e	e	PROPN
bjos-8668998	168	6	,	,	PUNCT
bjos-8668998	168	7	conti	conti	PROPN
bjos-8668998	168	8	g	g	PROPN
bjos-8668998	168	9	,	,	PUNCT
bjos-8668998	168	10	pedrini	pedrini	PROPN
bjos-8668998	168	11	n	n	CCONJ
bjos-8668998	168	12	,	,	PUNCT
bjos-8668998	168	13	schumacher	schumacher	PROPN
bjos-8668998	168	14	rf	rf	PROPN
bjos-8668998	168	15	,	,	PUNCT
bjos-8668998	168	16	majorana	majorana	PROPN
bjos-8668998	168	17	a.	a.	NOUN
bjos-8668998	168	18	low	low	ADJ
bjos-8668998	168	19	-	-	PUNCT
bjos-8668998	168	20	level	level	NOUN
bjos-8668998	168	21	laser	laser	NOUN
bjos-8668998	168	22	therapy	therapy	NOUN
bjos-8668998	168	23	for	for	ADP
bjos-8668998	168	24	treatment	treatment	NOUN
bjos-8668998	168	25	of	of	ADP
bjos-8668998	168	26	chemotherapy	chemotherapy	NOUN
bjos-8668998	168	27	-	-	ADJ
bjos-8668998	168	28	induced	induce	VERB
bjos-8668998	168	29	oral	oral	ADJ
bjos-8668998	168	30	mucositis	mucositis	NOUN
bjos-8668998	168	31	in	in	ADP
bjos-8668998	168	32	childhood	childhood	NOUN
bjos-8668998	168	33	:	:	PUNCT
bjos-8668998	168	34	a	a	DET
bjos-8668998	168	35	randomized	randomized	ADJ
bjos-8668998	168	36	double	double	ADJ
bjos-8668998	168	37	-	-	PUNCT
bjos-8668998	168	38	blind	blind	ADJ
bjos-8668998	168	39	controlled	control	VERB
bjos-8668998	168	40	study	study	NOUN
bjos-8668998	168	41	.	.	PUNCT
bjos-8668998	168	42	 	 	SPACE
bjos-8668998	169	1	lasers	laser	NOUN
bjos-8668998	169	2	med	med	PROPN
bjos-8668998	169	3	sci	sci	PROPN
bjos-8668998	169	4	.	.	PROPN
bjos-8668998	169	5	2016	2016	NUM
bjos-8668998	169	6	aug;31(6):1231	aug;31(6):1231	PROPN
bjos-8668998	169	7	-	-	PUNCT
bjos-8668998	169	8	6	6	NUM
bjos-8668998	169	9	.	.	PUNCT
bjos-8668998	169	10	doi	doi	NOUN
bjos-8668998	169	11	:	:	PUNCT
bjos-8668998	169	12	10.1007	10.1007	NUM
bjos-8668998	169	13	/	/	SYM
bjos-8668998	169	14	s10103	s10103	NOUN
bjos-8668998	169	15	-	-	PUNCT
bjos-8668998	169	16	016	016	NUM
bjos-8668998	169	17	-	-	PUNCT
bjos-8668998	169	18	1975	1975	NUM
bjos-8668998	169	19	-	-	PUNCT
bjos-8668998	169	20	y.	y.	NOUN
bjos-8668998	169	21	6	6	NUM
bjos-8668998	169	22	.	.	PUNCT
bjos-8668998	170	1	grkovic	grkovic	PROPN
bjos-8668998	170	2	l	l	PROPN
bjos-8668998	170	3	,	,	PUNCT
bjos-8668998	170	4	baird	baird	PROPN
bjos-8668998	170	5	k	k	PROPN
bjos-8668998	170	6	,	,	PUNCT
bjos-8668998	170	7	steinberg	steinberg	PROPN
bjos-8668998	170	8	sm	sm	PROPN
bjos-8668998	170	9	,	,	PUNCT
bjos-8668998	170	10	williams	williams	PROPN
bjos-8668998	170	11	km	km	PROPN
bjos-8668998	170	12	,	,	PUNCT
bjos-8668998	170	13	pulanic	pulanic	ADJ
bjos-8668998	170	14	d	d	NOUN
bjos-8668998	170	15	,	,	PUNCT
bjos-8668998	170	16	cowen	cowen	PROPN
bjos-8668998	170	17	ew	ew	PROPN
bjos-8668998	170	18	,	,	PUNCT
bjos-8668998	170	19	et	et	PROPN
bjos-8668998	170	20	al	al	PROPN
bjos-8668998	170	21	.	.	PROPN
bjos-8668998	171	1	clinical	clinical	ADJ
bjos-8668998	171	2	laboratory	laboratory	NOUN
bjos-8668998	171	3	markers	marker	NOUN
bjos-8668998	171	4	of	of	ADP
bjos-8668998	171	5	inflammation	inflammation	NOUN
bjos-8668998	171	6	as	as	ADP
bjos-8668998	171	7	determinants	determinant	NOUN
bjos-8668998	171	8	of	of	ADP
bjos-8668998	171	9	chronic	chronic	ADJ
bjos-8668998	171	10	graft	graft	NOUN
bjos-8668998	171	11	-	-	PUNCT
bjos-8668998	171	12	versus	versus	ADP
bjos-8668998	171	13	-	-	PUNCT
bjos-8668998	171	14	host	host	NOUN
bjos-8668998	171	15	disease	disease	NOUN
bjos-8668998	171	16	activity	activity	NOUN
bjos-8668998	171	17	and	and	CCONJ
bjos-8668998	171	18	nih	nih	PROPN
bjos-8668998	171	19	global	global	PROPN
bjos-8668998	171	20	severity	severity	PROPN
bjos-8668998	171	21	.	.	PUNCT
bjos-8668998	172	1	leukemia	leukemia	NOUN
bjos-8668998	172	2	.	.	PUNCT
bjos-8668998	173	1	2012	2012	NUM
bjos-8668998	173	2	apr;26(4):633	apr;26(4):633	NOUN
bjos-8668998	173	3	-	-	SYM
bjos-8668998	173	4	43	43	NUM
bjos-8668998	173	5	.	.	PUNCT
bjos-8668998	174	1	doi	doi	NOUN
bjos-8668998	174	2	:	:	PUNCT
bjos-8668998	174	3	10.1038	10.1038	NUM
bjos-8668998	174	4	/	/	SYM
bjos-8668998	174	5	leu.2011.254	leu.2011.254	PROPN
bjos-8668998	174	6	.	.	PUNCT
bjos-8668998	175	1	7	7	X
bjos-8668998	175	2	.	.	X
bjos-8668998	175	3	albuquerque	albuquerque	PROPN
bjos-8668998	175	4	r	r	PROPN
bjos-8668998	175	5	,	,	PUNCT
bjos-8668998	175	6	khan	khan	PROPN
bjos-8668998	175	7	z	z	PROPN
bjos-8668998	175	8	,	,	PUNCT
bjos-8668998	175	9	poveda	poveda	VERB
bjos-8668998	175	10	a	a	PRON
bjos-8668998	175	11	,	,	PUNCT
bjos-8668998	175	12	higham	higham	PROPN
bjos-8668998	175	13	j	j	PROPN
bjos-8668998	175	14	,	,	PUNCT
bjos-8668998	175	15	richards	richards	PROPN
bjos-8668998	175	16	a	a	PRON
bjos-8668998	175	17	,	,	PUNCT
bjos-8668998	175	18	monteiro	monteiro	PROPN
bjos-8668998	175	19	l	l	PROPN
bjos-8668998	175	20	,	,	PUNCT
bjos-8668998	175	21	et	et	PROPN
bjos-8668998	175	22	al	al	PROPN
bjos-8668998	175	23	.	.	PUNCT
bjos-8668998	175	24	management	management	NOUN
bjos-8668998	175	25	of	of	ADP
bjos-8668998	175	26	oral	oral	ADJ
bjos-8668998	175	27	graft	graft	NOUN
bjos-8668998	175	28	versus	versus	ADP
bjos-8668998	175	29	host	host	NOUN
bjos-8668998	175	30	disease	disease	NOUN
bjos-8668998	175	31	with	with	ADP
bjos-8668998	175	32	topical	topical	ADJ
bjos-8668998	175	33	agents	agent	NOUN
bjos-8668998	175	34	:	:	PUNCT
bjos-8668998	175	35	a	a	DET
bjos-8668998	175	36	systematic	systematic	ADJ
bjos-8668998	175	37	review	review	NOUN
bjos-8668998	175	38	.	.	PUNCT
bjos-8668998	176	1	med	med	ADJ
bjos-8668998	176	2	oral	oral	ADJ
bjos-8668998	176	3	patol	patol	NOUN
bjos-8668998	176	4	oral	oral	ADJ
bjos-8668998	176	5	cir	cir	NOUN
bjos-8668998	176	6	bucal	bucal	NOUN
bjos-8668998	176	7	.	.	PUNCT
bjos-8668998	177	1	2016	2016	NUM
bjos-8668998	177	2	jan;21(1):e72	jan;21(1):e72	PROPN
bjos-8668998	177	3	-	-	SYM
bjos-8668998	177	4	81	81	NUM
bjos-8668998	177	5	.	.	PUNCT
bjos-8668998	178	1	doi	doi	NOUN
bjos-8668998	178	2	:	:	PUNCT
bjos-8668998	178	3	10.4317	10.4317	NUM
bjos-8668998	178	4	/	/	SYM
bjos-8668998	178	5	medoral.20968	medoral.20968	NOUN
bjos-8668998	178	6	.	.	NOUN
bjos-8668998	178	7	8	8	NUM
bjos-8668998	178	8	.	.	PUNCT
bjos-8668998	178	9	bassim	bassim	PROPN
bjos-8668998	178	10	cw	cw	PROPN
bjos-8668998	178	11	,	,	PUNCT
bjos-8668998	178	12	fassil	fassil	ADJ
bjos-8668998	178	13	h	h	NOUN
bjos-8668998	178	14	,	,	PUNCT
bjos-8668998	178	15	mays	mays	PROPN
bjos-8668998	178	16	jw	jw	PROPN
bjos-8668998	178	17	,	,	PUNCT
bjos-8668998	178	18	edwards	edwards	PROPN
bjos-8668998	178	19	d	d	PROPN
bjos-8668998	178	20	,	,	PUNCT
bjos-8668998	178	21	baird	baird	PROPN
bjos-8668998	178	22	k	k	PROPN
bjos-8668998	178	23	,	,	PUNCT
bjos-8668998	178	24	steinberg	steinberg	PROPN
bjos-8668998	178	25	sm	sm	PROPN
bjos-8668998	178	26	,	,	PUNCT
bjos-8668998	178	27	et	et	PROPN
bjos-8668998	178	28	al	al	PROPN
bjos-8668998	178	29	.	.	PROPN
bjos-8668998	178	30	oral	oral	ADJ
bjos-8668998	178	31	disease	disease	NOUN
bjos-8668998	178	32	profiles	profile	NOUN
bjos-8668998	178	33	in	in	ADP
bjos-8668998	178	34	chronic	chronic	ADJ
bjos-8668998	178	35	graft	graft	NOUN
bjos-8668998	178	36	versus	versus	ADP
bjos-8668998	178	37	host	host	NOUN
bjos-8668998	178	38	disease	disease	NOUN
bjos-8668998	178	39	.	.	PUNCT
bjos-8668998	179	1	j	j	PROPN
bjos-8668998	179	2	dent	dent	NOUN
bjos-8668998	179	3	res	re	NOUN
bjos-8668998	179	4	.	.	PROPN
bjos-8668998	179	5	2015	2015	NUM
bjos-8668998	179	6	apr;94(4):547	apr;94(4):547	PROPN
bjos-8668998	179	7	-	-	PUNCT
bjos-8668998	179	8	54	54	NUM
bjos-8668998	179	9	.	.	PUNCT
bjos-8668998	180	1	doi	doi	NOUN
bjos-8668998	180	2	:	:	PUNCT
bjos-8668998	180	3	10.1177/0022034515570942	10.1177/0022034515570942	NUM
bjos-8668998	180	4	.	.	NOUN
bjos-8668998	181	1	9	9	NUM
bjos-8668998	181	2	.	.	X
bjos-8668998	181	3	inamoto	inamoto	NOUN
bjos-8668998	181	4	y.	y.	NOUN
bjos-8668998	182	1	[	[	X
bjos-8668998	182	2	2018	2018	NUM
bjos-8668998	182	3	update	update	NOUN
bjos-8668998	182	4	on	on	ADP
bjos-8668998	182	5	chronic	chronic	ADJ
bjos-8668998	182	6	graft	graft	NOUN
bjos-8668998	182	7	-	-	PUNCT
bjos-8668998	182	8	versus	versus	ADP
bjos-8668998	182	9	-	-	PUNCT
bjos-8668998	182	10	host	host	NOUN
bjos-8668998	182	11	disease	disease	NOUN
bjos-8668998	182	12	]	]	PUNCT
bjos-8668998	182	13	.	.	PUNCT
bjos-8668998	183	1	rinsho	rinsho	PROPN
bjos-8668998	183	2	ketsueki	ketsueki	PROPN
bjos-8668998	183	3	.	.	PUNCT
bjos-8668998	184	1	2018;59(10):2300	2018;59(10):2300	NUM
bjos-8668998	184	2	-	-	SYM
bjos-8668998	184	3	6	6	NUM
bjos-8668998	184	4	.	.	PUNCT
bjos-8668998	185	1	japanese	japanese	PROPN
bjos-8668998	185	2	.	.	PUNCT
bjos-8668998	186	1	doi	doi	NOUN
bjos-8668998	186	2	:	:	PUNCT
bjos-8668998	186	3	10.11406	10.11406	NUM
bjos-8668998	186	4	/	/	SYM
bjos-8668998	186	5	rinketsu.59.2300	rinketsu.59.2300	NOUN
bjos-8668998	186	6	.	.	PROPN
bjos-8668998	187	1	10	10	NUM
bjos-8668998	187	2	.	.	PUNCT
bjos-8668998	188	1	fall	fall	NOUN
bjos-8668998	188	2	-	-	PUNCT
bjos-8668998	188	3	dickson	dickson	PROPN
bjos-8668998	188	4	jm	jm	PROPN
bjos-8668998	188	5	,	,	PUNCT
bjos-8668998	188	6	pavletic	pavletic	PROPN
bjos-8668998	188	7	sz	sz	PROPN
bjos-8668998	188	8	,	,	PUNCT
bjos-8668998	188	9	mays	mays	PROPN
bjos-8668998	188	10	jw	jw	PROPN
bjos-8668998	188	11	,	,	PUNCT
bjos-8668998	188	12	schubert	schubert	PROPN
bjos-8668998	188	13	mm	mm	PROPN
bjos-8668998	188	14	.	.	PUNCT
bjos-8668998	189	1	oral	oral	ADJ
bjos-8668998	189	2	complications	complication	NOUN
bjos-8668998	189	3	of	of	ADP
bjos-8668998	189	4	chronic	chronic	ADJ
bjos-8668998	189	5	graft	graft	NOUN
bjos-8668998	189	6	-	-	PUNCT
bjos-8668998	189	7	versus	versus	ADP
bjos-8668998	189	8	-	-	PUNCT
bjos-8668998	189	9	host	host	NOUN
bjos-8668998	189	10	disease	disease	NOUN
bjos-8668998	189	11	.	.	PUNCT
bjos-8668998	190	1	j	j	PROPN
bjos-8668998	190	2	natl	natl	PROPN
bjos-8668998	190	3	cancer	cancer	PROPN
bjos-8668998	190	4	inst	inst	PROPN
bjos-8668998	190	5	monogr	monogr	PROPN
bjos-8668998	190	6	.	.	PUNCT
bjos-8668998	191	1	2019	2019	NUM
bjos-8668998	191	2	aug;2019(53):lgz007	aug;2019(53):lgz007	PROPN
bjos-8668998	191	3	.	.	PUNCT
bjos-8668998	192	1	doi	doi	NOUN
bjos-8668998	192	2	:	:	PUNCT
bjos-8668998	192	3	10.1093	10.1093	NUM
bjos-8668998	192	4	/	/	SYM
bjos-8668998	192	5	jncimonographs	jncimonograph	NOUN
bjos-8668998	192	6	/	/	SYM
bjos-8668998	192	7	lgz007	lgz007	VERB
bjos-8668998	192	8	.	.	PUNCT
bjos-8668998	193	1	11	11	NUM
bjos-8668998	193	2	.	.	PUNCT
bjos-8668998	194	1	zahorec	zahorec	PROPN
bjos-8668998	194	2	r.	r.	PROPN
bjos-8668998	194	3	ratio	ratio	PROPN
bjos-8668998	194	4	of	of	ADP
bjos-8668998	194	5	neutrophil	neutrophil	NOUN
bjos-8668998	194	6	to	to	ADP
bjos-8668998	194	7	lymphocyte	lymphocyte	ADJ
bjos-8668998	194	8	counts	count	NOUN
bjos-8668998	194	9	--	--	PUNCT
bjos-8668998	194	10	rapid	rapid	ADJ
bjos-8668998	194	11	and	and	CCONJ
bjos-8668998	194	12	simple	simple	ADJ
bjos-8668998	194	13	parameter	parameter	NOUN
bjos-8668998	194	14	of	of	ADP
bjos-8668998	194	15	systemic	systemic	ADJ
bjos-8668998	194	16	inflammation	inflammation	NOUN
bjos-8668998	194	17	and	and	CCONJ
bjos-8668998	194	18	stress	stress	NOUN
bjos-8668998	194	19	in	in	ADP
bjos-8668998	194	20	critically	critically	ADV
bjos-8668998	194	21	ill	ill	ADJ
bjos-8668998	194	22	.	.	PUNCT
bjos-8668998	195	1	bratisl	bratisl	PROPN
bjos-8668998	195	2	lek	lek	PROPN
bjos-8668998	195	3	listy	listy	PROPN
bjos-8668998	195	4	.	.	PUNCT
bjos-8668998	196	1	2001;102(1):5	2001;102(1):5	X
bjos-8668998	196	2	-	-	SYM
bjos-8668998	196	3	14	14	NUM
bjos-8668998	196	4	.	.	PUNCT
bjos-8668998	196	5	12	12	NUM
bjos-8668998	196	6	.	.	PUNCT
bjos-8668998	197	1	abayli	abayli	NOUN
bjos-8668998	197	2	b	b	NOUN
bjos-8668998	197	3	,	,	PUNCT
bjos-8668998	197	4	gençdal	gençdal	ADJ
bjos-8668998	197	5	g	g	NOUN
bjos-8668998	197	6	,	,	PUNCT
bjos-8668998	197	7	değirmencioğlu	değirmencioğlu	NOUN
bjos-8668998	197	8	s.	s.	PROPN
bjos-8668998	197	9	correlation	correlation	NOUN
bjos-8668998	197	10	between	between	ADP
bjos-8668998	197	11	neutrophil	neutrophil	ADJ
bjos-8668998	197	12	/	/	SYM
bjos-8668998	197	13	lymphocyte	lymphocyte	ADJ
bjos-8668998	197	14	ratio	ratio	NOUN
bjos-8668998	197	15	and	and	CCONJ
bjos-8668998	197	16	ranson	ranson	PROPN
bjos-8668998	197	17	score	score	NOUN
bjos-8668998	197	18	in	in	ADP
bjos-8668998	197	19	acute	acute	PROPN
bjos-8668998	197	20	pancreatitis	pancreatitis	PROPN
bjos-8668998	197	21	.	.	PUNCT
bjos-8668998	198	1	j	j	PROPN
bjos-8668998	198	2	clin	clin	PROPN
bjos-8668998	198	3	lab	lab	PROPN
bjos-8668998	198	4	anal	anal	PROPN
bjos-8668998	198	5	.	.	PUNCT
bjos-8668998	199	1	2018	2018	NUM
bjos-8668998	199	2	jul;32(6):e22437	jul;32(6):e22437	NOUN
bjos-8668998	199	3	.	.	PUNCT
bjos-8668998	200	1	doi	doi	NOUN
bjos-8668998	200	2	:	:	PUNCT
bjos-8668998	201	1	10.1002	10.1002	NUM
bjos-8668998	201	2	/	/	SYM
bjos-8668998	201	3	jcla.22437	jcla.22437	PROPN
bjos-8668998	201	4	.	.	NOUN
bjos-8668998	201	5	13	13	NUM
bjos-8668998	201	6	.	.	PUNCT
bjos-8668998	202	1	derin	derin	PROPN
bjos-8668998	202	2	s	s	PROPN
bjos-8668998	202	3	,	,	PUNCT
bjos-8668998	202	4	erdogan	erdogan	PROPN
bjos-8668998	202	5	s	s	PROPN
bjos-8668998	202	6	,	,	PUNCT
bjos-8668998	202	7	sahan	sahan	PROPN
bjos-8668998	202	8	m	m	PROPN
bjos-8668998	202	9	,	,	PUNCT
bjos-8668998	202	10	topal	topal	PROPN
bjos-8668998	202	11	h	h	NOUN
bjos-8668998	202	12	,	,	PUNCT
bjos-8668998	202	13	sozen	sozen	PROPN
bjos-8668998	202	14	h.	h.	PROPN
bjos-8668998	202	15	neutrophil	neutrophil	PROPN
bjos-8668998	202	16	–	–	PUNCT
bjos-8668998	202	17	lymphocyte	lymphocyte	ADJ
bjos-8668998	202	18	ratio	ratio	NOUN
bjos-8668998	202	19	in	in	ADP
bjos-8668998	202	20	patients	patient	NOUN
bjos-8668998	202	21	with	with	ADP
bjos-8668998	202	22	adenoidectomy	adenoidectomy	NOUN
bjos-8668998	202	23	.	.	PUNCT
bjos-8668998	203	1	j	j	PROPN
bjos-8668998	203	2	clin	clin	PROPN
bjos-8668998	203	3	diagn	diagn	PROPN
bjos-8668998	203	4	res	re	NOUN
bjos-8668998	203	5	.	.	PUNCT
bjos-8668998	204	1	2016	2016	NUM
bjos-8668998	204	2	mar;10(3):mc03–5	mar;10(3):mc03–5	PROPN
bjos-8668998	204	3	.	.	PUNCT
bjos-8668998	204	4	doi	doi	PROPN
bjos-8668998	204	5	:	:	PUNCT
bjos-8668998	204	6	10.7860	10.7860	NUM
bjos-8668998	204	7	/	/	SYM
bjos-8668998	204	8	jcdr/2016/16549.7360	jcdr/2016/16549.7360	PROPN
bjos-8668998	204	9	.	.	PUNCT
bjos-8668998	205	1	14	14	NUM
bjos-8668998	205	2	.	.	PUNCT
bjos-8668998	206	1	kuzucu	kuzucu	PROPN
bjos-8668998	206	2	i	i	PROPN
bjos-8668998	206	3	,	,	PUNCT
bjos-8668998	206	4	güler	güler	PROPN
bjos-8668998	206	5	i	i	PRON
bjos-8668998	206	6	,	,	PUNCT
bjos-8668998	206	7	kum	kum	PROPN
bjos-8668998	206	8	ro	ro	PROPN
bjos-8668998	206	9	,	,	PUNCT
bjos-8668998	206	10	baklaci	baklaci	NOUN
bjos-8668998	206	11	d	d	PROPN
bjos-8668998	206	12	,	,	PUNCT
bjos-8668998	206	13	özcan	özcan	PROPN
bjos-8668998	206	14	m.	m.	NOUN
bjos-8668998	206	15	increased	increase	VERB
bjos-8668998	206	16	neutrophil	neutrophil	ADJ
bjos-8668998	206	17	lymphocyte	lymphocyte	ADJ
bjos-8668998	206	18	ratio	ratio	NOUN
bjos-8668998	206	19	and	and	CCONJ
bjos-8668998	206	20	platelet	platelet	VERB
bjos-8668998	206	21	lymphocyte	lymphocyte	ADJ
bjos-8668998	206	22	ratio	ratio	NOUN
bjos-8668998	206	23	in	in	ADP
bjos-8668998	206	24	malignant	malignant	ADJ
bjos-8668998	206	25	parotid	parotid	ADJ
bjos-8668998	206	26	tumors	tumor	NOUN
bjos-8668998	206	27	.	.	PUNCT
bjos-8668998	207	1	braz	braz	PROPN
bjos-8668998	207	2	j	j	PROPN
bjos-8668998	207	3	otorhinolaryngol	otorhinolaryngol	NOUN
bjos-8668998	207	4	.	.	PUNCT
bjos-8668998	208	1	2020	2020	NUM
bjos-8668998	208	2	jan	jan	PROPN
bjos-8668998	208	3	-	-	PUNCT
bjos-8668998	208	4	feb;86(1):105	feb;86(1):105	NOUN
bjos-8668998	208	5	-	-	PUNCT
bjos-8668998	208	6	10	10	NUM
bjos-8668998	208	7	.	.	PUNCT
bjos-8668998	209	1	doi	doi	NOUN
bjos-8668998	209	2	:	:	PUNCT
bjos-8668998	209	3	10.1016	10.1016	NUM
bjos-8668998	209	4	/	/	SYM
bjos-8668998	209	5	j.bjorl.2019.02.009	j.bjorl.2019.02.009	NOUN
bjos-8668998	209	6	.	.	PROPN
bjos-8668998	209	7	15	15	NUM
bjos-8668998	209	8	.	.	PUNCT
bjos-8668998	210	1	stefaniuk	stefaniuk	NOUN
bjos-8668998	210	2	p	p	NOUN
bjos-8668998	210	3	,	,	PUNCT
bjos-8668998	210	4	szymczyk	szymczyk	VERB
bjos-8668998	210	5	a	a	PRON
bjos-8668998	210	6	,	,	PUNCT
bjos-8668998	210	7	podhorecka	podhorecka	NOUN
bjos-8668998	210	8	m.	m.	NOUN
bjos-8668998	210	9	the	the	DET
bjos-8668998	210	10	neutrophil	neutrophil	NOUN
bjos-8668998	210	11	to	to	PART
bjos-8668998	210	12	lymphocyte	lymphocyte	VERB
bjos-8668998	210	13	and	and	CCONJ
bjos-8668998	210	14	lymphocyte	lymphocyte	ADJ
bjos-8668998	210	15	to	to	ADP
bjos-8668998	210	16	monocyte	monocyte	NOUN
bjos-8668998	210	17	ratios	ratio	NOUN
bjos-8668998	210	18	as	as	ADP
bjos-8668998	210	19	new	new	ADJ
bjos-8668998	210	20	prognostic	prognostic	ADJ
bjos-8668998	210	21	factors	factor	NOUN
bjos-8668998	210	22	in	in	ADP
bjos-8668998	210	23	hematological	hematological	ADJ
bjos-8668998	210	24	malignancies	malignancy	NOUN
bjos-8668998	210	25	–	–	PUNCT
bjos-8668998	210	26	a	a	DET
bjos-8668998	210	27	narrative	narrative	NOUN
bjos-8668998	210	28	review	review	NOUN
bjos-8668998	210	29	.	.	PUNCT
bjos-8668998	211	1	cancer	cancer	NOUN
bjos-8668998	211	2	manag	manag	PROPN
bjos-8668998	211	3	res	re	NOUN
bjos-8668998	211	4	.	.	PROPN
bjos-8668998	211	5	2020	2020	NUM
bjos-8668998	211	6	apr;12:2961	apr;12:2961	NOUN
bjos-8668998	211	7	-	-	PUNCT
bjos-8668998	211	8	77	77	NUM
bjos-8668998	211	9	.	.	PUNCT
bjos-8668998	212	1	doi	doi	NOUN
bjos-8668998	212	2	:	:	PUNCT
bjos-8668998	212	3	10.2147	10.2147	NUM
bjos-8668998	212	4	/	/	SYM
bjos-8668998	212	5	cmar.s245928	cmar.s245928	X
bjos-8668998	212	6	.	.	PUNCT
bjos-8668998	213	1	10	10	NUM
bjos-8668998	213	2	quadras	quadra	NOUN
bjos-8668998	213	3	et	et	PROPN
bjos-8668998	213	4	al	al	PROPN
bjos-8668998	213	5	.	.	PROPN
bjos-8668998	214	1	braz	braz	PROPN
bjos-8668998	215	1	j	j	PROPN
bjos-8668998	215	2	oral	oral	PROPN
bjos-8668998	215	3	sci	sci	PROPN
bjos-8668998	215	4	.	.	PUNCT
bjos-8668998	216	1	2023;22	2023;22	NUM
bjos-8668998	216	2	:	:	PUNCT
bjos-8668998	216	3	e238998	e238998	PROPN
bjos-8668998	216	4	16	16	NUM
bjos-8668998	216	5	.	.	PUNCT
bjos-8668998	217	1	solmaz	solmaz	PROPN
bjos-8668998	217	2	medeni	medeni	PROPN
bjos-8668998	217	3	s	s	PART
bjos-8668998	217	4	,	,	PUNCT
bjos-8668998	217	5	acar	acar	VERB
bjos-8668998	217	6	c	c	NOUN
bjos-8668998	217	7	,	,	PUNCT
bjos-8668998	217	8	olgun	olgun	NOUN
bjos-8668998	217	9	a	a	PRON
bjos-8668998	217	10	,	,	PUNCT
bjos-8668998	217	11	acar	acar	VERB
bjos-8668998	217	12	a	a	PRON
bjos-8668998	217	13	,	,	PUNCT
bjos-8668998	217	14	seyhanlı	seyhanlı	NOUN
bjos-8668998	217	15	a	a	NOUN
bjos-8668998	217	16	,	,	PUNCT
bjos-8668998	217	17	taskıran	taskıran	NOUN
bjos-8668998	217	18	e	e	NOUN
bjos-8668998	217	19	,	,	PUNCT
bjos-8668998	217	20	et	et	PROPN
bjos-8668998	217	21	al	al	PROPN
bjos-8668998	217	22	.	.	PROPN
bjos-8668998	218	1	can	can	AUX
bjos-8668998	218	2	neutrophil	neutrophil	ADJ
bjos-8668998	218	3	-	-	PUNCT
bjos-8668998	218	4	tolymphocyte	tolymphocyte	NOUN
bjos-8668998	218	5	ratio	ratio	NOUN
bjos-8668998	218	6	,	,	PUNCT
bjos-8668998	218	7	monocyte	monocyte	NOUN
bjos-8668998	218	8	-	-	PUNCT
bjos-8668998	218	9	to	to	ADP
bjos-8668998	218	10	-	-	PUNCT
bjos-8668998	218	11	lymphocyte	lymphocyte	NOUN
bjos-8668998	218	12	ratio	ratio	NOUN
bjos-8668998	218	13	,	,	PUNCT
bjos-8668998	218	14	and	and	CCONJ
bjos-8668998	218	15	platelet	platelet	NOUN
bjos-8668998	218	16	-	-	PUNCT
bjos-8668998	218	17	to	to	ADP
bjos-8668998	218	18	-	-	PUNCT
bjos-8668998	218	19	lymphocyte	lymphocyte	ADJ
bjos-8668998	218	20	ratio	ratio	NOUN
bjos-8668998	218	21	at	at	ADP
bjos-8668998	218	22	day	day	NOUN
bjos-8668998	218	23	+100	+100	NUM
bjos-8668998	218	24	be	be	AUX
bjos-8668998	218	25	used	use	VERB
bjos-8668998	218	26	as	as	ADP
bjos-8668998	218	27	a	a	DET
bjos-8668998	218	28	prognostic	prognostic	ADJ
bjos-8668998	218	29	marker	marker	NOUN
bjos-8668998	218	30	in	in	ADP
bjos-8668998	218	31	multiple	multiple	ADJ
bjos-8668998	218	32	myeloma	myeloma	NOUN
bjos-8668998	218	33	patients	patient	NOUN
bjos-8668998	218	34	with	with	ADP
bjos-8668998	218	35	autologous	autologous	ADJ
bjos-8668998	218	36	transplantation	transplantation	NOUN
bjos-8668998	218	37	?	?	PUNCT
bjos-8668998	219	1	clin	clin	PROPN
bjos-8668998	219	2	transplant	transplant	NOUN
bjos-8668998	219	3	.	.	PUNCT
bjos-8668998	220	1	2018	2018	NUM
bjos-8668998	220	2	sep;32(9):e13359	sep;32(9):e13359	X
bjos-8668998	220	3	.	.	PUNCT
bjos-8668998	221	1	doi	doi	NOUN
bjos-8668998	221	2	:	:	PUNCT
bjos-8668998	221	3	10.1111	10.1111	NUM
bjos-8668998	221	4	/	/	SYM
bjos-8668998	221	5	ctr.13359	ctr.13359	ADJ
bjos-8668998	221	6	.	.	PUNCT
bjos-8668998	222	1	17	17	NUM
bjos-8668998	222	2	.	.	PUNCT
bjos-8668998	223	1	shi	shi	PROPN
bjos-8668998	223	2	g	g	PROPN
bjos-8668998	223	3	,	,	PUNCT
bjos-8668998	223	4	zhao	zhao	PROPN
bjos-8668998	223	5	jw	jw	PROPN
bjos-8668998	223	6	,	,	PUNCT
bjos-8668998	223	7	ming	ming	PROPN
bjos-8668998	223	8	l.	l.	PROPN
bjos-8668998	224	1	[	[	X
bjos-8668998	224	2	clinical	clinical	ADJ
bjos-8668998	224	3	significance	significance	NOUN
bjos-8668998	224	4	of	of	ADP
bjos-8668998	224	5	peripheral	peripheral	ADJ
bjos-8668998	224	6	blood	blood	NOUN
bjos-8668998	224	7	neutrophil	neutrophil	ADJ
bjos-8668998	224	8	-	-	PUNCT
bjos-8668998	224	9	lymphocyte	lymphocyte	NOUN
bjos-8668998	224	10	ratio	ratio	NOUN
bjos-8668998	224	11	and	and	CCONJ
bjos-8668998	224	12	plateletlymphocyte	plateletlymphocyte	NOUN
bjos-8668998	224	13	ratio	ratio	NOUN
bjos-8668998	224	14	in	in	ADP
bjos-8668998	224	15	patients	patient	NOUN
bjos-8668998	224	16	with	with	ADP
bjos-8668998	224	17	asthma	asthma	NOUN
bjos-8668998	224	18	]	]	PUNCT
bjos-8668998	224	19	.	.	PUNCT
bjos-8668998	225	1	nan	nan	PROPN
bjos-8668998	225	2	fang	fang	PROPN
bjos-8668998	225	3	yi	yi	PROPN
bjos-8668998	225	4	ke	ke	PROPN
bjos-8668998	225	5	da	da	PROPN
bjos-8668998	225	6	xue	xue	PROPN
bjos-8668998	225	7	bao	bao	PROPN
bjos-8668998	225	8	.	.	PROPN
bjos-8668998	226	1	2017	2017	NUM
bjos-8668998	226	2	jan;37(1):84	jan;37(1):84	NOUN
bjos-8668998	226	3	-	-	SYM
bjos-8668998	226	4	8	8	NUM
bjos-8668998	226	5	.	.	PUNCT
bjos-8668998	227	1	chinese	chinese	PROPN
bjos-8668998	227	2	.	.	PUNCT
bjos-8668998	228	1	doi	doi	NOUN
bjos-8668998	228	2	:	:	PUNCT
bjos-8668998	228	3	10.3969	10.3969	NUM
bjos-8668998	228	4	/	/	SYM
bjos-8668998	228	5	j.issn.1673	j.issn.1673	PROPN
bjos-8668998	228	6	-	-	PUNCT
bjos-8668998	228	7	4254.2017.01.15	4254.2017.01.15	PROPN
bjos-8668998	228	8	.	.	PUNCT
bjos-8668998	229	1	18	18	NUM
bjos-8668998	229	2	.	.	PUNCT
bjos-8668998	230	1	zhang	zhang	PROPN
bjos-8668998	230	2	b	b	PROPN
bjos-8668998	230	3	,	,	PUNCT
bjos-8668998	230	4	du	du	PROPN
bjos-8668998	230	5	w	w	PROPN
bjos-8668998	230	6	,	,	PUNCT
bjos-8668998	230	7	gan	gan	PROPN
bjos-8668998	230	8	k	k	PROPN
bjos-8668998	230	9	,	,	PUNCT
bjos-8668998	230	10	fang	fang	PROPN
bjos-8668998	230	11	q	q	X
bjos-8668998	230	12	,	,	PUNCT
bjos-8668998	230	13	zhan	zhan	PROPN
bjos-8668998	230	14	x.	x.	NOUN
bjos-8668998	230	15	significance	significance	NOUN
bjos-8668998	230	16	of	of	ADP
bjos-8668998	230	17	the	the	DET
bjos-8668998	230	18	neutrophil	neutrophil	NOUN
bjos-8668998	230	19	-	-	PUNCT
bjos-8668998	230	20	to	to	ADP
bjos-8668998	230	21	-	-	PUNCT
bjos-8668998	230	22	lymphocyte	lymphocyte	ADJ
bjos-8668998	230	23	ratio	ratio	NOUN
bjos-8668998	230	24	in	in	ADP
bjos-8668998	230	25	young	young	ADJ
bjos-8668998	230	26	patients	patient	NOUN
bjos-8668998	230	27	with	with	ADP
bjos-8668998	230	28	oral	oral	ADJ
bjos-8668998	230	29	squamous	squamous	ADJ
bjos-8668998	230	30	cell	cell	NOUN
bjos-8668998	230	31	carcinoma	carcinoma	NOUN
bjos-8668998	230	32	.	.	PUNCT
bjos-8668998	231	1	cancer	cancer	NOUN
bjos-8668998	231	2	manag	manag	PROPN
bjos-8668998	231	3	res	re	NOUN
bjos-8668998	231	4	.	.	PROPN
bjos-8668998	232	1	2019	2019	NUM
bjos-8668998	232	2	aug;11:7597	aug;11:7597	NOUN
bjos-8668998	232	3	-	-	PUNCT
bjos-8668998	232	4	603	603	NUM
bjos-8668998	232	5	.	.	PUNCT
bjos-8668998	233	1	doi	doi	NOUN
bjos-8668998	233	2	:	:	PUNCT
bjos-8668998	233	3	10.2147	10.2147	NUM
bjos-8668998	233	4	/	/	SYM
bjos-8668998	233	5	cmar.s211847	cmar.s211847	NOUN
bjos-8668998	233	6	.	.	PROPN
bjos-8668998	234	1	19	19	NUM
bjos-8668998	234	2	.	.	PUNCT
bjos-8668998	234	3	asahina	asahina	PROPN
bjos-8668998	234	4	a	a	PROPN
bjos-8668998	234	5	,	,	PUNCT
bjos-8668998	234	6	kubo	kubo	PROPN
bjos-8668998	234	7	n	n	CCONJ
bjos-8668998	234	8	,	,	PUNCT
bjos-8668998	234	9	umezawa	umezawa	PROPN
bjos-8668998	234	10	y	y	PROPN
bjos-8668998	234	11	,	,	PUNCT
bjos-8668998	234	12	honda	honda	NOUN
bjos-8668998	234	13	h	h	PROPN
bjos-8668998	234	14	,	,	PUNCT
bjos-8668998	234	15	yanaba	yanaba	PROPN
bjos-8668998	234	16	k	k	PROPN
bjos-8668998	234	17	,	,	PUNCT
bjos-8668998	234	18	nakagawa	nakagawa	PROPN
bjos-8668998	234	19	h.	h.	PROPN
bjos-8668998	234	20	neutrophil	neutrophil	PROPN
bjos-8668998	234	21	-	-	PUNCT
bjos-8668998	234	22	lymphocyte	lymphocyte	NOUN
bjos-8668998	234	23	ratio	ratio	NOUN
bjos-8668998	234	24	,	,	PUNCT
bjos-8668998	234	25	platelet	platelet	ADJ
bjos-8668998	234	26	-	-	PUNCT
bjos-8668998	234	27	lymphocyte	lymphocyte	NOUN
bjos-8668998	234	28	ratio	ratio	NOUN
bjos-8668998	234	29	and	and	CCONJ
bjos-8668998	234	30	mean	mean	VERB
bjos-8668998	234	31	platelet	platelet	NOUN
bjos-8668998	234	32	volume	volume	NOUN
bjos-8668998	234	33	in	in	ADP
bjos-8668998	234	34	japanese	japanese	ADJ
bjos-8668998	234	35	patients	patient	NOUN
bjos-8668998	234	36	with	with	ADP
bjos-8668998	234	37	psoriasis	psoriasis	NOUN
bjos-8668998	234	38	and	and	CCONJ
bjos-8668998	234	39	psoriatic	psoriatic	ADJ
bjos-8668998	234	40	arthritis	arthritis	NOUN
bjos-8668998	234	41	:	:	PUNCT
bjos-8668998	234	42	response	response	NOUN
bjos-8668998	234	43	to	to	ADP
bjos-8668998	234	44	therapy	therapy	NOUN
bjos-8668998	234	45	with	with	ADP
bjos-8668998	234	46	biologics	biologic	NOUN
bjos-8668998	234	47	.	.	PUNCT
bjos-8668998	235	1	j	j	PROPN
bjos-8668998	235	2	dermatol	dermatol	NOUN
bjos-8668998	235	3	.	.	PUNCT
bjos-8668998	236	1	2017	2017	NUM
bjos-8668998	236	2	oct;44(10):1112	oct;44(10):1112	X
bjos-8668998	236	3	-	-	SYM
bjos-8668998	236	4	21	21	NUM
bjos-8668998	236	5	.	.	PUNCT
bjos-8668998	237	1	doi	doi	NOUN
bjos-8668998	237	2	:	:	PUNCT
bjos-8668998	237	3	10.1111/1346	10.1111/1346	NUM
bjos-8668998	237	4	-	-	SYM
bjos-8668998	237	5	8138.13875	8138.13875	NUM
bjos-8668998	237	6	.	.	PUNCT
bjos-8668998	238	1	20	20	NUM
bjos-8668998	238	2	.	.	PUNCT
bjos-8668998	238	3	erre	erre	PROPN
bjos-8668998	238	4	gl	gl	PROPN
bjos-8668998	238	5	,	,	PUNCT
bjos-8668998	238	6	paliogiannis	paliogiannis	PROPN
bjos-8668998	238	7	p	p	NOUN
bjos-8668998	238	8	,	,	PUNCT
bjos-8668998	238	9	castagna	castagna	PROPN
bjos-8668998	238	10	f	f	PROPN
bjos-8668998	238	11	,	,	PUNCT
bjos-8668998	238	12	mangoni	mangoni	PROPN
bjos-8668998	238	13	aa	aa	PROPN
bjos-8668998	238	14	,	,	PUNCT
bjos-8668998	238	15	carru	carru	VERB
bjos-8668998	238	16	c	c	NOUN
bjos-8668998	238	17	,	,	PUNCT
bjos-8668998	238	18	passiu	passiu	VERB
bjos-8668998	238	19	g	g	PROPN
bjos-8668998	238	20	,	,	PUNCT
bjos-8668998	238	21	et	et	PROPN
bjos-8668998	238	22	al	al	PROPN
bjos-8668998	238	23	.	.	PUNCT
bjos-8668998	239	1	meta	meta	VERB
bjos-8668998	239	2	-	-	PUNCT
bjos-8668998	239	3	analysis	analysis	NOUN
bjos-8668998	239	4	of	of	ADP
bjos-8668998	239	5	neutrophilto	neutrophilto	NOUN
bjos-8668998	239	6	-	-	PUNCT
bjos-8668998	239	7	lymphocyte	lymphocyte	ADJ
bjos-8668998	239	8	and	and	CCONJ
bjos-8668998	239	9	platelet	platelet	NOUN
bjos-8668998	239	10	-	-	PUNCT
bjos-8668998	239	11	to	to	ADP
bjos-8668998	239	12	-	-	PUNCT
bjos-8668998	239	13	lymphocyte	lymphocyte	ADJ
bjos-8668998	239	14	ratio	ratio	NOUN
bjos-8668998	239	15	in	in	ADP
bjos-8668998	239	16	rheumatoid	rheumatoid	NOUN
bjos-8668998	239	17	arthritis	arthritis	NOUN
bjos-8668998	239	18	.	.	PUNCT
bjos-8668998	240	1	eur	eur	PROPN
bjos-8668998	240	2	j	j	PROPN
bjos-8668998	240	3	clin	clin	PROPN
bjos-8668998	240	4	invest	invest	PROPN
bjos-8668998	240	5	.	.	PUNCT
bjos-8668998	241	1	2019	2019	NUM
bjos-8668998	241	2	jan;49(1):e13037	jan;49(1):e13037	NOUN
bjos-8668998	241	3	.	.	PUNCT
bjos-8668998	242	1	doi	doi	NOUN
bjos-8668998	242	2	:	:	PUNCT
bjos-8668998	242	3	10.1111	10.1111	NUM
bjos-8668998	242	4	/	/	SYM
bjos-8668998	242	5	eci.13037	eci.13037	NOUN
bjos-8668998	242	6	.	.	PUNCT
bjos-8668998	243	1	21	21	NUM
bjos-8668998	243	2	.	.	PUNCT
bjos-8668998	243	3	rifaioglu	rifaioglu	PROPN
bjos-8668998	243	4	en	en	PROPN
bjos-8668998	243	5	,	,	PUNCT
bjos-8668998	243	6	şen	şen	PROPN
bjos-8668998	243	7	bb	bb	NOUN
bjos-8668998	243	8	,	,	PUNCT
bjos-8668998	243	9	ekiz	ekiz	NOUN
bjos-8668998	243	10	ö	ö	PROPN
bjos-8668998	243	11	,	,	PUNCT
bjos-8668998	243	12	dogramaci	dogramaci	NOUN
bjos-8668998	243	13	ac	ac	PROPN
bjos-8668998	243	14	.	.	PUNCT
bjos-8668998	244	1	neutrophil	neutrophil	ADJ
bjos-8668998	244	2	to	to	ADP
bjos-8668998	244	3	lymphocyte	lymphocyte	ADJ
bjos-8668998	244	4	ratio	ratio	NOUN
bjos-8668998	244	5	in	in	ADP
bjos-8668998	244	6	behçet	behçet	PROPN
bjos-8668998	244	7	’s	’s	PART
bjos-8668998	244	8	disease	disease	NOUN
bjos-8668998	244	9	as	as	ADP
bjos-8668998	244	10	a	a	DET
bjos-8668998	244	11	marker	marker	NOUN
bjos-8668998	244	12	of	of	ADP
bjos-8668998	244	13	disease	disease	NOUN
bjos-8668998	244	14	activity	activity	NOUN
bjos-8668998	244	15	.	.	PUNCT
bjos-8668998	245	1	acta	acta	PROPN
bjos-8668998	245	2	dermatovenerol	dermatovenerol	PROPN
bjos-8668998	245	3	alp	alp	PROPN
bjos-8668998	245	4	pannonica	pannonica	PROPN
bjos-8668998	245	5	adriat	adriat	PROPN
bjos-8668998	245	6	.	.	PUNCT
bjos-8668998	246	1	2014;23(4):65	2014;23(4):65	NUM
bjos-8668998	246	2	-	-	SYM
bjos-8668998	246	3	7	7	NUM
bjos-8668998	246	4	.	.	PUNCT
bjos-8668998	246	5	doi	doi	NOUN
bjos-8668998	246	6	:	:	PUNCT
bjos-8668998	246	7	10.15570	10.15570	NUM
bjos-8668998	246	8	/	/	SYM
bjos-8668998	246	9	actaapa.2014.16	actaapa.2014.16	PROPN
bjos-8668998	246	10	.	.	PUNCT
bjos-8668998	247	1	22	22	NUM
bjos-8668998	247	2	.	.	PUNCT
bjos-8668998	248	1	yang	yang	PROPN
bjos-8668998	248	2	ap	ap	PROPN
bjos-8668998	248	3	,	,	PUNCT
bjos-8668998	248	4	liu	liu	PROPN
bjos-8668998	248	5	jp	jp	PROPN
bjos-8668998	248	6	,	,	PUNCT
bjos-8668998	248	7	tao	tao	PROPN
bjos-8668998	248	8	wq	wq	PROPN
bjos-8668998	248	9	,	,	PUNCT
bjos-8668998	248	10	li	li	PROPN
bjos-8668998	248	11	hm	hm	PROPN
bjos-8668998	248	12	.	.	PUNCT
bjos-8668998	249	1	the	the	DET
bjos-8668998	249	2	diagnostic	diagnostic	ADJ
bjos-8668998	249	3	and	and	CCONJ
bjos-8668998	249	4	predictive	predictive	ADJ
bjos-8668998	249	5	role	role	NOUN
bjos-8668998	249	6	of	of	ADP
bjos-8668998	249	7	nlr	nlr	PROPN
bjos-8668998	249	8	,	,	PUNCT
bjos-8668998	249	9	d	d	PROPN
bjos-8668998	249	10	-	-	PUNCT
bjos-8668998	249	11	nlr	nlr	NOUN
bjos-8668998	249	12	and	and	CCONJ
bjos-8668998	249	13	plr	plr	NOUN
bjos-8668998	249	14	in	in	ADP
bjos-8668998	249	15	covid19	covid19	NOUN
bjos-8668998	249	16	patients	patient	NOUN
bjos-8668998	249	17	.	.	PUNCT
bjos-8668998	250	1	int	int	NOUN
bjos-8668998	250	2	immunopharmacol	immunopharmacol	PROPN
bjos-8668998	250	3	.	.	PUNCT
bjos-8668998	251	1	2020	2020	NUM
bjos-8668998	251	2	jul;84:106504	jul;84:106504	PROPN
bjos-8668998	251	3	.	.	PUNCT
bjos-8668998	252	1	doi	doi	NOUN
bjos-8668998	252	2	:	:	PUNCT
bjos-8668998	252	3	10.1016	10.1016	NUM
bjos-8668998	252	4	/	/	SYM
bjos-8668998	252	5	j.intimp.2020.106504	j.intimp.2020.106504	PROPN
bjos-8668998	252	6	.	.	PUNCT
bjos-8668998	253	1	23	23	NUM
bjos-8668998	253	2	.	.	PUNCT
bjos-8668998	254	1	zeng	zeng	PROPN
bjos-8668998	254	2	z	z	PROPN
bjos-8668998	254	3	,	,	PUNCT
bjos-8668998	254	4	wang	wang	PROPN
bjos-8668998	254	5	c	c	PROPN
bjos-8668998	254	6	,	,	PUNCT
bjos-8668998	254	7	wang	wang	PROPN
bjos-8668998	254	8	b	b	PROPN
bjos-8668998	254	9	,	,	PUNCT
bjos-8668998	254	10	wang	wang	PROPN
bjos-8668998	254	11	n	n	PROPN
bjos-8668998	254	12	,	,	PUNCT
bjos-8668998	254	13	yang	yang	PROPN
bjos-8668998	254	14	y	y	PROPN
bjos-8668998	254	15	,	,	PUNCT
bjos-8668998	254	16	guo	guo	PROPN
bjos-8668998	254	17	s	s	PROPN
bjos-8668998	254	18	,	,	PUNCT
bjos-8668998	254	19	et	et	PROPN
bjos-8668998	254	20	al	al	PROPN
bjos-8668998	254	21	.	.	PROPN
bjos-8668998	254	22	prediction	prediction	NOUN
bjos-8668998	254	23	of	of	ADP
bjos-8668998	254	24	neutrophil	neutrophil	ADJ
bjos-8668998	254	25	-	-	PUNCT
bjos-8668998	254	26	to	to	ADP
bjos-8668998	254	27	-	-	PUNCT
bjos-8668998	254	28	lymphocyte	lymphocyte	ADJ
bjos-8668998	254	29	ratio	ratio	NOUN
bjos-8668998	254	30	in	in	ADP
bjos-8668998	254	31	the	the	DET
bjos-8668998	254	32	diagnosis	diagnosis	NOUN
bjos-8668998	254	33	and	and	CCONJ
bjos-8668998	254	34	progression	progression	NOUN
bjos-8668998	254	35	of	of	ADP
bjos-8668998	254	36	autoimmune	autoimmune	ADJ
bjos-8668998	254	37	encephalitis	encephalitis	NOUN
bjos-8668998	254	38	.	.	PUNCT
bjos-8668998	255	1	neurosci	neurosci	PROPN
bjos-8668998	255	2	lett	lett	PROPN
bjos-8668998	255	3	.	.	PROPN
bjos-8668998	256	1	2019	2019	NUM
bjos-8668998	256	2	feb	feb	NOUN
bjos-8668998	256	3	16;694:129	16;694:129	NUM
bjos-8668998	256	4	-	-	SYM
bjos-8668998	256	5	135	135	NUM
bjos-8668998	256	6	.	.	PUNCT
bjos-8668998	257	1	doi	doi	NOUN
bjos-8668998	257	2	:	:	PUNCT
bjos-8668998	257	3	10.1016	10.1016	NUM
bjos-8668998	257	4	/	/	SYM
bjos-8668998	257	5	j.neulet.2018.12.003	j.neulet.2018.12.003	PROPN
bjos-8668998	257	6	.	.	PROPN
bjos-8668998	257	7	24	24	NUM
bjos-8668998	257	8	.	.	PUNCT
bjos-8668998	257	9	elad	elad	PROPN
bjos-8668998	257	10	s.	s.	PROPN
bjos-8668998	258	1	the	the	DET
bjos-8668998	258	2	mascc	mascc	PROPN
bjos-8668998	258	3	/	/	SYM
bjos-8668998	258	4	isoo	isoo	ADJ
bjos-8668998	258	5	mucositis	mucositis	PROPN
bjos-8668998	258	6	guidelines	guideline	NOUN
bjos-8668998	258	7	2019	2019	NUM
bjos-8668998	258	8	:	:	PUNCT
bjos-8668998	258	9	the	the	DET
bjos-8668998	258	10	second	second	ADJ
bjos-8668998	258	11	set	set	NOUN
bjos-8668998	258	12	of	of	ADP
bjos-8668998	258	13	articles	article	NOUN
bjos-8668998	258	14	and	and	CCONJ
bjos-8668998	258	15	future	future	ADJ
bjos-8668998	258	16	directions	direction	NOUN
bjos-8668998	258	17	.	.	PUNCT
bjos-8668998	259	1	support	support	NOUN
bjos-8668998	259	2	care	care	NOUN
bjos-8668998	259	3	cancer	cancer	NOUN
bjos-8668998	259	4	.	.	PUNCT
bjos-8668998	260	1	2020	2020	NUM
bjos-8668998	260	2	may;28(5):2445	may;28(5):2445	NOUN
bjos-8668998	260	3	-	-	PUNCT
bjos-8668998	260	4	7	7	PROPN
bjos-8668998	260	5	.	.	PUNCT
bjos-8668998	260	6	doi	doi	NOUN
bjos-8668998	260	7	:	:	PUNCT
bjos-8668998	260	8	10.1007	10.1007	NUM
bjos-8668998	260	9	/	/	SYM
bjos-8668998	260	10	s00520	s00520	NOUN
bjos-8668998	260	11	-	-	PUNCT
bjos-8668998	260	12	019	019	NUM
bjos-8668998	260	13	-	-	PUNCT
bjos-8668998	260	14	05153	05153	NUM
bjos-8668998	260	15	-	-	PUNCT
bjos-8668998	260	16	w	w	NOUN
bjos-8668998	260	17	.	.	PUNCT
bjos-8668998	261	1	25	25	NUM
bjos-8668998	261	2	.	.	PUNCT
bjos-8668998	261	3	pavletic	pavletic	PROPN
bjos-8668998	261	4	sz	sz	PROPN
bjos-8668998	261	5	,	,	PUNCT
bjos-8668998	261	6	vogelsang	vogelsang	PROPN
bjos-8668998	261	7	gb	gb	PROPN
bjos-8668998	261	8	,	,	PUNCT
bjos-8668998	261	9	lee	lee	PROPN
bjos-8668998	261	10	sj	sj	PROPN
bjos-8668998	261	11	.	.	PROPN
bjos-8668998	261	12	2014	2014	NUM
bjos-8668998	261	13	national	national	PROPN
bjos-8668998	261	14	institutes	institutes	PROPN
bjos-8668998	261	15	of	of	ADP
bjos-8668998	261	16	health	health	PROPN
bjos-8668998	261	17	consensus	consensus	PROPN
bjos-8668998	261	18	development	development	NOUN
bjos-8668998	261	19	project	project	NOUN
bjos-8668998	261	20	on	on	ADP
bjos-8668998	261	21	criteria	criterion	NOUN
bjos-8668998	261	22	for	for	ADP
bjos-8668998	261	23	clinical	clinical	ADJ
bjos-8668998	261	24	trials	trial	NOUN
bjos-8668998	261	25	in	in	ADP
bjos-8668998	261	26	chronic	chronic	ADJ
bjos-8668998	261	27	graft	graft	NOUN
bjos-8668998	261	28	-	-	PUNCT
bjos-8668998	261	29	versus	versus	ADP
bjos-8668998	261	30	-	-	PUNCT
bjos-8668998	261	31	host	host	NOUN
bjos-8668998	261	32	disease	disease	NOUN
bjos-8668998	261	33	:	:	PUNCT
bjos-8668998	261	34	preface	preface	NOUN
bjos-8668998	261	35	to	to	ADP
bjos-8668998	261	36	the	the	DET
bjos-8668998	261	37	series	series	NOUN
bjos-8668998	261	38	.	.	PUNCT
bjos-8668998	262	1	biol	biol	PROPN
bjos-8668998	262	2	blood	blood	NOUN
bjos-8668998	262	3	marrow	marrow	PROPN
bjos-8668998	262	4	transplant	transplant	NOUN
bjos-8668998	262	5	.	.	PUNCT
bjos-8668998	263	1	2015	2015	NUM
bjos-8668998	263	2	mar;21(3):387	mar;21(3):387	PROPN
bjos-8668998	263	3	-	-	PUNCT
bjos-8668998	263	4	8	8	NUM
bjos-8668998	263	5	.	.	PUNCT
bjos-8668998	264	1	doi	doi	NOUN
bjos-8668998	264	2	:	:	PUNCT
bjos-8668998	264	3	10.1016	10.1016	NUM
bjos-8668998	264	4	/	/	SYM
bjos-8668998	264	5	j.bbmt.2014.12.035	j.bbmt.2014.12.035	NOUN
bjos-8668998	264	6	.	.	PUNCT
bjos-8668998	265	1	26	26	NUM
bjos-8668998	265	2	.	.	PUNCT
bjos-8668998	266	1	amonchaisakda	amonchaisakda	PROPN
bjos-8668998	266	2	n	n	CCONJ
bjos-8668998	266	3	,	,	PUNCT
bjos-8668998	266	4	aiempanakit	aiempanakit	NOUN
bjos-8668998	266	5	k.	k.	PROPN
bjos-8668998	266	6	clinical	clinical	PROPN
bjos-8668998	266	7	characteristics	characteristic	NOUN
bjos-8668998	266	8	,	,	PUNCT
bjos-8668998	266	9	mortality	mortality	NOUN
bjos-8668998	266	10	,	,	PUNCT
bjos-8668998	266	11	and	and	CCONJ
bjos-8668998	266	12	prognostic	prognostic	ADJ
bjos-8668998	266	13	factors	factor	NOUN
bjos-8668998	266	14	for	for	ADP
bjos-8668998	266	15	bullous	bullous	ADJ
bjos-8668998	266	16	pemphigoid	pemphigoid	NOUN
bjos-8668998	266	17	in	in	ADP
bjos-8668998	266	18	a	a	DET
bjos-8668998	266	19	thai	thai	ADJ
bjos-8668998	266	20	population	population	NOUN
bjos-8668998	266	21	.	.	PUNCT
bjos-8668998	267	1	medicine	medicine	NOUN
bjos-8668998	267	2	(	(	PUNCT
bjos-8668998	267	3	baltimore	baltimore	PROPN
bjos-8668998	267	4	)	)	PUNCT
bjos-8668998	267	5	.	.	PUNCT
bjos-8668998	268	1	2020	2020	NUM
bjos-8668998	268	2	oct;99(43):e22850	oct;99(43):e22850	NOUN
bjos-8668998	268	3	.	.	PUNCT
bjos-8668998	268	4	doi	doi	NOUN
bjos-8668998	268	5	:	:	PUNCT
bjos-8668998	268	6	10.1097	10.1097	NUM
bjos-8668998	268	7	/	/	SYM
bjos-8668998	268	8	md.0000000000022850	md.0000000000022850	NOUN
bjos-8668998	268	9	.	.	PUNCT
bjos-8668998	269	1	27	27	NUM
bjos-8668998	269	2	.	.	PUNCT
bjos-8668998	270	1	forget	forget	VERB
bjos-8668998	270	2	p	p	NOUN
bjos-8668998	270	3	,	,	PUNCT
bjos-8668998	270	4	khalifa	khalifa	PROPN
bjos-8668998	270	5	c	c	NOUN
bjos-8668998	270	6	,	,	PUNCT
bjos-8668998	270	7	defour	defour	ADJ
bjos-8668998	270	8	jp	jp	NOUN
bjos-8668998	270	9	,	,	PUNCT
bjos-8668998	270	10	latinne	latinne	PROPN
bjos-8668998	270	11	d	d	PROPN
bjos-8668998	270	12	,	,	PUNCT
bjos-8668998	270	13	pel	pel	PROPN
bjos-8668998	270	14	mcv	mcv	PROPN
bjos-8668998	270	15	,	,	PUNCT
bjos-8668998	270	16	kock	kock	PROPN
bjos-8668998	270	17	m.	m.	PROPN
bjos-8668998	270	18	what	what	PRON
bjos-8668998	270	19	is	be	AUX
bjos-8668998	270	20	the	the	DET
bjos-8668998	270	21	normal	normal	ADJ
bjos-8668998	270	22	value	value	NOUN
bjos-8668998	270	23	of	of	ADP
bjos-8668998	270	24	the	the	DET
bjos-8668998	270	25	neutrophil	neutrophil	NOUN
bjos-8668998	270	26	-	-	PUNCT
bjos-8668998	270	27	to	to	ADP
bjos-8668998	270	28	-	-	PUNCT
bjos-8668998	270	29	lymphocyte	lymphocyte	ADJ
bjos-8668998	270	30	ratio	ratio	NOUN
bjos-8668998	270	31	?	?	PUNCT
bjos-8668998	271	1	bmc	bmc	ADJ
bjos-8668998	271	2	res	re	NOUN
bjos-8668998	271	3	notes	note	NOUN
bjos-8668998	271	4	.	.	PUNCT
bjos-8668998	272	1	2017	2017	NUM
bjos-8668998	272	2	jan;10(1):12	jan;10(1):12	PROPN
bjos-8668998	272	3	.	.	PROPN
bjos-8668998	272	4	doi	doi	PROPN
bjos-8668998	272	5	:	:	PUNCT
bjos-8668998	272	6	10.1186	10.1186	NUM
bjos-8668998	272	7	/	/	SYM
bjos-8668998	272	8	s13104	s13104	NOUN
bjos-8668998	272	9	-	-	PUNCT
bjos-8668998	272	10	016	016	NUM
bjos-8668998	272	11	-	-	PUNCT
bjos-8668998	272	12	2335	2335	NUM
bjos-8668998	272	13	-	-	SYM
bjos-8668998	272	14	5	5	NUM
bjos-8668998	272	15	.	.	NOUN
bjos-8668998	272	16	28	28	NUM
bjos-8668998	272	17	.	.	PUNCT
bjos-8668998	273	1	volpato	volpato	PROPN
bjos-8668998	273	2	le	le	PROPN
bjos-8668998	273	3	,	,	PUNCT
bjos-8668998	273	4	silva	silva	PROPN
bjos-8668998	273	5	tc	tc	PROPN
bjos-8668998	273	6	,	,	PUNCT
bjos-8668998	273	7	oliveira	oliveira	PROPN
bjos-8668998	273	8	tm	tm	PROPN
bjos-8668998	273	9	,	,	PUNCT
bjos-8668998	273	10	sakai	sakai	PROPN
bjos-8668998	273	11	vt	vt	PROPN
bjos-8668998	273	12	,	,	PUNCT
bjos-8668998	273	13	machado	machado	PROPN
bjos-8668998	273	14	ma	ma	PROPN
bjos-8668998	273	15	.	.	PROPN
bjos-8668998	273	16	radiation	radiation	NOUN
bjos-8668998	273	17	therapy	therapy	NOUN
bjos-8668998	273	18	and	and	CCONJ
bjos-8668998	273	19	chemotherapy	chemotherapy	NOUN
bjos-8668998	273	20	-	-	ADJ
bjos-8668998	273	21	induced	induce	VERB
bjos-8668998	273	22	oral	oral	ADJ
bjos-8668998	273	23	mucositis	mucositis	NOUN
bjos-8668998	273	24	.	.	PUNCT
bjos-8668998	274	1	braz	braz	PROPN
bjos-8668998	274	2	j	j	PROPN
bjos-8668998	274	3	otorhinolaryngol	otorhinolaryngol	PROPN
bjos-8668998	274	4	.	.	PUNCT
bjos-8668998	275	1	2007	2007	NUM
bjos-8668998	276	1	jul	jul	PROPN
bjos-8668998	276	2	-	-	PUNCT
bjos-8668998	276	3	aug;73(4):562	aug;73(4):562	NUM
bjos-8668998	276	4	-	-	PUNCT
bjos-8668998	276	5	8	8	NUM
bjos-8668998	276	6	.	.	PUNCT
bjos-8668998	277	1	doi	doi	NOUN
bjos-8668998	277	2	:	:	PUNCT
bjos-8668998	277	3	10.1016	10.1016	NUM
bjos-8668998	277	4	/	/	SYM
bjos-8668998	277	5	s1808	s1808	NOUN
bjos-8668998	277	6	-	-	PUNCT
bjos-8668998	277	7	8694(15)30110	8694(15)30110	NUM
bjos-8668998	277	8	-	-	PUNCT
bjos-8668998	277	9	5	5	NUM
bjos-8668998	277	10	.	.	NOUN
bjos-8668998	277	11	29	29	NUM
bjos-8668998	277	12	.	.	PUNCT
bjos-8668998	278	1	carlens	carlens	PROPN
bjos-8668998	278	2	s	s	PART
bjos-8668998	278	3	,	,	PUNCT
bjos-8668998	278	4	ringdén	ringdén	NOUN
bjos-8668998	278	5	o	o	NOUN
bjos-8668998	278	6	,	,	PUNCT
bjos-8668998	278	7	remberger	remberger	NOUN
bjos-8668998	278	8	m	m	PROPN
bjos-8668998	278	9	,	,	PUNCT
bjos-8668998	278	10	lönnqvist	lönnqvist	PROPN
bjos-8668998	278	11	b	b	PROPN
bjos-8668998	278	12	,	,	PUNCT
bjos-8668998	278	13	hägglund	hägglund	ADJ
bjos-8668998	278	14	h	h	NOUN
bjos-8668998	278	15	,	,	PUNCT
bjos-8668998	278	16	klaesson	klaesson	NOUN
bjos-8668998	278	17	s	s	PROPN
bjos-8668998	278	18	,	,	PUNCT
bjos-8668998	278	19	et	et	PROPN
bjos-8668998	278	20	al	al	PROPN
bjos-8668998	278	21	.	.	PUNCT
bjos-8668998	279	1	risk	risk	NOUN
bjos-8668998	279	2	factors	factor	NOUN
bjos-8668998	279	3	for	for	ADP
bjos-8668998	279	4	chronic	chronic	ADJ
bjos-8668998	279	5	graft	graft	NOUN
bjos-8668998	279	6	-	-	PUNCT
bjos-8668998	279	7	versus	versus	ADP
bjos-8668998	279	8	-	-	PUNCT
bjos-8668998	279	9	host	host	NOUN
bjos-8668998	279	10	disease	disease	NOUN
bjos-8668998	279	11	after	after	ADP
bjos-8668998	279	12	bone	bone	NOUN
bjos-8668998	279	13	marrow	marrow	NOUN
bjos-8668998	279	14	transplantation	transplantation	NOUN
bjos-8668998	279	15	:	:	PUNCT
bjos-8668998	279	16	a	a	DET
bjos-8668998	279	17	retrospective	retrospective	ADJ
bjos-8668998	279	18	single	single	ADJ
bjos-8668998	279	19	centre	centre	NOUN
bjos-8668998	279	20	analysis	analysis	NOUN
bjos-8668998	279	21	.	.	PUNCT
bjos-8668998	280	1	bone	bone	NOUN
bjos-8668998	280	2	marrow	marrow	PROPN
bjos-8668998	280	3	transplant	transplant	NOUN
bjos-8668998	280	4	.	.	PUNCT
bjos-8668998	281	1	1998	1998	NUM
bjos-8668998	282	1	oct;22(8):755	oct;22(8):755	NOUN
bjos-8668998	282	2	-	-	SYM
bjos-8668998	282	3	61	61	NUM
bjos-8668998	282	4	.	.	PUNCT
bjos-8668998	283	1	doi	doi	NOUN
bjos-8668998	283	2	:	:	PUNCT
bjos-8668998	283	3	10.1038	10.1038	NUM
bjos-8668998	283	4	/	/	SYM
bjos-8668998	283	5	sj.bmt.1701423	sj.bmt.1701423	NOUN
bjos-8668998	283	6	.	.	PUNCT